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ABSTRACT 
Jessica Grimes: Public Health Nurse Intervention for Depression Screening During Sexually 
Transmitted Disease Risk Assessments 
(Under the direction of Jean Davison) 
 
The United States Preventive Services Task Force (2016) recommends screening 
adolescents and adults for depression. Depression screening is important during sexually 
transmitted disease (STD) risk assessments due to the association between depression and STD 
risk behavior. STD Enhanced Role Registered Nurses (ERRNs) are ideally positioned to 
incorporate depression screening into STD risk assessments. 
Purposes: 
1. Expand the STD ERRNs’ education to include an understanding of the association of 
depression with STD risk factors, be able to identify those at high risk for depression, 
and give them an evidence-based tool to screen for depression, thus enhancing the 
STD ERRNs’ comfort and self-efficacy to screen for depression to facilitate 
evidence-based practice change in the clinical setting  
2. Provide the STD ERRNs with a temporary policy addendum and depression 
screening guidelines to support them as they perform depression screens in the STD 
clinic 
Methods: A Needs Assessment Survey was given to STD ERRNs to determine knowledge and 
practice gaps. A pilot educational course was provided to one local health department (LHD). A 
temporary policy addendum was created and granted to eliminate the policy barrier. The course, 
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pretest, and posttest were sent to all remaining STD ERRNs. Two follow-up surveys were sent to 
determine depression screening goal attainment, barriers, and supportive factors.  
Results: The Needs Assessment Survey found a low percentage of STD ERRNs screened for 
depression due to time and policy barriers. Pilot LHD feedback included changes to the 
screening tool and development of an implementation timeline. The course showed an 
improvement in comfort levels with administering depression screens and reported improved 
knowledge of depression and risk for STDs. The follow-up surveys showed that the majority of 
STD ERRNs were able to meet or exceed their depression screening goals, although some STD 
ERRNs experienced a time barrier related to the referral process. 
Limitations: Limitations included the reliability/validity of the pretest and posttest test 
questions, self-report nature of the survey questions, and small sample size (Phase 1 n = 63; 
Phase 2 n = 35; Phase 3 1st follow-up n = 14, Phase 3 2nd follow-up n = 17). 
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CHAPTER ONE: INTRODUCTION 
The increase in Sexually Transmitted Diseases (STDs) is a national epidemic. Jonathan 
Mermin, the director of the Centers for Disease Control and Prevention (CDC)’s National Center 
for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, stated, “STDs are a persistent enemy, 
growing in number, and outpacing our ability to respond” (Centers for Disease Control and 
Prevention, 2017f). To reduce the risk of STDs, public health efforts typically focus on increased 
screening, early treatment, and reducing STD risk factors (such as intravenous drug use or 
unprotected sex). Depression is an additional risk factor that co-exists with other STD risks. 
Reducing the risk of STDs requires depression screening and treatment due to the close 
association between risk for STDs, risky behaviors, and depression (Jackson et al., 2015). 
Depression and STDs are closely correlated. Young adults aged 18 to 25 are 60% more 
likely to suffer from depression than adults aged 50 and over (National Alliance on Mental 
Illness, 2017). Similarly, young adults are also at the greatest risk for STDs. Young adults ages 
15 to 24 years old account for 25% of all sexually active individuals but make up 50% of the 20 
million new STD cases that occur in the United States every year (Centers for Disease Control 
and Prevention, 2017). The close relationship between depression and STDs could be mediated 
by depression’s effect on decision-making, leading to risky behaviors. Depressed people have 
difficulty making decisions, are less likely to use effective decision-making techniques, and have 
impaired intuition (National Alliance on Mental Illness, 2017; Leykin, Robers, and DeRubeis, 
2011; Remmers, Topolinski, Dietrich, & Michalak, 2015). Impaired decision-making is a 
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particular problem for adolescents, as this is a developmental time period when they are 
developing advanced reasoning skills and beginning to think abstractly (Sanders, 2013).  
 The relationship between risky behaviors, depression, and the risk of contracting STDs 
can also be described through the Syndemic Framework. Parsons, Grov, and Golub (2012) state 
that a Syndemic Framework occurs when multiple risk factors compound in a synergistic fashion 
that increases the risk of developing a disease or increases the morbidity of a disease. Syndemic 
risk factors such as psychosocial health problems like depression or substance abuse compound 
the risk for developing STDs. Therefore, STDs disproportionately affect individuals who 
experience greater psychosocial issues and multiple risk factors together. To decrease the risk of 
STDs, public health efforts must target risky behaviors as well as depression due to their close 
correlation. 
The Prevalence of STDs 
Targeting STD risk factors (including depression) is important because of the continual 
increase in STDs. In 2016, over two million cases of chlamydia, gonorrhea, and syphilis were 
reported to the CDC, the largest number of STDs ever reported (Centers for Disease Control and 
Prevention, 2017f). From 2015 to 2016, chlamydia increased by 4%, gonorrhea by 18.5%, and 
primary and secondary syphilis by 17.6% (Centers for Disease Control and Prevention, 2017b). 
There are 20 million new STDs every year and half of these STD cases are aged 15 to 24. STDs 
cost the United States an estimated $16 billion dollars annually (Centers for Disease Control and 
Prevention, 2017d). 
North Carolina has the 6th highest rate of chlamydia, 5th highest rate of gonorrhea, and 8th 
highest rate of syphilis in the nation (Centers for Disease Control and Prevention, 2017e). From 
2014 to 2016 the number of chlamydia, gonorrhea, and syphilis cases have increased every year. 
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Table 1 shows the increase in chlamydia, gonorrhea, and syphilis cases in North Carolina from 
2014-2016 (North Carolina Department of Health and Human Services, 2016; North Carolina 
Department of Health and Human Services, 2017). 
Table 1 
Number of Chlamydia, Gonorrhea, and Syphilis Cases in North Carolina  
from 2014-2016 
 2014 2015 2016 
Chlamydia 49,956 54,384 58,078 
Gonorrhea 14,970 17,049 19,724 
Syphilis 1,137 1,886 1,894 
 
Note. Information derived from the North Carolina Department of Health and Human Services, 2016; and the North 
Carolina Department of Health and Human Services, 2017. 
The increasing rate of STDs increases the risk for contracting human immunodeficiency 
virus (HIV) because of similar risk factors and immunology; individuals infected with STDs are 
two to five times more likely to acquire HIV (Centers for Disease Control and Prevention, 2010). 
HIV affects 1.1 million people in the United States; out of these 1.1 million people, 1 out of 7 are 
unaware they are infected (Centers for Disease Control and Prevention, 2017a). The lifetime risk 
for acquiring HIV in the South is higher than any other region. In North Carolina, the lifetime 
risk for acquiring HIV is 1 out of 93. The CDC reports that this disparity could be due to the fact 
that the South is behind other regions in key HIV prevention and care indicators (Centers for 
Disease Control and Prevention, 2016b). As a result, people in the South are less likely to know 
they are infected with HIV, less likely to receive HIV care within three months of diagnosis, and 
more likely to die from acquired immune deficiency syndrome (AIDS). North Carolina did not 
meet the 2015 National HIV/AIDS Strategy goals to increase the knowledge of HIV status to 
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90% (North Carolina’s rate was 87%) and reduce late-stage HIV diagnoses to 19.1% (North 
Carolina was at 24.6%) (Centers for Disease Control and Prevention, 2015). 
STD Risk Factors 
Factors that increase an individual’s risk for contracting STDs include:  
• Risky sexual practices such as unprotected sex, multiple sex partners, exchanging sex for 
drugs or money, sex with individuals who are STD-positive, or sex with partners who are 
unaware of their STD or HIV status; 
• Drug use (particularly intravenous drug use and/or sharing needles); and 
• Previous diagnosis of an STD. 
Demographics that increase an individual’s risk for contracting an STD: 
• Low socioeconomic status such as poverty, low employment rates, low education levels, 
and/or homelessness; 
• Minority race; 
• Men who have sex with men; 
• Sexually active persons aged 13 to 24 years old; and  
• Incarceration. 
(Office of Disease Prevention and Health Promotion, 2017; U.S. Department of Health and 
Human Services, 2017). 
The Prevalence of Depression 
Depression affects 7.6% of the United States population (Centers for Disease Control and 
Prevention, 2016c). The World Health Organization states that depression is the leading cause of 
disability in the world (World Health Organization, 2012). Even with the high prevalence of 
depression, many individuals with depression are not detected, preventing adequate mental 
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health treatment. Of those with severe depression, only 35% have had contact with a mental 
health professional in the past year (Centers for Disease Control and Prevention, 2014). The 
prevalence of depression creates a financial burden. In 2010, Greenberg, Fournier, Pike, & 
Kessler (2015) estimated that in the United States, depression accounts for an estimated $210.5 
billion each year in medical care costs due to suicide, loss of workplace productivity, and costs 
of comorbidities related to depression. To increase the recognition and early treatment of 
depression, the United States Preventive Services Task Force (USPSTF) recommends depression 
screening for all adolescents and adults (U.S. Preventive Services Task Force, 2016). 
Depression Screening Recommendations 
The USPSTF is an organization that reviews current evidence and makes 
recommendations to health care professionals. The USPSTF gives a Grade B recommendation to 
screen all adolescents and adults for depression, with additional screening for those at high risk 
for depression. A Grade B recommendation is a recommendation with “high certainty that the 
net benefit is moderate or there is moderate certainty that the net benefit is moderate to 
substantial” (U.S. Preventive Services Task Force, 2016). Screening should be conducted in 
settings with “adequate systems in place to ensure accurate diagnosis, effective treatment, and 
appropriate follow-up” (U.S. Preventive Services Task, 2016). Table 2 shows the USPSTF 
recommendations for adolescents and adults in further detail. 
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Table 2 
 
USPSTF Depression Screening Recommendations  
 
Note.  From the U.S. Preventative Services Task Force, 2016. 
 
 
 
 
 
 
Age group USPSTF depression screening recommendation Grade Date of 
recommendation 
Adolescents The USPSTF recommends screening for major 
depressive disorder (MDD) in adolescents 
aged 12 to 18 years. Screening should be 
implemented with adequate systems in place 
to ensure accurate diagnosis, effective 
treatment, and appropriate follow-up. 
 
B February 2016 
Adults 
 
The USPSTF recommends screening for 
depression in the general adult population, 
including pregnant and postpartum women. 
Screening should be implemented with 
adequate systems in place to ensure accurate 
diagnosis, effective treatment, and appropriate 
follow-up. 
B January 2016 
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CHAPTER TWO: REVIEW OF LITERATURE 
 This literature review establishes the connection between depression and risky behaviors 
to illustrate the importance of depression screening for populations at risk for STDs. The 
literature review was conducted from January 2017 to May 2017 using the terms “risk* 
behavior*” AND “STDs/HIV” AND “depression” using the CINAHL and PubMed databases. 
Articles were included if they discussed the risk of HIV or STDs, risky behavior such as sexual 
risk behavior or drug use, were written in English, were focused on the United States or Canada, 
were conducted within the past five years, and had subjects 11 years or older. Articles were 
excluded if they were focused outside the United States or Canada, had pediatric subjects defined 
as ten years or younger, exclusively used HIV-positive people as subjects, or studied other 
psychiatric conditions besides depression. The CINAHL database produced 109 results and 
PubMed produced 333 articles, creating a total of 442 articles. PubMed does not include a 
geographical filter so this search limit could not be applied. Seventy-eight articles remained after 
the title screen. Thirty articles remained after the abstract screen. Two additional articles 
(Jackson, Seth, DiClemente, & Lin, 2015 and Mimiaga, 2015), found through the reference list 
of the other articles, were added to the literature review. In total, the literature review included 
32 articles. Out of the 32 articles, 6 were selected for review in this paper: the six articles chosen 
had the highest quality of evidence and represented a variety of populations at risk for STDs and 
depression (Fendrich, Avci, Johnson, & Macksey-Amiti, 2012; Jackson, Seth, DiClemente, & 
Lin, 2015; Rogers, Lemstra, & Moraros, 2015; Storholm, Satre, Kapadia, Halkitis, 2016; Tross et 
al., 2015; Wilson, Stadler, Boone, Bolger, 2014). 
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Minority Stress Theory 
As this literature review will show, minorities are disproportionately affected by STDs 
and depression. For example, African Americans make up 13% of the United States population 
but account for 45% of all new STD diagnoses (Centers for Disease Control and Prevention, 
2016a). Similarly, the National Alliance on Mental Illness (2017) stated that African Americans 
were 20% more likely to suffer from serious mental health problems like suicide than the general 
population. Likewise, the lesbian gay bisexual transgender queer and questioning (LGBTQ) 
community is three times more likely to suffer from a mental illness than the general population. 
LGBTQ youth aged 10-24 are four times more likely to attempt suicide. The Minority Stress 
Theory is one way to elucidate the relationship between minorities, psychosocial health 
problems, and risky sexual behavior. The Minority Stress Theory states minorities are at an 
increased risk of psychosocial health problems, which affects risky sexual behavior. Minorities’ 
increased risk is related to stigma, unequal treatment by health care professions, and 
discrimination they receive in the health care setting (Storholm, Satre, Kakpdai, & Halkitis, 
2015). Therefore, it is important for all health care organizations, especially those that care for 
minorities, to include evidenced-based interventions that address the psychosocial needs of their 
most at-risk patients and be conscientious about any potential discrimination that could affect 
patient care. 
Substance Abuse 
Depression has long been associated with an increased risk of substance abuse disorders; 
when they occur together, they represent a dual diagnosis. Depression and substance abuse have 
a synergistic effect. A person with depression may seek out drugs or alcohol in efforts to relieve 
depression, or a person who drinks alcohol or uses other central nervous system depressants may 
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experience the sadness and hopelessness that leads to depression (DualDiagnosis.org, 2017). In 
the context of populations at risk for STDs, depression and substance abuse together increase 
risky behaviors and therefore increase the risk of contracting STDs. Jackson, Seth, DiClemente, 
and Lin (2015) performed a study among 701 African American female adolescents and found 
that depressive symptoms and substance abuse together significantly increased the likelihood of 
risky sexual behaviors over the course of two years. Adolescents who were depressed and used 
drugs were also more likely to acquire sexually transmitted diseases. Similar results are seen in 
the older-age population. Tross et al. (2015) studied drug use in 1,258 adult patients in outpatient 
substance abuse treatment programs using the Drug and Alcohol Severity Index (DAST-10). The 
purpose of the study was to compare DAST-10 scores with unprotected sex with primary and 
non-primary partners and unprotected sex when drunk or high. Results showed a statistically 
significant difference in unprotected sex with primary and non-primary partners when the 
DAST-10 score increased. With each standard deviation increase in DAST-10, unprotected sex 
while drunk or high increased by 23%. For injection drug users, unprotected sex while high 
increased by 78%.  
Given that depression is strongly associated with substance abuse, mental health 
interventions for depression could decrease sexual risk behavior (Tross et al., 2015). Reducing 
the risk of STDs requires depression screening and treatment due to the association between 
substance abuse, depression, and the risk of STDs (Jackson et al., 2015). 
Risky Sexual Behaviors 
 Risky sexual behaviors are also associated with depression. As part of the Chicago Male 
Drug Use and Health Survey, Fendrich, Avci, Johnson, & Macksey-Amiti (2012) used a sample 
cohort of 216 men who have sex with men and found that participants who had the highest level 
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of depression, as measured by the Centers for Epidemiological Studies–Depression (CES–D) 
screen, were 5.7 times more likely to engage in both receptive and insertive unprotected anal 
intercourse with a serodiscordant partner. At Columbia University, researchers Wilson, Stadler, 
Boone, and Bolger (2014) sampled STD-positive men weekly for six weeks to measure the 
number of unprotected anal intercourse episodes with a corresponding CES–D. This study found 
that the severity of depression correlated with the number of unprotected sexual encounters. 
The relationship between depression and risky behaviors expands outside of the United 
States. In Canada, Rogers, Lemstra, and Moraros (2015) completed a study examining the 
behaviors of sex trade workers, men who have sex with sex trade workers, people living with 
STDs, populations at risk for contracting STDs, and men who have sex with men. Participants 
completed the CES–D depression screening tool and a risk behaviors assessment that included 
questions about drug use and trading sex for money. Results showed that injection drug use 
significantly increased the risk of depression. In addition, 84.6% of sex trade workers were 
identified as depressed based on the CES–D screening tool. Sex trade workers who were 
depressed were more likely to have a low self-efficacy for sexual health practices such as using a 
condom with clients or other partners. Furthermore, the severity of depression correlated with a 
greater probability of sexual risk episodes.  
Risky sexual behaviors such as unprotected sex or sex for drugs or money are associated 
with depression. Due to this relationship, it is necessary to treat depression as a risk factor for 
contracting STDs and screen for it during STD risk assessments. Preventive health programs that 
aim to reduce the risk of STDs must conduct depression screenings and provide mental health 
treatment to reduce the risk of exacerbating risky sexual behavior (Fendrich et al., 2012).  
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People Living with HIV 
Depression is a risk factor not only for populations at risk for STDs but also for people 
living with HIV. People living with HIV are more likely to be depressed. In the United States, 
7.6% of adults suffer from depression compared to 20 to 30% of adults with HIV who suffer 
from depression (CDC, 2016; Bess et al., 2013). Despite this knowledge, people living with HIV 
are less likely to be screened for depression (Bess et al., 2013).  
Depressed people with HIV are less likely to be adherent to antiretroviral medications, 
increasing the risk of HIV transmission (Bess et al., 2013; Sin & DiMatteo, 2014). The odds of a 
depressed person with HIV adhering to antiretroviral medications is 83% higher if he or she is 
treated for depression (Sin & DiMatteo, 2014). People with HIV and depression have a higher 
morbidity and mortality rate than people with HIV and no depression (Adams et al., 2012). 
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CHAPTER THREE: PROBLEM STATEMENT 
Depression increases the risk of contracting STDs because depression is associated with 
risky behaviors such as drug use, sexual compulsivity, unprotected sex, sex with sex workers, 
and/or sex for drugs or money. People who suffer from depression are more likely to engage in 
these risky behaviors and are thus at a higher risk for contracting STDs than those without 
depression (Storholm, Satre, Kapadia, & Halkitis, 2014). This quality improvement project is 
consistent with the USPSTF guidelines and the evidence demonstrating the close relationship 
between depression and risky behaviors because it directs clinicians to screen all populations at 
risk for STDs for depression and to refer them to mental health services as appropriate to reduce 
their risk of contracting STDs.  
Project Setting 
This Doctor of Nursing Practice (DNP) project focuses on the STD Enhanced Role 
Registered Nurses (STD ERRNs) who work in STD clinics in local health departments (LHD) in 
North Carolina. LHDs are comprised of a variety of clinics, such as the maternal health clinic, 
family planning clinic, and STD clinic. STD clinics are an ideal setting for this project because 
they serve populations at risk for STDs and see a larger male population that is not as prevalent 
in the other clinics.  
Every LHD STD clinic has different policies, procedures, and documentation systems 
that have changed over time. Prior to 2014, mental health questions were included in the STD 
assessment. In 2014, these mental health questions were removed citing this reason (taken from 
2014 meeting minutes):  
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If the LHDs have a plan in place as to what they will do if the patient endorses [mental 
health] issues, i.e. who to refer to and if suicidal/homicidal how to assure the patient 
either goes to the ED or get police involved, then it is a good idea to assess for mental 
health issues. But without a firm plan in place, [mental health questions] could do more 
harm than good and it is definitely a liability issue if you ask a question that elicits a 
response that suggests the patient is a danger to themselves or others, but then you do 
nothing about it.  
 
The variations amongst STD clinics to include the barrier described above pose depression 
screening challenges for the STD ERRNs. One of this project’s purposes is to address this 
challenge and promote practice change.  
Project Population 
The STD ERRNs are registered nurses who have completed additional training to screen, 
assess, and treat certain STDs based on standing orders, program policies, and protocols to serve 
populations at risk for STDs and decrease communicable STD rates. Currently, the requirements 
to become a STD ERRN include the basic education and training necessary to recognize signs 
and symptoms of depression, interpret depression screenings, and/or refer to mental health 
services if needed.  
Project Purpose 
Even though the STD ERRN certification course provides the STD ERRNs with basic 
depression knowledge, they may not consistently conduct depression screens for two probable 
reasons. First, they may not have a comprehensive understanding of the association between 
depression and the risk for STDs and thus the value of depression screening in their STD clinic. 
Second, their LHD’s procedures, policies, or time constraints do not allow for easy incorporation 
of depression screens into the STD visit. To mitigate these barriers and promote practice change 
the purpose of this DNP project was to: 
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1. Expand the STD ERRNs’ education to include an understanding of the association of 
depression with STD risk factors, be able to identify those at high risk for depression, and 
give them an evidence-based tool to screen for depression, thus enhancing the STD 
ERRNs’ comfort and self-efficacy to screen for depression to facilitate evidence-based 
practice change in the clinical setting  
2. Provide the STD ERRNs with a temporary policy addendum and depression screening 
guidelines to support them as they perform depression screens in the STD clinic 
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CHAPTER FOUR: THEORETICAL FRAMEWORK 
To fulfill the project purposes, the ERRNs were given new knowledge to include 
evidence-based guidelines and had to transition this knowledge into practice. According to David 
Kolb’s theory of experiential learning, learning requires reflective practice (1984). In order for 
new knowledge to transition into practice, learners must take and reflect on the concrete 
experiences from their everyday practice and then form, conceptualize, and test a new abstract 
concept in a new situation (Kolb, 1984). STD ERRNs have concrete experience in completing 
STD risk assessments. An evidence-based educational intervention required the STD ERRNs to 
reflect on their current practice and attempt to integrate a new concept into what they already 
knew. After the education, the STD ERRNs had the opportunity to incorporate the evidence-
based education into their professional practice.   
In addition to conceptualizing and testing a new theory into practice, STD ERRNs had to 
believe and have confidence in their ability to change their practice. Albert Bandura’s (1994) 
theory of self-efficacy states that a person’s perceived self-efficacy contributes to his or her 
ability to change their performance. One way to increase self-efficacy is through social 
persuasion. Social persuasion occurs when people are encouraged to believe or are convinced 
that they have the capability to succeed. When an individual’s social persuasion increases, the 
individual is more likely to generate the personal motivation and effort to sustain a lasting 
change. The evidence-based education on depression screening was designed to persuade the 
STD ERRNs that they would have the capabilities to screen patients for depression because they 
would have the evidence-based tool and the knowledge to do so. This confidence was meant to 
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enable them to sustain the changes they made to their practice and consistently perform 
depression screens (Bandura, 1994).  
Once in practice, the STD ERRNs needed to utilize Orlando’s nursing process discipline 
theory in patient interactions. This theory describes the type and quality of an interaction 
necessary for the STD ERRNs to recognize the need to screen for depression. According to this 
theory, there are three components to each interaction between a nurse and a patient: the 
behavior of the patient, the reaction of the nurse, and the resulting nursing action to benefit the 
patient. A patient may state a chief complaint but have other unmet needs/problems that were not 
stated but must be addressed as well. It is up to the nurse to interpret these unmet needs, validate 
the needs with the patient, and take action to address the concerns (Faust, 2002). In the context of 
this DNP project, populations at risk for STDs present to STD ERRNs to receive screening for 
STDs. During the screening, STD ERRNs may identify high-risk behaviors associated with 
STDs and depression. However, patients may not explicitly state they are depressed or know that 
their risk behaviors are exacerbated by untreated depression. STD ERRNs are pivotal in this 
interaction because they have an opportunity to communicate concerns about high-risk behaviors 
for STDs or STDs associated with depression to the patient. If the concerns for depression are 
validated by the patient through a screening tool, STD ERRNs can take immediate action to 
connect the patient with mental health resources. 
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CHAPTER FIVE: PROJECT PLAN 
Project Description 
The goal of this project was to provide evidenced-based education to STD ERRNs about 
the association of depression with risky behaviors, offer an evidence-based screening tool to 
prepare STD ERRNs to screen and refer clients if necessary, and provide a temporary policy 
addendum and depression screening guidelines. In practice, STD ERRNs use a state-mandated 
Sexually Transmitted Disease Patient Assessment Form 2808 (Appendix 1) to guide patient 
visits that includes a sexual risk assessment. This sexual risk assessment does not include any 
depression screen such as the Patient Health Questionnaire-2 or PHQ-2 (Appendix 2). 
The sexual risk assessment section of the STD Form 2808 asks the patient her or his 
number of sexual partners in the past sixty days, date of their last sexual encounter, number of 
sexual encounters in the past 2 weeks, number of sexual encounters in the past two weeks 
without using a condom, sex with the same sex, sex with a bisexual male, sex for drugs or 
money, sex with an intravenous drug user, sex with an STD positive partner, use of shared 
needles, and use of alcohol or intravenous drugs. Despite the association of depression with these 
risky behaviors, the form does not include a depression screen (Appendix 1). The USPSTF 
recommends depression screening for all adolescents and adults, with adequate systems in place 
to ensure accurate diagnosis and appropriate follow-up (U.S. Preventive Services Task Force, 
2016). Thus, STD ERRNs should screen all adolescents and adults for depression using an 
evidence-based tool such as the PHQ-2, because the STD clinic patient population is at risk for 
STDs and therefore is also at risk for or may have depression. STD clinics see males more 
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frequently than the clinics providing family planning or maternal health services that typically 
conduct depression screens. If STD ERRNs conduct depression screens in the STD clinic, they 
will have a greater opportunity to screen a sub-population that is not as prevalent in the other 
LHD clinics. 
Screening Tool 
The Patient Health Questionnaire-2 (PHQ-2) and Patient Health Questionnaire-9 (PHQ-
9) are two validated depression screening tools that are designed to screen (not diagnose) patients 
for self-reported depression symptoms, have a high sensitivity and specificity, and contain the 
same depression symptomology criteria as the Diagnostic and Statistical Manual of Mental 
Disorders Fifth Edition (DSM-5) published by the American Psychiatric Association (APA) 
(Kroenke, Spitzer, & Williams, 2003; Kroenke Spitzer, & Williams, 2001; American Psychiatric 
Association, 2013). The APA is the largest psychiatric association in the world and 
internationally respected for its classification and diagnostic criteria for many psychiatric 
conditions (American Psychiatric Association, 2013). 
Patient Health Questionnaire-2 
A significant barrier to depression screening in the STD clinic is time. The Patient Health 
Questionnaire-2 is the best screening tool to use in the STD clinic because of its brevity and ease 
of use. The PHQ-2 provides an initial depression screen but does not establish a diagnosis. It 
consists of two questions that ask the patient to self-report the frequency of depressed mood and 
loss of interest (anhedonia) over the past two weeks (Appendix 2). Responses are categorized 
into “not at all” for 0 points, “several days” for 1 point, “more than half the days” for 2 points, 
and “nearly every day” for 3 points. As a result, scores can range from 0 to 6. The higher the 
score, the greater the likelihood the patient has a depressive disorder. If a patient scores 3 or 
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greater, the clinician should refer the patient to mental health resources or could also follow up 
with the PHQ-9, which serves as a more comprehensive screening tool (Kurt, Spitzer, & 
Williams, 2003). The PHQ-2 is a valid screening tool because of its high specificity and 
sensitivity. If a patient scores equal to or greater than 3, there is a sensitivity of 83% and 
specificity of 92% for Major Depressive Disorder. A high specificity in depression screens is 
very important, as false positives can create an additional burden on under-resourced mental 
health services (Kroenke, Spitzer, & Williams, 2003).  
Patient Health Questionnaire-9  
If a patient scores 3 or greater on the PHQ-2, the clinician should connect the patient with 
mental health resources and/or administer the PHQ-9 (Appendix 3). The PHQ-9 serves as a more 
detailed screening tool and has the ability to monitor depression severity and response to 
depression treatment. The form consists of nine questions asking the patient if he or she has 
experienced anhedonia, depressed mood, trouble sleeping, poor appetite, feelings of 
worthlessness, difficulty concentrating, moving slower than usual or feeling more restless than 
usual, and thoughts of self-harm or suicide over the past two weeks (Appendix 3). As mentioned 
previously, the first two symptoms, anhedonia and depressed mood, are the questions from the 
PHQ-2. The PHQ-9 adds an additional seven symptoms to its screening tool. Responses are 
scored based on the number of days a patient experiences the symptom, in the same manner as 
the PHQ-2 scores responses. In the PHQ-9, scores can range from 0 to 27. Scoring and 
instructions for use are detailed in Appendix 3. Scores less than or equal to 4 indicate minimal 
depression, scores from 5-9 indicate mild depression, 10-14 moderate depression, 15-19 
moderately severe depression, and 20-27 severe depression (Kroenke, Spitzer, & Williams, 
2011). In clinical studies, Kroenke, Spitzer, and Williams (2011) tested the PHQ-9 in the primary 
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care setting in conjunction with a mental health professional interview and concluded that scores 
greater than or equal to 10 have a sensitivity of 88% and specificity of 88%, with an internal 
reliability Cronbach’s 𝛼 score of 0.89. 
DSM-5, the PHQ-2, and the PHQ-9 
The DSM-5 lists nine symptoms that detail depression diagnostic criteria. These nine 
symptoms are the same symptoms addressed in the PHQ-9. To aid in the diagnosis of depression, 
a patient must have a mental health professional interview, have five of the nine symptoms for 
the same two-week period and one of the following two symptoms: depressed mood or 
anhedonia–the same symptoms as on the PHQ-2. Thus, if a patient screens positive on the PHQ-
2, he or she has fulfilled one of the DSM-5’s three main indicators of depression. Together, the 
PHQ-2 and PHQ-9 are widely accepted and utilized tools for the STD ERRNs to use because of 
their high specificity and sensitivity and congruence with DSM-5 guidelines (American 
Psychiatric Association, 2013).   
Plan for Depression Screening in the STD Clinic 
The LHD STD clinics are busy and may not have enough time to conduct an entire PHQ-
9 screen. To remedy this time barrier, this project recommended STD ERRNs use the PHQ-2 
only. If positive, the STD ERRN would ensure that the final PHQ-9 question, how often have 
you had “thoughts that you would be better off dead or of hurting yourself in some way” was 
asked (Kroenke et al., 2011). A positive screen on the PHQ-2, with or without suicidal ideation, 
warranted a mental health referral. If an individual endorsed suicidal ideation, the STD ERRN 
would refer the patient to emergency services. 
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Design Plan 
This project was completed in three phases: 
1. Phase One: The STD ERRNs completed a voluntary Needs Assessment Survey to 
determine the STD ERRN’s baseline knowledge, depression screening practices, and 
depression screening barriers.  
2. Phase Two: The author of this project designed and offered an evidence-based 
Continuing Nurse Education (CNE) course about depression screening to the STD 
ERRNs to address their knowledge gaps, skills gaps, and the screening barriers they 
had identified in the Needs Assessment Survey. STD ERRNs completed a pretest and 
posttest before and after the course. The educational course was first piloted to a 
small group of STD ERRNs at one LHD. This pilot course was formatted in the same 
way as the final course to evaluate the quality of the CNE course, pretest, and posttest 
questions. After the pilot was administered at one local health department, the course 
was offered across the state of NC to all STD ERRNs. 
3. Phase Three: The STD ERRNs who volunteered to participate in Phase 3 received 
two surveys spaced three weeks apart to evaluate their Specific, Measurable, 
Achievable, Realistic, and Timely (SMART) goal progress. 
Timeline 
• The proposal defense was completed on April 3, 2017.  
• The proposal was submitted to IRB and the UNC graduate school after committee 
approval. This project received exemption notification from IRB approval on May 30, 
2017 (Appendix 4).  
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• The Phase One memo to the LHD directors of nursing (DONs) and nurse supervisors 
was sent on June 11, 2017 (Appendix 5). Feedback was received by email 
immediately following (Appendix 6). 
• The Needs Assessment Survey was sent on June 19, 2017 (Appendix 7).  
• Two weeks following the dissemination of the Needs Assessment Survey, on July 3, 
2017, the results were analyzed and adjustments were made to the CNE course, as 
applicable (Appendix 8).  
• A temporary policy addendum was sent to two NC DPH branch heads for approval on 
August 29, 2017 (Appendix 9). 
• The pilot of Phase Two occurred on September 19, 2017 at one local health 
department in central North Carolina. 
• On September 25, 2017, an email was sent to all local health department DONs and 
nurse supervisors requesting support for the STD ERRNs to perform depression 
screening in the STD clinic (Appendix 10).  
• The online course was disseminated to the STD ERRNs on October 1, 2017 
(Appendix 11).  Initially, they were given from October 1, 2017 to October 16, 2017 
to take the course. This end date was later extended to October 30, 2017 to increase 
participation.  
• The STD ERRNs were allotted two weeks from October 16, 2017, to October 30, 
2017 to communicate with their DONs and nurse supervisors to determine the best 
way to proceed with implementing depression screens in their LHD.  
• The STD ERRNs began screening on October 30, 2017.  
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• The first follow-up for all LHDs, other than the pilot LHD, was on November 20, 
2017 (Appendix 12). 
• The final follow-up for all LHDs, other than the pilot LHD, was on December 11, 
2017 (Appendix 12). 
• The follow-up was extended for the pilot group, as they needed additional time; the 
first follow-up for the pilot LHD was on December 18, 2017 (Appendix 12). 
• The final follow-up for the pilot LHD was on January 8, 2017 (Appendix 12). 
Ethical Considerations and Confidentiality 
The author of this project completed the online training entitled Protecting Human 
Research Participants developed by the National Institutes of Health to ensure appropriate 
understanding and protection of the rights of human subjects. On May 30, 2017, this DNP 
project was reviewed by the University of North Carolina Office of Human Research Ethics, 
which determined that “this submission does not constitute human subjects as defined under 
federal regulations [45 CFR 46.102 (d or f) and 21 CFR 56.102(c)(e)(l)] and does not require 
Institutional Review Board (IRB) approval” (Appendix 4).   
The following paragraphs detail the protections taken to ensure the ethical conduct and 
confidentiality of all participants prior to implementation. 
 The STD ERRN participants were contacted during the Phase One Needs Assessment 
Survey, the Phase Two CNE pretest and posttest, and the Phase Three follow-up surveys. The 
ethical considerations for Phase One were separate from the considerations for Phases Two and 
Three. Phases Two and Phase Three were combined because the participants who agreed to take 
the course were the same participants who completed the follow-up surveys. 
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During the Phase One Needs Assessment Survey, STD ERRNs were sent an email link to 
take a voluntary, anonymous survey.  The email addresses were obtained from the North 
Carolina Division of Public Health (NC DPH) Public Health Nursing and Professional 
Development Unit and the Needs Assessment Survey was sent through the Public Health 
Nursing and Professional Development Unit on behalf of the DNP candidate. The first question 
stated “Thank you for voluntarily taking this survey. This is a Doctor of Nursing Practice project 
with the University of North Carolina at Chapel Hill School of Nursing. Your responses will be 
anonymous and data will be complied so that your comments and responses will not be 
associated with your email or personal identifying information”; participants were then asked to 
enter their email addresses and the county they worked in. Results of the survey were analyzed 
without associating personal identifying information.  
During Phase Two, the pretest and posttest results were secured separately from personal 
identifying information; STD ERRNs were not required to use this course as CNE but if they 
chose to do so, they followed the NC DPH Public Health Nursing and Professional Development 
Unit policy to receive the credit and obtained their CNE certificate through a link at the end of 
the posttest. If Phase Two participants wanted to be part of the follow-up survey, they 
volunteered their email for follow-up in the 2 surveys. The follow-up survey results were secured 
separately from personal identifying information.  
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CHAPTER SIX: PHASE ONE- NEEDS ASSESSMENT SURVEY 
Methods 
Memo to the Directors of Nursing and Nurse Supervisors 
A memo was sent to the NC LHD directors of nursing (DONs) and the nurse supervisors. 
The LHD DONs and nurse supervisors oversee all STD ERRNs. The memo gave these 
administrators insight into the DNP project and offered them an opportunity to ask questions and 
give or receive feedback. The memo detailing the project’s objectives and methodology was sent 
on June 11, 2017. A copy of the email and attached memo can be found in Appendix 5. 
One nurse supervisor and five DONs responded to the email. The nurse supervisor stated 
there were no STD ERRNs practicing in her STD clinic. One DON stated she was in support of 
the project but unfortunately was resigning from her current position and therefore would not be 
able to participate. The second DON stated she would forward the email and memo to her 
clinical nurse managers to assess the availability of the STD ERRNs to participate in this project. 
The third DON had questions about the project procedures, which were directed to and answered 
by Dr. Susan Little, committee member and Director of Continuing Nurse Education for the NC 
Division of Public Health. The questions concerned support from other leadership within the 
STD clinics, the depression screening recommendations and screening tools, and where the 
education would take place. Two DONs responded with support for the project, citing their 
experiences with clients presenting to the STD clinics who would have benefited from mental 
health resources. See the emails with the project questions and project support from the DONs in 
Appendix 6. The DONs’ names are removed from Appendix 6 for confidentiality.  
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Because the DONs and nurse supervisors were stakeholders and could provide needed 
support for successful implementation, their email responses were important to this project as 
they described both barriers and facilitators that could impact project implementation. The 
collective response from the LHD DONs showed that this is a needed behavioral health 
intervention that could improve the health of the STD clinic patients, but that there are policy 
barriers in regard to the current education and job requirements for the STD ERRNs. It was 
important to address these barriers in the CNE content to maximize the STD ERRNs’ likelihood 
of changing their practice.  
Needs Assessment Survey 
Following the preparation memo sent to the DONs and nurse supervisors, the STD 
ERRNs were sent an email through the Public Health Nursing and Professional Development 
Unit on behalf of the DNP candidate on 6/19/2017 offering a survey in anticipation of the CNE 
course through the Qualtrics Survey Software. The survey accepted responses for two weeks, 
closing 7/3/17. Participants were incentivized by an offer to enter a drawing to win a $50 retail 
gift card. This survey served as a needs assessment and obtained:  
• Basic demographics of the participating STD ERRNs; 
• LHD clinics’ depression screening practices; 
• The STD ERRNs’ professional depression screening practices;  
• The STD ERRNs’ baseline knowledge of the association of risky behaviors with 
depression;  
• The STD ERRNs’ baseline self-efficacy and comfort level with administering depression 
screens;  
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• Barriers to screening for depression in the STD clinic. The Needs Assessment Survey is 
found in Appendix 7. 
Results 
The results of the Needs Assessment Survey were analyzed using descriptive statistics 
based on the participants’ responses. Sixty three of 176 STD ERRNs from 45 health departments 
responded.  The map below shows the four health department regions and corresponding 
counties. The county names printed in red represent where the survey participants worked as 
STD ERRNs.  
 
Figure 1. NC Communicable Disease Branch Health Department Regions. The county names 
printed in red represent the locations of the survey participants (NC Communicable Disease 
Branch, 2017). 
 
 The Needs Assessment survey population identified multiple barriers to screening for 
depression in the STD Clinic. Question 7 in Appendix 7 asked the STD ERRNs what barriers 
existed using a “select all that apply” format. Figure 2 shows the results (n = 59). 
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Figure 2. Question 7, barriers to screening for depression in the STD clinic as reported by the 
Needs Assessment Survey participants. The two most popular responses were lack of time and 
lack of support in the STD clinic.  
 
The remaining survey responses were analyzed using cross tabulation. Groups of 
questions were set up to understand the correlation between different variables and to show how 
correlations changed from one variable grouping to another.  For this survey, cross tabs 
compared the STD ERRN’s years of experience, how often the STD ERRN screened for 
depression, the average number of patients the STD clinics saw weekly, the STD ERRN’s 
comfort level with administering depression screens, and the STD ERRN’s understanding of the 
association between the risk of STDs and depression. The cross-tabulation tables are detailed in 
Appendix 8. 
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Sixty-one survey participants responded to question 6 in Appendix 7 as follows: 11%, or 
7 out of 61, responded that they did not screen for depression at all, 38% (23/61) screened for 
depression in the women’s health and prenatal clinics but not the STD clinic, 41% (25/61) 
screened for depression if the patient presented with signs and symptoms of depression, and 10% 
(6/61) responded they screened all patients for depression. If STD ERRNs indicated that they 
“screened for depression if a patient presented with signs or symptoms of depression”, the signs 
and symptoms described in the question were as follows: apathy in regard to treatment of STDs, 
lack of social support, depressed mood, expressing feelings of hopelessness, self-care deficit, or 
changes in behavior, mood, or affect if they saw this patient on multiple occasions. 
Table 3 shows the relationship between how often the STD ERRN screens for depression 
and the STD ERRN’s years of experience.  
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Table 3 
 
ERRN Years of Experience with Depression Screening Practices  
 ERRN years of experience 
  0-1 years 1-2 years 3-4 years 
5 years or 
more Total 
I personally do not screen 
for depression. 1 (11%) 2 (20%) 1 (8%) 3 (10%) 7 (11%) 
I personally do not screen 
for depression in the STD 
clinic, but screen in 
women’s health and/or 
prenatal clinics. 3 (33%) 2 (20%) 9 (75%) 9 (30%) 23 (38%) 
I personally screen for 
depression if a patient 
presents with signs of 
depression. 2 (22%) 5 (50%) 2 (17%) 16 (53%) 25 (41%) 
I personally screen all 
patients for depression 
regardless of subjective or 
objective signs of 
depression. 3 (33%) 1 (10%) 0 (0%) 2 (7%) 6 (10%) 
Total number (n) 9 10 12 30 61 
 
Thirty-three percent of STD ERRNs with 0-1 years of experience (n = 9) screened for 
depression in other clinics but not in the STD clinic or screened all patients for depression, 22% 
(2/9) screened if a patient had signs of depression, and 11% (1/9) did not screen for depression.  
For STD ERRNs with 5 years of experience or more (n = 30), the majority screened if the patient 
presented with signs and symptoms of depression (53% or 16/30), 30% (9/30) screened outside 
the STD clinics, 10% (3/30) did not screen, and 6% (2/30) screened all patients. 
If a participant answered choice a or b to question 6 in Appendix 7 (“I personally screen 
for depression if a patient presents with signs of depression” and “I personally screen all patients 
for depression regardless of subjective or objective signs of depression”), they were asked how 
they screened for depression. Out of the STD ERRNs who screened all patients for depression 
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regardless of subjective or objective signs of depression (n = 6), 83% (5/6) used a validated 
screening tool and 17% (1/6) used their own questions– whatever questions they felt were most 
appropriate for the patient or situation. Out of the 25 STD ERRNs who screened if the patient 
presented with signs or symptoms of depression, 40% (10/25) used a validated screening tool 
and 60% (15/25) used their own questions. In total (n = 31), 48% (15/31) used a validated 
screening tool and 52% (16/31) used their own questions.  
Question 8 in Appendix 7 asked the STD ERRNs how strongly they agreed to the 
following statement: “I am comfortable and confident in my ability to screen for depression and 
refer to mental health services if needed.” Fifty-nine responded to this question; 8% stated they 
strongly agreed, 56% agreed, 24% neither agreed nor disagreed, 10% disagreed, and 2% strongly 
disagreed. Table 4 shows the reported comfort level in conjunction with the STD ERRNs’ years 
of experience. Those with 5 years of experience or more were the most likely to agree with the 
statement that they were comfortable and confident in their ability to screen for depression and 
refer to mental health services if needed (66% or 19/29).   
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Table 4  
 
ERRN Years of Experience with Comfort Level with Administering Depression Screens and 
Referring to Mental Health 
 ERRN years of experience  
“I am comfortable and 
confident in my ability to 
screen for depression and 
refer to mental health 
services if needed.” 0-1 years 1-2 years 3-4 years 
5 years 
or more Total 
Strongly disagree 0 (0%) 0 (0%) 1 (9%) 0 (0%) 1 (2%) 
Disagree 1 (11%) 1 (10%) 1 (9%) 3 (10%) 6 (10%) 
Neither agree nor disagree 2 (22%) 4 (40%) 4 (36%) 4 (14%) 14 (24%) 
Agree 5 (56%) 5 (50%) 4 (36%) 19 (66%) 33 (56%) 
Strongly agree 1 (11%) 0 (0%) 1 (9%) 3 (10%) 5 (8%) 
Total number (n) 9 10 11 29 59 
 
 Table 5 compares comfort levels with depression screening practices.  
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Table 5  
 
ERRN’s Comfort Level with Administering Depression Screens and Referring to Mental Health 
with Depression Screening Practices 
 
“I am comfortable and confident in my ability to screen for 
depression and refer to mental health services if needed.” 
Strongly 
disagree Disagree 
Neither 
agree 
nor 
disagree Agree 
Strongly 
agree 
 
 
Total 
I personally do not 
screen for depression.     0 (0%) 
3  
(50%) 
3  
(21%) 
1  
(3%) 
0  
(0%) 
7  
(12%) 
I personally do not 
screen for depression in 
the STD clinic, but 
screen in women’s 
health and/or prenatal 
clinics. 
1 
 (100%) 
1  
(17%) 
4  
(29%) 
12 
 (36%) 
3  
(60%) 
21 
 (36%) 
I personally screen for 
depression if a patient 
presents with signs of 
depression. 
0  
(0%) 
2  
(33%) 
6  
(43%) 
15 
 (45%) 
2  
(40%) 
25 
 (42%) 
I personally screen all 
patients for depression 
regardless of subjective 
or objective signs of 
depression. 
0  
(0%) 
0  
(0%) 
1  
(7%) 
5  
(15%) 
0  
(0%) 
6  
(10%) 
Total number (n) 1 6 14 33 5 59 
 
STD ERRNs had differing screening practices based on their comfort level and 
confidence with screening for depression and referring to mental health when indicated. Of the 
STD ERRNs who stated they strongly agreed with the statement “I am comfortable and 
confident in my ability to screen for depression and refer to mental health services if needed” (n 
= 6), 3/5 (60%) did not screen for depression in the STD clinic and 2/5 (40%) screened if a 
patient presented with signs and symptoms of depression. None in the “strongly agree” (0% or 
0/6) group did not screen or always screened for depression. Of the six STD ERRNs who 
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disagreed, 50% (3/6) did not screen for depression, 17% (1/6) did not screen in the STD clinic, 
33% (2/6) screened if a patient presented with signs and symptoms of depression, and no STD 
ERRNs (0/6) screened all patients. 
STD ERRN’s screening practices also varied with their knowledge about the risk for 
STDs and depression, shown in Table 6. Question 12 in Appendix 7 asked the STD ERRNs their 
agreement with the following statement: “I understand the association between populations at 
risk for STDs/HIV and depression and can apply this concept into my role as an Enhanced Role 
RN”. Fifty-eight participants responded. The majority of the participants (57% or 33/58) agreed 
with this statement. Of the STD ERRNs who strongly agreed with this statement (n = 7), none 
(0/7) replied they did not screen, 43% (3/7) screened outside the STD clinic, 43% (3/7) screened 
if the patient appeared to be depressed, and 14% (1/7) screened all patients. Of the 2 participants 
who disagreed with this statement one (50%) screened outside of the STD clinic and one (50%) 
screened if the patient presented with signs and symptoms of depression. 
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Table 6 
 
ERRN’s Understanding of the Association between STDs/HIV and Depression with Depression 
Screening Practices 
 I understand the association between populations at risk for 
STDs/HIV and depression and can apply this concept into my 
role as an Enhanced Role RN. 
Disagree Neither 
agree nor 
disagree 
Agree Strongly 
agree 
Total 
I personally do not screen 
for depression. 
 
0 (0%) 
 
3 (19%) 
 
4 (12%) 
 
0 (0%) 
 
7 (12%) 
I personally do not screen 
for depression in the STD 
clinic, but screen in 
women’s health and/or 
prenatal clinics.  1 (50%) 5 (31%) 12 (36%) 3 (43%) 21 (36%) 
I personally screen for 
depression if a patient 
presents with signs of 
depression. 1 (50%) 5 (31%) 15 (45%) 3 (43%) 24 (42%) 
I personally screen all 
patients for depression 
regardless of subjective or 
objective signs of 
depression. 0 (0%) 3 (19%) 2 (6%) 1 (14%) 6 (10%) 
Total number (n)             2 16 33 7 58 
  
Table 7 exhibits the relationship between the average numbers of patients seen per week 
in the STD clinic and the STD ERRN’s depression screening practices.  
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Table 7 
 
Average Number of Patients Seen per Week with Depression Screening Practices 
 Average number of patients seen in STD clinic per week 
 1-5 
patients 
6-10 
patients 
11-15 
patients 
16-20 
patients 
21 patients 
or more 
Total 
I personally do 
not screen for 
depression. 0 (0%) 1 (8%) 0 (0%) 1 (14%) 5 (33%) 7 (11%) 
I personally do 
not screen for 
depression in 
the STD clinic, 
but screen in 
women’s 
health and/or 
prenatal 
clinics. 9 (47%) 5 (42%) 3 (38%) 2 (29%) 4 (27%) 23 (38%) 
I personally 
screen for 
depression if a 
patient 
presents with 
signs of 
depression. 8 (42%)  (50%)  (38%)  (57%)  (27%) 5 (41%) 
I personally 
screen all 
patients for 
depression 
regardless of 
subjective or 
objective signs 
of depression. 2 (11%) 0 (0%) 2 (25%) 0 (0%) 2 (13%) 6 (10%) 
Total number 19 (31%)  12 (20%) 8 (13%) 7 (11%) 15 (25%) 61 
 
Thirty-one percent (19/61) of respondents assess an average of 1-5 STD patients per 
week, 20% (12/61) see 6-10 patients per week, 13% (8/61) see 11-15 patients per week, 11% 
(7/61) see 16-20 patients per week, and 25% (15/31) see 21 patients or more per week. Of the 
nineteen STD ERRNs who see the smallest number of patients (1 to 5 per week), 47% (9/19) do 
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not screen in the STD clinic, 42% (8/19) screen if a patient presents with signs of depression, and 
11% (2/19) screen all patients. In the busiest clinics, with 21 patients or more per week, 33% 
(5/15) responded that they do not screen for depression, 27% (4/15) do not screen in the STD 
clinic, 27% (4/15) screen if a patient presents with signs of depression, and 13% (2/15) screen all 
patients.  
 Of the 6 out of 61, or 10%, of participants that reported screening all patients for 
depression regardless of the subjective or objective signs of depression, 83% (5/6) agreed with 
the statement that they were comfortable with screening for depression and 17% (1/6) stated they 
neither agreed nor disagreed. 50% (3/6) stated they agreed with the statement that they 
understand the association of risk for STDs/HIV with depression and can apply it to practice, 
33% (2/6) neither agreed nor disagreed, and 17% (1/6) stated they strongly agreed. 
In comparison, 7 out of 61 or 11% of the participants did not screen for depression. In 
this group, 57% (4/7) neither agreed nor disagreed, 29% (2/7) disagreed, and only 14% (1/7) 
agreed with the statement that they were comfortable with screening for depression. Fifty-seven 
percent (4/7) agreed and 43% (3/7) neither agreed nor disagreed with the statement that they 
understood the association of risk for STDs/HIV and depression. 
Analysis and Discussion of Needs Assessment Survey 
 The results of the Needs Assessment Survey highlighted the STD ERRN’s practice and 
knowledge gaps, which were addressed in the development of the Phase Two CNE course. Three 
out of nine (33%) of the STD ERRNs with less than one year of experience screened all patients 
for depression and were the most likely group to screen all patients for depression compared to 2 
out of 30 (6%) STD ERRNs with five or more years of experience. This may be interpreted to 
indicate that depression screening practices decrease as the STD ERRN gains more experience.  
 
 
 
 
38 
This could be due to a few reasons. Experienced STD ERRNs are further away from their 
training, which includes some information on depression so they may not be as comfortable 
screening for depression as new STD ERRNs. They also could have a deeper understanding of 
barriers or have had bad experiences with screening for depression and referring to mental health 
resources, which could have decreased the experienced STD ERRNs’ likelihood that they would 
screen for depression.   
Only 10%, or 6 out of 61, survey respondents reported screening all patients for 
depression as part of their everyday practice. Of those who screened all patients for depression, 
50% (3/6) of STD ERRNs had 0-1 years of experience, 17% (1/6) had 1-2 years of experience, 
0% (0/6) had 3-4 years, and only 33% (2/6) had 5 years or more. Despite this, 76% (22/29) of 
STD ERRNs with 5 or more years of experience reported that they agreed or strongly agreed 
with the statement that they are comfortable and confident in their ability to screen for 
depression. This shows that despite the comfort level the experienced STD ERRNs report, there 
may be different barriers, depending on the LHD, that inhibit depression screening, such as 
policy or time limitations. The participants identified time as the top barrier and “depression 
screening is not recommended or supported in the STD clinic” as the second most common 
barrier. The NC DPH does not currently have a policy dictating how the STD ERRN should 
screen for depression. A lack of policy to support depression screening in the STD clinic could 
make the STD ERRN unsure of how to proceed in screening, documentation, and referral of 
patients who are depressed. If the STD ERRN chooses to go outside of the job duties and 
responsibilities dictated by policy, they could be liable for the consequences of their decision. An 
STD ERRN with more years of experience could be more familiar with the organizational 
structure and policy of their LHD, which may make them less likely to step outside of these 
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boundaries. STD ERRNs may also not have enough time to complete a depression screen. Even 
though the screen itself does not take a lot of time to administer and interpret, a positive screen 
would lengthen the appointment time because the STD ERRN would then need to make time to 
refer the patient to mental health resources. 
 There was a positive correlation with comfort level and STD ERRNs who always 
screened for depression. Seven percent (1/14) of STD ERRNs who neither agreed nor disagreed 
about their comfort level always screened for depression, in comparison to 15% (5/33) of STD 
ERRNs who agreed that they were comfortable screening for depression.  
There was not a strong correlation between STD ERRNs who stated they “[understood] 
the association between populations at risk for STDs/HIV and depression and [could] apply this 
concept into [their] role as an Enhanced Role RN” and STD ERRNs that screened all patients for 
depression. Of the 7 STD ERRNs who strongly agreed with this statement, only 1 out of 7, or 
14%, screened all patients for depression, and only 2 out of 33, or 6%, of STD ERRNs who 
agreed, screened all patients. Four out of thirty-three, or 12%, of STD ERRNs agreed but did not 
screen for depression. These data show that despite STD ERRNs strongly agreeing or agreeing 
with the statement that depression is associated with the risk for STDs/HIV, they were not using 
this knowledge in practice by screening all patients who presented to the STD clinic, 
demonstrating either a lack in complete understanding or difficulty applying this concept in 
practice. Also, STD ERRNs who did not have any opinion on the association of depression with 
STDs/HIV were the most likely not to screen, demonstrating that a lack of understanding can 
contribute to poor practice as well.  
 The average number of STD patients seen per week also had an effect on depression 
screening practices. The respondents who worked in the busier clinics were less likely to screen 
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for depression. Zero out of the 19 STD ERRNs that saw an average of 1-5 clients per week did 
not screen for depression, 1/12, or 8%, of STD ERRNs who worked in clinics with 6-10 clients 
did not screen, 0/8, or 0%, of STD ERRNs in clinics with 11-15 did not screen, 1/7, or 14%, of 
STD ERRNs who worked in clinics with 16-20 clients did not screen, and 5/15, or 33%, of STD 
ERRNs who worked in clinics with 21 patients or more did not screen for depression. The 
increasing likelihood that an STD patient would not be screened in busier clinics indicated that 
time was one barrier to conducting depression screens. Table 7 shows that time was not the only 
barrier. Only 2/19, or 11%, of STD ERRNs who worked in the least-busy clinic, seeing 1-5 
clients per week, reported they screened all patients for depression.  
Respondents who screened all patients were more likely to use a validated tool than 
respondents who screened based upon the presence of signs and symptoms of depression. Out of 
the STD ERRNs who screened all patients for depression regardless of subjective or objective 
signs of depression (n = 6), 83% (5/6) used a validated screening tool. Out of the 25 STD 
ERRNs who screened if the patient presented with signs or symptoms of depression, 40% 
(10/25) used a validated screening tool and 60% (15/25) used their own questions. It can be 
interpreted that an STD ERRN may be more likely to screen for depression by using a validated 
screening tool because the tool makes it easier to measure depression objectively or because the 
STD ERRN has a deeper understanding of depression, including the importance of screening 
with a validated tool.  The respondents who screened if the patient presented with signs and 
symptoms but without a validated screening tool risked missing patients suffering from 
depression because their exam was highly subjective.  
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Limitations  
 Limitations of the Needs Assessment Survey include self-report and a small sample size. 
The survey questions required the STD ERRNs to subjectively report their depression screening 
practices and estimate the average number of patients the STD ERRN saw in the STD clinic per 
week. This information could be incorrect and, if so, would decrease the validity of the survey 
results. In addition, while 63 out of 176 STD ERRNs is a positive response rate when looking at 
the survey results as a whole, the cross tabs break this sample into much smaller groups for each 
question which makes generalizations about different groups of STD ERRNs difficult.  
Conclusions 
 The Needs Assessment Survey was important to the success of this project because it 
helped to determine the learning needs that were incorporated into the course to optimize the 
likelihood that the learning and practice outcomes would be met. The course needed to address 
comfort level with depression screening and referring to mental health, the understanding of the 
association between STDs and depression, the need for an evidence-based screening tool, and 
how to address barriers such as time.  Using cross tab analysis, trends showed, first, that the STD 
ERRNs who were more comfortable screening for depression and referring to mental health 
resources were more likely to screen for depression, but less than 50% used an evidence-based 
tool. In the course, STD ERRNs were provided with a thorough review of depression and 
evidence-based screening tool. Second, the reduced translation of knowledge between the risk 
for STDs and depression to depression screening practices showed that STD ERRNs would 
benefit from a review of the close relationship and impact that depression screens can have on 
reducing the risk of STDs. Third, a lack of recommendation or support was the second most 
common barrier. A temporary policy addendum was granted and provided to the STD ERRNs to 
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support them in implementing depression screens. Finally, since time was identified as a barrier 
to screening, particularly in the busier STD clinics, the course recommended using the PHQ-2 as 
an initial depression screen, with one follow-up question should the patient screen positive (“Are 
you having thoughts you would be better off dead or of hurting yourself?”). Teaching the use and 
importance of the PHQ-2 was needed, as more than half of STD ERRNs that did screen were not 
using a validated screening tool, which could potentially make screening longer and is subject to 
bias. 
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 CHAPTER SEVEN: PHASE TWO – PILOT AND FULL  
IMPLEMENTATION OF A CONTINUING EDUCATION COURSE 
 
 In Phase Two the author of this project designed an evidence-based Continuing Nurse 
Education (CNE) course on depression screening, drafted a temporary policy addendum, piloted 
the course with STD ERRNs at one LHD in central NC, and disseminated the course to all North 
Carolina (NC DPH) STD ERRNs. 
Continuing Nurse Education Content Planning 
Course planning took place before the pilot. The course content was derived from the 
knowledge and skills gaps identified in the review of literature and the results of the Phase One 
Needs Assessment Survey (Appendix 13). The content was delivered using an online 
asynchronized training model in order to reach the target population, who work across the state. 
The knowledge and skills gaps were the foundation for the learning outcomes listed in the 
following section.  
For the course to be approved for Continuing Nurse Education (CNE) contact hours, the 
course needed to be in compliance with the American Nurses Credentialing Center (ANCC) 
Commission on Accreditation criteria. The ANCC requires that the nurse planner document the 
learning gap, supporting evidence to validate the learning gap, educational needs, target 
audience, learning outcomes, description of the education provided, learner engagement 
strategies, criteria for successful completion, evaluation method, and the method by which the 
learners will demonstrate successful CNE completion and evaluation on the Activity Planning 
Table form (Appendix 14). The NC DPH required a Conflict of Interest Form (Appendix 14) to 
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ensure that the individual administering or planning the CNE does not have a commercial or 
financial interest in the content or planning of the course.  
Learning Outcomes 
There were three learning outcomes planned for this DNP project. After completing the 
CNE training and follow up, the learners were to have increased: 
1. Their knowledge of the relationship between depression and the risk of STDs, as 
measured by a statistically significant increase in correct answers from the pretest 
at the beginning of the CNE to the posttest at the end of the CNE. 
2. Their comfort level with administering depression screens and referring to mental 
health resources as appropriate, as measured by a statistically significant increase 
in comfort levels from the CNE pretest to the CNE posttest using a 5-point Likert 
scale. 
3. Their progress on their individual SMART goal to increase depression screenings 
and refer to mental health services as needed, as measured by an improvement on 
the Goal Attainment Scale. 
Temporary Policy Addendum 
 The NC DPH’s policies support the STD ERRNs’ roles and responsibilities. On the 
Needs Assessment Survey, the STD ERRNs identified a lack of recommendation or support for 
depression screening as the second most common barrier. Without a policy, there is no 
standardized or consistent request to screen for depression. In order for this project and the STD 
ERRNs to be successful, the STD ERRNs needed a temporary policy addendum to screen for 
depression in the STD clinics. The temporary policy addendum created was designed to be 
adopted or adapted by each LHD to optimize individualization and success. The author of this 
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project, committee member Dr. Little, and the STD nurse consultant for the southern region 
drafted the temporary policy addendum and sent it to the Technical Assistance and Training 
branch head and the Communicable Disease branch head for approval (Appendix 9). The 
Technical Assistance and Training branch head approved the policy without further questions. 
The Communicable Disease branch head approved the policy with three remarks. She asked 
what data would be collected, stated she was pleased the project was voluntary, and asked to see 
the mental health resources handout.  The author of this project responded with a summary of the 
Phase Two methods and the mental health resources handout in Appendix 15. The temporary 
policy addendum was designed to be reviewed by the STD ERRNs and the STD ERRNs’ 
leadership at their LHDs and later adopted or adapted as the LHDs saw fit.  
Pilot 
Methods 
The purpose of the pilot was to evaluate the efficacy, quality, validity, and reliability of 
the course and pre/posttest prior to sending the final course and pre/posttest to all STD ERRNs. 
The pilot also provided an opportunity to receive feedback on the course and depression 
screening implementation plan. 
The pilot took place on September 19, 2017, at one LHD in central NC. In attendance 
were the five STD ERRNs from the LHD, the clinic nurse manager, the Technical Assistance 
and Training Program (TATP) STD nurse consultant representing the southern region’s health 
departments, committee member Dr. Little, and committee chair Dr. Davison. The TATP STD 
nurse consultants for the northern and eastern regions joined via conference call.  
This LHD was selected for the pilot because they were willing to participate and had the 
highest number of STD ERRNs out of all LHDs. Four out of five, or 80%, of the STD ERRNs at 
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this LHD had 5 years or more experience, and one out of five, or 20%, had 1-2 years of 
experience. STD services at this LHD were available five days a week or more. Patients were 
screened for depression in the Family Planning, Maternity, Refugee, Child Health and Teen 
clinics but not the STD clinic.  
On September 14, 2017, the five STD ERRNs were sent an email (Appendix 16) 
containing the link to the course, pretest (Appendix 17), posttest (Appendix 18), printout of the 
PHQ-2 (Appendix 19), list of mental health resources by county (Appendix 15), and a copy of 
the course slides (Appendix 13). The STD ERRNs were allotted time during their work day on 
September 15, 2017, to complete the course. 
The course disseminated to the pilot group was in the same format as the final course. 
The course content is in Appendix 13. The course was developed using PowerPoint software 
accompanied by audio and video recording. STD ERRNs were given access to the course by 
following an online link that led them to the recording. The pretest and posttest were offered 
through the Qualtrics Survey Software. 
The pretest consisted of 17 questions (Appendix 17). Questions 1-11 and questions 16-17 
derived from the Needs Assessment Survey, asked for demographic data (questions 1-6), 
depression screening practices (questions 7 and 8), barriers to screening for depression (question 
9), familiarity with mental health resources (question 10), shared risk factors between STDs/HIV 
(question 11), how well the STD ERRN understood the association between risk for STDs and 
depression (question 16), and the STD ERRN’s comfort level with depression screening 
(question 17). The additional questions (12-15) were derived from the course content.  
The pilot posttest (Appendix 18) included the same questions as the pretest, except for 
questions 5-9. Pretest questions 5-9 were not repeated in the posttest because these questions 
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asked for demographic and depression screening information that was obtained in the pretest. 
The posttest added questions 13-18. Question 13 asked the STD ERRNs to create a SMART 
goal, questions 14-16 asked questions required for all NC DPH CNE, question 17 asked the STD 
ERRNs for course feedback, and question 18 asked the STD ERRNs to enter their email 
addresses if they wanted to be a part of the voluntary follow-up surveys. 
Pretest and Posttest Results 
On pretest question 8, all five STD ERRNs stated they screened for depression if a 
patient presented with signs and symptoms of depression. Pretest question 9 asked the STD 
ERRNs what depression screening barriers existed in the STD clinic. One hundred percent of 
STD ERRNs stated time was a barrier, 2/5, or 40%, stated there were no adequate referrals to 
mental health services, and 2/5, or 40%, indicated they could not bill for depression screens in 
the STD clinic. Although 2/5, or 40%, stated that a lack of mental health resources was a barrier 
to depression screening in the STD clinic, only 2/5, or 40%, were familiar with the mental health 
resources available to their patients. 
 For the course-based knowledge questions (pretest questions 11-15 and posttest questions 
6-10), all STD ERRNs got all questions on the pretest and posttest correct except for question 15 
(posttest 10), “The PHQ-2 asks the following two questions.” Two out of five, or 40%, of STD 
ERRNs answered this question correctly on the pretest and 100% answered correctly on the 
posttest.  
 The STD ERRNs reported a greater understanding of the association between STDs and 
depression and a greater comfort level with depression screening from the pretest to the posttest. 
Pretest question 16 and posttest question 11 asked the STD ERRNs’ agreement with the 
following statement: “I understand the association between populations at risk for STDs/HIV and 
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can apply this concept in my role as an Enhanced Role RN.” The figure below shows the 
increase in STD ERRNs’ agreement from pretest to posttest (n = 5). 
 
Figure 3. Comparison between STD ERRN’s agreement from pretest question 16 to posttest 
question 11. On the pretest, 2/5 (40%) neither agreed nor disagreed, 3/5 (60%) agreed, and 
nobody strongly agreed. On the posttest, nobody neither agreed nor disagreed, 3/5 (60%) agreed, 
and 2/5 (40%) strongly agreed.  
 
Pretest question 17 and posttest question 12 asked the STD ERRNs their agreement with 
the following statement: “I am comfortable and confident in my ability to screen for depression 
and refer to mental health resources as necessary.” Figure 4 shows the increase in STD ERRNs 
who agreed and strongly agreed with this statement from pretest to posttest (n = 5). 
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Figure 4. Comparison between STD ERRN’s agreement from pretest question 17 and posttest 
question 12. On the pretest, 1/5 (20%) neither agreed nor disagreed, 4/5 (80%) agreed, and 
nobody strongly agreed. On the posttest, nobody neither agreed nor disagreed, 3/5 (60%) agreed, 
and 2/5 (40%) strongly agreed. 
 
Pilot Feedback 
The STD nurse consultants and pilot STD ERRNs provided feedback and questions about 
the target learner population, the efficacy of the course and pretest/posttest, PHQ-2 handout, 
SMART goal follow-up, and the implementation process the LHDs should take to begin 
depression screening.  
One pilot STD ERRN asked if other providers can take the course and participate in the 
follow-up because STD ERRNs are not the only providers who assess patients presenting to the 
STD clinic. It was explained that the target learner population for this DNP project were the STD 
ERRNs. The course can be viewed by any provider the LHD sees fit, however, the STD ERRNs 
are the only ones who can take the pretest, posttest, and two follow up surveys. 
All STD ERRNs stated they felt the course was valuable, relevant, and pertinent to their 
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job roles. One STD ERRN pointed out she specifically appreciated the Needs Assessment 
Survey statistics that were placed in the course because it helped to highlight the gaps between 
knowledge and practice. The STD ERRNs were in agreement that the pretest and posttest 
questions were derived from the course, appropriate in difficulty, and able to gauge mastery of 
the course content.  
The PHQ-2 handout for the pilot (Appendix 19) included the two questions from the 
PHQ-2. STD ERRNs were originally requested to ask the patient the final PHQ-9 question 
(“Have you had any thoughts that you would be better off dead or of hurting yourself in some 
way?”) if the patient got a score of three or above on the PHQ-2. After communicating with the 
pilot STD ERRNs, the PHQ-9 question was placed on the handout along with the PHQ-2 
(Appendix 20). It was discussed that having this question next to the PHQ-2 questions would 
keep all of the screening questions and results in one place and ensure that this important PHQ-9 
question was asked. For the PHQ-9 question, we decided to use a yes/no response rather than a 
score based on the number of days because we wanted to get mental health referrals for any 
patient experiencing suicidal thoughts. A yes/no response also increased simplicity, which would 
be ideal for a busy STD clinic. 
Some of the STD ERRNs reported confusion on how to evaluate their SMART goal or 
thought they had to evaluate their goal using client data. In response, questions 13 and 18 of the 
pilot posttest were modified. Question 13 of the pilot posttest read: 
Create a SMART goal to help you implement depression screens in the STD clinic. For 
example: “I will use the PHQ-2 to screen 60% of patients in the STD Clinic by one 
month.” To make sure your goal is a SMART goal, please write in how your goal is 
specific, measurable, attainable, relevant, and timely.  
 
This question was rewritten as: 
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 Create a SMART goal to help you implement depression screens in the STD clinic. For 
example: “I will use the PHQ-2 to screen 60% of patients in the STD Clinic by one 
month.” To make sure your goal is a SMART goal, please write in how your goal is 
specific, measurable, attainable, relevant, and timely. This goal does not have to be 
evaluated using actual client data. You can evaluate your goal based on your personal 
self-report or how well you think you are meeting your goal. 
 
Question 18 of the pilot posttest read: 
Please provide your email address if you are willing to be contacted via email twice over 
the next 4-8 weeks to follow up on your SMART goal progress and to answer any 
questions you may have or provide support. All participants will be entered to win a gift 
card.  
 
Question 18 was rewritten as: 
Please provide your email address if you are willing to be contacted via email twice over 
the next 4-8 weeks to follow up on your SMART goal progress and to answer any 
questions you may have or provide support. All participants will be entered to win a $50 
gift card. In the follow-up, you will be self-evaluating your progress on your goal and do 
not have to obtain real client data about how many patients you screen for depression. 
Your goal will be measured based on your subjective report of how many patients you 
believe you screened for depression.  
 
The revised and final posttest disseminated to all STD ERRNs is in Appendix 21. 
The final pilot feedback addressed the method by which LHDs should implement 
depression screening. Prior to the pilot, the plan was to ask the STD ERRNs to begin screening 
immediately after course completion. It was discussed that every LHD should be given an 
additional two weeks after course completion to develop an implementation process for their 
STD ERRNs to screen for depression. This process was important because every LHD has 
different capabilities, documentation systems, leadership, and policies that affect how their STD 
ERRNs would be able to screen. During the additional two weeks, the LHDs were asked to adopt 
or adapt the temporary policy addendum and determine the best way to document depression 
screens to meet the capabilities of their LHD. For example, the pilot LHD was able to add the 
depression screen with the STD assessment questions into their electronic documentation system 
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with relative ease. Other LHDs may have had documentation systems wherein adding a 
depression screen would be a tedious process; these LHDs may have had to document using the 
paper PHQ-2 provided (Appendix 20). A timeline was developed to allow the STD ERRNs time 
to take the course, assess how depression screens would best be implemented in their LHDs, 
develop a plan with their LHD leadership, and begin screening. This timeline was added into the 
PowerPoint presentation (slide 51) and recorded for the final course. The timeline discussed was 
as follows: 
1. October 2 to October 16: Course open 
2. October 16 to October 30: The STD ERRNs were asked to communicate with their DON 
and nurse supervisors to decide the best way to implement depression screens in their 
clinics (either through adopting or adapting the temporary policy addendum). 
3. October 30: The STD ERRNs began depression screening. 
4. November 20: The STD ERRNs were sent their first follow-up to measure their SMART 
goal progress. 
5. December 11: The STD ERRNs were sent the final follow-up to measure their SMART 
goal progress. 
The DONs and nurse supervisors were sent an email on September 25, 2017, with a 
course reminder and the new implementation timeline. This email was sent to facilitate 
conversations between leadership and STD ERRNs and to ensure leadership had adequate time 
to prepare for potential policy or process modifications (Appendix 10). Five DONs and 2 nurse 
supervisors responded to the email. Two DONs stated their LHDs were already performing 
depression screens in the STD clinics. One DON asked whether providers other than the STD 
ERRNs were expected or allowed to take the course; this question was answered as stated 
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previously. Another DON stated their sole STD ERRN could not participate due to other 
obligations. The final DON stated they had no STD ERRNs. The first nurse supervisor said she 
had an ERRN in the prenatal clinic and was informed this project targeted STD ERRNs. The last 
nurse supervisor asked how long the training would take and how many CNE hours the course 
provided. 
Analysis and Discussion of Pilot 
Other than posttest question 13 and 18, the rest of the pretest and posttest questions 
remained unchanged. The only addition to the course was the timeline that allowed for additional 
planning to foster successful implementation. As verbalized by the pilot STD ERRNs, the course 
was effective at meeting the learning objectives as evidenced by an increase in reported comfort 
level with screening for depression and reported knowledge of the association between STDs and 
depression. 
The DONs’ and nurse supervisors’ feedback demonstrated the LHDs’ variability in 
depression screening practices and staffing capabilities. This DNP project is important because it 
provides resources, support, and education to LHDs who are not routinely screening for 
depression. The feedback also confirms that time is a barrier, as indicated by the DON who 
stated their only STD ERRN had too many responsibilities and that time could not be allotted to 
take this course. 
Limitations 
This pilot was limited in its retrospective nature; STD ERRNs took the course four days 
prior to the day of the pilot, which could have caused the STD ERRNs to forget some of their 
feedback. The pilot could also have been expanded to include more than one LHD so as to 
incorporate more feedback of greater variety into the final course. Different LHDs have STD 
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ERRNs of varying demographics and years of experiences. At this pilot LHD, 80% of the STD 
ERRNs had five years or more of experience and therefore the feedback could have been in favor 
of an experienced STD ERRN.  
Finally, none of the course-based knowledge questions (pretest questions 11-15 and 
posttest questions 6-10) were modified for the final course, even though all pilot STD ERRNs 
answered pretest questions 11-14 and posttest questions 6-10 correctly. In retrospect, these 
questions should have been modified so that the course could exhibit a greater impact on any 
improved knowledge. If this course were to be used again in the future, the instructor should 
modify pretest questions 11-14/posttest questions 6-9 to see if the results would better 
demonstrate a change in knowledge as a result of the course.  The pilot STD ERRNs could have 
all answered pretest 11-14 correctly because this group of STD ERRNs screened more often and 
reported greater comfort with screening than the Needs Assessment Survey participants. In the 
pilot group, 100% screened if a patient presented with signs or symptoms of depression; in the 
Needs Assessment Survey group, 41% screened with presenting symptoms and 10% screened all 
patients. The pilot STD ERRNs also reported greater comfort with depression screening than the 
Needs Assessment Survey participants. In the pilot group, 80% agreed with the statement that 
they were comfortable with screening; in the Needs Assessment Survey group, 56% agreed and 
8% strongly agreed. Both of these statistics show that the pilot STD ERRNs were at a higher 
baseline comfort and skill level than the Needs Assessment Survey participants. While these 
factors could have played a role in the high number of correct answers, the questions still should 
have been modified.  
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Conclusions 
The pilot was critical to the success of the course because the feedback was used to 
modify the course, posttest questions 13 & 18, PHQ-2 handout, and create an implementation 
timeline that optimized the project’s opportunity for sustainability and success. In retrospect, 
knowledge pretest questions 11-14 should have been changed to make them more difficult to 
answer so as to test knowledge gain from taking the course. 
Final Course Methods 
Content 
After incorporating feedback from the pilot, the final course content included: 
• Results of the Needs Assessment Survey, to demonstrate the practice gap and need for 
this project education and practice change  
• Statistics indicating the high prevalence of STDs with an emphasis on STD disparities 
• The correlation between STDs and depression 
• Statistics indicating the high prevalence of depression 
• Depression: etiology, signs, symptoms, and management 
• Mental health terminology  
• Suicide risk factors and protective factors 
• Management of psychiatric emergencies 
• Mental health resources by county 
• USPSTF depression screening guidelines 
• How to perform depression screens using the PHQ-2 and PHQ-9 
• Guidelines for performing depression screens in the STD clinic 
• SMART goals 
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• Implementation timeline 
The PowerPoint course slides can be found in Appendix 13.  
SMART Goals 
One of the outcomes of this DNP project was to increase the ERRN’s self-efficacy and 
comfort when using depression screenings. To accomplish this outcome, the ERRNs who took 
the course were asked in posttest question 13 to set one individual SMART goal to improve the 
percentage of patients they screened for depression. A SMART goal is a goal that is Specific, 
Measurable, Attainable, Relevant, and Timely. The SMART goal is unique because the goal 
setter must think about a realistic goal that can be accomplished amongst preexisting barriers. 
The goal must be specific to the aim in mind, measurable, achievable given the setting, pertinent 
to the goal setter’s job, and contain a specific end or reevaluation point. The SMART goal is 
unique for the STD ERRNs because it allows them to acknowledge screening barriers while 
setting an achievable goal to increase depression screening. This goal was a subjective self-
report. The STD ERRNs were not asked to look in the patients’ medical records to see if the 
patients they assessed were screened. 
In the follow-up surveys (Phase 3), the participants were asked to evaluate their SMART 
goal progress using the Goal Attainment Scale (GAS). The GAS is a way to evaluate an 
individual’s progress toward a goal. After the individual has set a goal, the individual will rate 
his or her progress using the GAS scores that range from -2 to +2. A score of zero indicates the 
person’s set goal was met. A score of +1 means the goal was minimally exceeded, and +2 means 
the goal was moderately exceeded. In the same way, a score of -1 means the goal was minimally 
not met, and a score of -2 means the goal was moderately not met. The GAS scores enabled 
objective analysis of the SMART goals through a standardized approach (Pharmaceutical 
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Physician, 2014). 
Dissemination 
The online course was disseminated to the STD ERRNs on October 1, 2017 via email 
(Appendix 11). The email addresses were obtained from the NC DPH Public Health Nursing and 
Professional Development Unit, and the course email was sent through the Public Health 
Nursing and Professional Development Unit on behalf of the DNP candidate. The email to the 
course contained links to the pretest, posttest, and course as well as a handout of the PHQ-2, 
mental health resources, and PowerPoint slides. The course, pretest, posttest, and handouts were 
created as described in the pilot feedback and pilot discussion section. The course used 
PowerPoint slides with a video and audio voiceover. The pretest and posttest were delivered 
through the Qualtrics survey software. Initially, the STD ERRNs were given from October 1, 
2017, to October 16, 2017, to take the course. This end date was later extended to October 30, 
2017 to increase participation. Participants who took the pretest, course, and posttest were 
awarded 2 CNE contact hours eligible toward the annual ERRN CNE requirement.  
Sample Population 
Forty-three participants took the pretest. Four pretest participants did not complete the 
entire pretest and one participant took the pretest twice; these responses were discarded, leaving 
38 pretest participants for analysis. Forty participants took the posttest. Three posttest 
participants took the survey twice and two did not complete; these responses were discarded, 
leaving 35 posttest participants for analysis.  
Figure 5 shows the years of experience the STD ERRN participants reported on pretest 
question 3.  
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Figure 5. Pretest Question 3, the participants’ years of experience as an STD ERRN. Most 
participants had 5 years of experience or greater (23/38 or 61%). Eighteen percent (7/38) had 1-2 
years; 13% (5/38) had 3-4 years; 8% (3/38) had 0-1 years of experience. 
 
The LHDs varied in the number of days STD services were available and the average 
number of patients an STD ERRN assessed per week. Thirty-six out of thirty-eight, or 95%, 
worked at an agency with STD services available 5 days or more per week. Only 2/38, or 5%, of 
STD ERRNs worked at an agency with STD services available 1-2 days per week. The average 
number of patients an STD ERRN saw in the STD clinic per week was more varied. Figure 6 
shows the results from pretest question 5, “What is the average number of patients/clients you 
assess as a STD ERRN in the STD clinic per week?”.  
3
7
5
23
0
5
10
15
20
25
0-1 years 1-2 years 3-4 years 5 years or greater
N
um
be
r o
f S
TD
 E
R
R
N
s
Years of Experience as an STD ERRN
Years Worked as an STD ERRN
 
 
 
 
59 
 
Figure 6. Pretest Question 5, the average number of clients assessed per week in the STD clinic.  
Eighteen, or 47%, saw 1-5 clients; 24% (9/38) saw 21 clients or more; 13% (5/38) saw 6-10 
clients; 11% (4/38) saw 11-15 clients; and 8% (2/38) saw 16-20 clients. 
 
Depression screening practices varied between agencies and within the participants’ 
personal practice. Figure 7 shows the how often the participants reported their agency screened 
for depression (pretest question 7) and Figure 8 shows the participants’ reported professional 
practice (pretest question 8).  
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Figure 7. Pretest Question 7, how the participants reported their agency screened for depression. 
Nineteen out of 38, or 50%, reported their agency screened in some other agency clinics but not 
the STD clinic; 17/38, or 45%, screened females in certain clinics; and 2/38, or 5%, screened all 
patients regardless of clinic. 
 
*Certain clinics refers to the prenatal clinic, women’s health, family planning, and/or Breast and 
Cervical Cancer Control Program clinics.  
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Figure 8. Pretest Question 8, the participants reported professional screening practices. 
Seventeen out of 38 (45%) STD ERRNs reported they did not screen in the STD clinic but 
screened in the women’s health and/or prenatal clinics. Nine out of 38, or 24%, stated they did 
not screen due to their comfort level, lack of mental health resources available, or because 
depression screening was not required on their LHD assessment forms. Eight out of 38, or 21%, 
reported they screened if a patient presented with signs or symptoms of depression. The smallest 
group, 4/38, or 11%, screened all patients regardless of subjective or objective signs of 
depression.  
 
Twelve STD ERRNs reported screening in the STD clinic; this includes 8 STD ERRNs 
that stated they screened with signs or symptoms of depression and 4 STD ERRNs that screened 
all patients. These twelve participants were directed to a logic question stating “How do you 
screen for depression?” The results are detailed in Figure 9. 
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Figure 9. Logic question from pretest question 8, how do you screen for depression. Eight out of 
the 12, or 67%, screened using their own questions they felt were most appropriate for the patient 
or situation. Four out of 12, or 33%, used a validated screening tool.  
 
Participants who reported they did not screen for depression (n = 9) were directed to a 
logic question from pretest question 8. This question was a “select all that apply” question asking 
why the participant did not screen for depression. All stated that depression screens were not 
required on their STD visit assessment forms, 2/9 (22%) stated they believed mental health 
referral options were limited should a patient screen positive, and 1/9 (11%) noted comfort level.  
Pretest question 9 asked the participants to select any screening barriers from a list of 
commonly encountered barriers. Figures 10 and 11 compare barriers identified by the 
participants from the two most common clinics, those with STD ERRNs assessing 1-5 clients per 
week and those who assessed 21 clients or more. 
4
8
0
1
2
3
4
5
6
7
8
9
Used a validated screening tool Used their own questions
N
um
be
r o
f S
TD
 E
R
R
N
s
How the STD ERRN screened for depression
Method of Screening 
 
 
 
 
63 
 
Figure 10. Pretest question 9, barriers STD ERRNs who assess 1-5 clients per week identified. 
MH = mental health.  
 
*I am concerned with what to do if I get a positive result.  
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Figure 11. Pretest question 9, barriers STD ERRNs who assess 21 clients or more per week 
identified. MH = mental health.  
 
*I am concerned with what to do if I get a positive result.  
Pretest and Posttest Data 
Pretest and Posttest Scores 
The pretest and posttest contained the same five knowledge-based questions (pretest 
questions 11-15 and posttest questions 6-10). The pilot group did not take the course and 
pretest/posttest a second time. The data presented here is only from the general STD ERRN 
population participants. All questions (pretest questions 11-15 and posttest 6-10) were included 
in the analyses and each question was weighted equally. All data was analyzed using an alpha 
score of 0.05. If the p value was less than 0.05, the null hypothesis was rejected and the 
conclusion that the difference between the mean test scores was not due to chance was made. 
The STD ERRNs were given a score from 0-5 based on the number of correct answers. If the 
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STD ERRNs increased their score from pretest to posttest, they were given a number 1. If the 
STD ERRNs did not improve or got worse, they were given a 0.  
The data was first analyzed using general statistics (Table 8) and then with a one-tailed, 
paired samples t-test to determine whether the scores improved from pretest to posttest (Table 9). 
These analyses were performed using SPSS software. The sample size (N) was 35 because paired 
t-tests require matched pairs and there were 3 extra participants in the pretest. Table 10 presents 
the binary logistic regression used to determine whether there was a correlation between years of 
experience, the average number of patients assessed each week, and personal screening practices 
with improvement on the posttest. This binary logistic regression was performed using SAS 
software. The sample size analyzed for the binary logistic regression was also 35 due to the 3 
that did not complete the posttest. For analysis, the group with 3-4 years of experience had to be 
combined with the group with 5 years of experience or more because no STD ERRNs in the 3-4 
year group improved, scoring a total of 0. This was done to avoid an appearance of missing data 
that would skew results.  
Table 8 
Pretest (questions 11-15) and Posttest (questions 6-10) Score General Statistics (N = 35) 
 Mean N SD Standard error 
mean 
Pretest 3.89 35 0.72 0.12 
Posttest 4.23 35 0.77 0.13 
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Table 9 
Pretest (questions 11-15) and Posttest (questions 6-10) Score Analysis Using One-Tailed, Paired 
Samples t-Test (N = 35) 
 
 Mean SD Standard 
error 
mean 
95% CI t dF p 
Posttest - 
pretest 
0.343 1.056 0.178 -.02 - 
0.71 
1.92 34 .03 
Note. CI = Confidence Interval. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
67 
Table 10 
Improvement in Posttest Scores in Relationship to Additional Factors using Binary Logistic 
Regression (N = 35) 
 
Improvement Odds ratio Standard 
error 
Wald 
c 2 
p > c 2 95% confidence 
interval 
Years of Experience as an STD ERRN (compared to 0-1 years) 
1-2 years 0.46   1.88 0.17 0.68 .01 – 18.11 
3- 5 years or more 0.59 1.67 0.10 0.75     .02 – 15.50 
Average Number of Patients Assessed Per Week (compared to 1-5 patients) 
6-10 patients 9.00 1.64 1.8 0.18 0.36 – 223.18 
11-15 patients 0.70 1.50 .06 0.81 .04 – 13.17 
16-20 patients 1.60 1.58 .001 0.97 .05 – 23.37 
21 patients or more 0.30 1.38 0.77 0.38 .02 – 4.46 
Personal Screening Practices (compared to those that do not screen for depression) 
Screen in clinics 
other than STD 
4.09 1.50 0.89 0.35     0.22 – 76.93 
Screen with signs of 
depression 
1.02 1.85 0.0002 0.99 0.03 – 38.12 
Screen all 7.00  2.04 0.91 0.34 0.13 – 378.07 
Baseline odds  1.589 0.35 0.55  
Note: Number of observations = 35; likelihood ratio * c 2 (9) = 10.55; probability > c 2 = 0.31 
There was a statistically significant improvement between scores on pretest questions 11-
15 (M = 3.89, SD = 0.72) to posttest questions 6-10 (M = 4.23, SD = 0.77), t (34) = 1.922, p 
value = .032. The binary logistic regression results indicated there was an insignificant 
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association between improvement on the posttest with STD ERRNs’ years of experience, 
number of patients assessed per week, and personal screening practices (c2 (9) = 10.55, p = 0.31).  
Mental Health Familiarity 
Pretest question 10 and posttest question 5 asked the participants if they were familiar 
with the mental health resources available to their patients in their community. Responses could 
be “no,” “yes,” or “maybe.” The percentage of participants who were familiar with mental health 
resources increased from pretest to posttest; see Figure 12.  
 
Figure 12. Differences in the familiarity with mental health resources between pretest and 
posttest participants.  
 
Familiarity with mental health resources increased from pretest to posttest. This is a 
positive indicator of the course content based on the unfamiliarity barrier identified in the pretest. 
On the pretest 7/38, or 18%, stated they were unfamiliar with mental health resources and 25/38, 
or 66%, stated they were familiar. On the posttest, nobody stated they were unfamiliar, and 
29/35, or 83%, stated they were familiar. 
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Change in Comfort and Knowledge 
Participants responded to two sets of questions that asked about their comfort level and 
understanding of the course material. The first set of questions were pretest question 17 and 
posttest question 12 that read “I am comfortable and confident in my ability to screen for 
depression and refer to mental health services as necessary.”  The second set of questions were 
pretest question 16 and posttest question 11 that read “I understand the association between 
populations at risk for STDs/HIV and can apply this concept into my role as an [STD ERRN].” 
Responses were recorded using a 5-point Likert scale from “strongly disagree” with a score of 1 
to “strongly agree” with a score of 5.  
The data was analyzed using general statistics of the pretest and posttest comfort levels to 
show the change in the comfort score means (Table 11) and one-tailed, paired samples t-test to 
evaluate for a statistically significant change in comfort scores from pretest to posttest (Table 
12). Both analyses were conducted with SPSS software and used a sample size of 35 due to the 
missing cases on the posttest.  
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Table 11 
Change in Comfort Level Statistics (Pretest question 17 and posttest question 12; N = 35) 
 Mean N SD Standard 
error 
mean 
Pretest 
comfort 
level (1-5) 
2.37 35 0.77 0.13 
Posttest 
comfort 
level (1-5) 
3.09 35 0.66 0.11 
 
Table 12 
Pretest and Posttest Comfort Level Analysis Using One-Tailed, Paired Samples t-Test (Pretest 
question 17 and posttest question 12; N = 35) 
 
 Mean SD Standard 
error 
mean 
95% 
CI 
t dF Significance 
Posttest 
comfort 
– 
pretest 
comfort  
 
0.71 
 
0.96 
 
0.16 
 
0.39 
– 
1.04 
 
4.42 
 
34 
 
p < .001 
Note. CI = Confidence Interval 
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 There was a statistically significant difference in improvement from pretest question 17 
(M = 2.37, SD = 0.77) to posttest question 12 (M = 3.09, SD = 0.66; t [34] = 4.415, p < .001) that 
read “I am comfortable and confident in my ability to screen for depression and refer to metal 
health resources as necessary.” 
The second set of questions, pretest question 16 and posttest question 11, were also 
scored 1 to 5, with 1 representing “strongly disagree” to 5 representing “strongly agree.” Table 
13 shows the general statistics to compare the mean knowledge scores on the pretest and posttest. 
Table 14 uses a one-tailed, paired samples t-test to evaluate for a statistically significant 
difference in reported knowledge from pretest to posttest. These tests were conducted with SPSS 
software and used a sample size of 35 to account for the missing cases in the posttest. 
Table 13 
Change in Pretest and Posttest Reported Knowledge Level (Pretest question 16 and posttest 
question 11; N = 35) 
 
 Mean N SD Standard error 
mean 
Pretest 
Knowledge 
Level (1-5) 
2.54 35 0.82 0.14 
Posttest 
Knowledge 
Level (1-5) 
3.37 35 0.60 0.10 
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Table 14 
Pretest and Posttest Reported Knowledge Level Analysis Using One-Tailed, Paired Samples t-
Test (Pretest question 16 and posttest question 11; N = 35) 
 
 Mean SD Standard 
error 
mean 
95% CI t dF Significance 
Posttest 
knowledge -  
pretest 
knowledge 
 
0.829 
 
0.822 
 
0.139 
 
0.546 - 
1.111 
 
5.964 
 
34 
 
p < .001  
Note. CI = Confidence Interval. 
There was a statistically significant improvement in agreement from the pretest question 
16 (M = 2.54, SD = 0.82) to posttest question 11 (M = 3.37, SD = 0.60; t [34] = 5.964, p < .001) 
that read “I understand the association between populations at risk for STDs/HIV and depression 
and can apply this concept in my role as an [ERRN].” 
Posttest Comments 
Question 17 of the posttest asked for any input on the training, initial depression 
screening during STD visits, using the PHQ-2 in practice, or any other comments. Twenty-two 
out of 38 participants responded to this question. Eleven comments were positive and noted the 
utility of the information in practice. STD ERRNs commented “very informative, anticipating 
PHQ-2 will be easy to incorporate into STD screening”; “found this information to be very 
informative and an important piece of STD screening that is missing”; “this training made me 
more aware of the correlation between depression, drug abuse, and STDs”; “I feel it is definitely 
needed in working with our STD clients.”  
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 Eleven comments expressed concerns for depression screening barriers in the STD clinic. 
Eight STD ERRNs stated time was a barrier, 1 stated there was a policy barrier, and 2 expressed 
concerns over mental health resources. Time was a barrier in two different ways: the time to 
administer the screen and the time needed to refer the positive screens. Three STD ERRNs 
commented on the time to administer the screen. These comments included: 
• “I do not believe I will be given additional time to do this screening”; 
•  “My only concern is time. It is already difficult to see the assigned number of patients 
and get them out within allotted time to get to the next patient. Some of my patients 
become impatient if not seen close to the allotted time”; and 
• “With patients being scheduled every half hour, it may be difficult to assess the client, 
get them referred if needed, and counsel them regarding STDs before the next person 
comes in and without getting backed up. Also, may have a lot of noncompliance with the 
patients as far as keeping the appointment(s) they get so the nurse may feel that all that 
time spent on the phone and counseling was wasted.” 
 The other STD ERRNs stated the extra time would be due to the time needed to refer 
positive screens. As an STD ERRN explained, “Good detail in training. Adding the PHQ-2 
depression screen to other questions in STD will require little time, but referral and follow-up for 
positive answers will require staff resources we do not have.” Another STD ERRN commented, 
While I think that [screening for depression in the STD clinic] is potentially a good idea, 
I feel like this is another thing added to the list…asking the questions is not the hard part, 
the hard part is if there is ever a positive screen…often times when someone… [is given] 
referrals the person does not follow up about the depression….  
 
 Another STD ERRN noted a lack of policy for suicidal patients. This STD ERRN stated, 
“This has precipitated awareness that we do not have a policy in place to address clients with 
suicidal ideations and how to provide for their safety until a Mobile Crisis Unit arrives.” 
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Similarly, an STD ERRN asked for a handout on the local resources available for her patients 
(which was provided in the resources accompanying the slides and presentation). Another 
expressed concern that some of the mental health resources like counseling would not be 
available to self-pay patients. 
Analysis and Discussion of the Course 
 The course sample population was similar to the Needs Assessment Survey population in 
terms of years of experience and number of clients assessed per week. The similarities increased 
the likelihood that the results were indicative of the true population of STD ERRNs and 
strengthened the Phase Two results. In the Needs Assessment Survey, most of the course 
participants had 5 years of experience or more (23/38 or 61%). For the course participants, the 
majority of the STD ERRNs also had 5 years of experience or more (30/61 or 49%). About half 
of the Needs Assessment Survey participants assessed 1-5 clients per week (18/38 or 47%) 
followed by 21 clients or more (9/38 or 24%). The course sample population was most likely to 
see either 1-5 clients per week (19/61 or 31%) followed by 21 clients or more (15/61 or 25%).  
STD ERRNs who assessed 1-5 clients per week or 21 clients or more per week both 
reported time was a top barrier. The next most commonly reported barrier for the 1-5 client 
group was a concern for adequate referral options. The larger client group’s second greatest 
concern was split among a lack of adequate referrals, concern with what to do with a positive 
result, or unfamiliarity with mental health services available. Most of the STD ERRNs were 
experienced and appeared to be familiar with depression screening because they reported doing 
so in other clinics. Despite this, these experienced STD ERRNs were not screening in the STD 
clinic. This shows that the barriers to screening for depression are largely related to the time 
required to screen in the STD clinic, regardless of experience or the number of clients assessed. 
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Multiple posttest comments affirmed time was a barrier. The time concern was mostly associated 
with getting a positive screening result due to the difficulty with setting up mental health 
services. Time could also be a barrier for patients who identified as suicidal because there was 
not a policy or safety plan in place.  
There were three learning outcomes for this DNP project, two of which were associated 
with the course; the final learning outcome will be addressed in Phase 3. The course met the first 
learning outcome: to increase the STD ERRNs’ knowledge of the relationship between 
depression and risk of STDs as measured by a statistically significant increase in correct answers 
from pretest questions 11-15 at the beginning of the CNE to posttest questions 6-10 at the end of 
the CNE. In corroboration, the STD ERRNs reported an increase in familiarity with mental 
health resources and showed a statistically significant difference in their reported understanding 
of the association between STDs and depression.  Posttest comments stated the course was 
informative, helpful, and needed. The course also met the second learning outcome: to increase 
the STD ERRNs’ comfort level with administering depression screens and referring to mental 
health resources, as appropriate, as measured by a statistically significant increase in comfort 
levels from the CNE pretest to the CNE posttest using a 5-point Likert scale.  
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CHAPTER EIGHT: PHASE THREE – POST COURSE  
FOLLOW-UP SURVEYS AND SMART GOAL ACHIEVEMENT 
 
Methods 
 Posttest question 18 asked the course participants to provide their email addresses if they 
would be willing to participate in two follow-up surveys about their SMART goal progress 
and/or provide additional support (Appendix 21). Out of the 36 participants who completed the 
posttest, 20 agreed to be a part of the follow-up group (response rate of 55%). The pilot site 
previously agreed to be a part of the follow-up. This site consisted of six ERRNs, for a total of 
26 STD ERRNs interested in the follow-up (response rate 72%). 
The first follow-up to the 20 general participants was sent on November 11, 2017 and 
elicited 12 responses. The second follow-up survey was sent on December 11, 2017 and elicited 
14 responses. Although the email was sent out to the same group of STD ERRNs, some of them 
participated in one or the other survey instead of both.  
The 6 pilot site participants needed additional time to prepare their STD clinic for 
depression screenings. These 6 participants were sent the first follow up survey on December 18, 
2017 and returned 2 responses. The 2nd pilot follow-up survey was sent on January 8, 2018 and 
received 4 responses; one response from the pilot was incomplete, leaving 3 responses for 
analysis.  
The pilot and general participants’ responses were combined so that in total, there were 
14 participants analyzed for the first follow-up and 17 participants analyzed for the second 
follow-up. These participants were sent the 2 surveys through the Qualtrics software. 
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 The first follow-up survey consisted of 4 questions asking the STD ERRNs to measure 
their progress using the Goal Attainment Scale (GAS), to list barriers encountered, to note 
supportive factors, and to provide additional comments. The final follow-up survey consisted of 
9 questions: the same four questions from the first follow-up plus the 5 knowledge-based 
questions from the pretest/posttest (pretest questions 11-15 and posttest questions 6-10). The 
follow-up surveys used the GAS because it enabled objective measurement of SMART goals and 
demonstrated how often the STD ERRNs screened. The 2 GAS scores combined were capable of 
showing a change in screening efficacy over the course of 6 weeks. It was important to ask about 
the barriers and supportive factors to see what STD clinic factors hindered or enhanced the STD 
ERRNs’ screening efficacy. Comments were important to this project in order to learn any 
additional information that was not asked in the previous surveys. The five knowledge-based 
questions in the posttest were repeated to assess whether the ERRNs had maintained their 
knowledge by the time of the final follow-up. 
Results 
SMART Goals 
The SMART goals the STD ERRNs set ranged from increasing screening from 50% to 
100% of clients. Examples of SMART goals the STD ERRNs set included: 
• “I will use the PHQ-2 to screen 60% of patients by one month.” 
• “I will screen 80% of my patients in the STD clinic from 10/30/17 to 12/11/2017.” 
• “I will use the PHQ-2 screening on 100% of the patients I see as an ERRN in the STD 
clinic by one month.” 
• “I will screen 90% of STD patients for depression at the beginning of their visit by one 
month.” 
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• “I will use the PHQ-2 to screen 50% of patients in the STD Clinic by one month.” 
Figures 13 and 14 detail how the STD ERRNs rated their success on their SMART goals 
using the GAS on the 1st follow-up and the 2nd follow-up respectively. The sample size for the 
first follow-up was 14. The sample size for the second follow-up was 17.  
 
 
Figure 13. Goal Attainment Scale scores from participants that responded to the first follow-up 
survey (n = 14). The majority of participants, 10 out of 14, or 71%, met (GAS score 0) or 
exceeded (GAS 1 or 2) their SMART goal. Out of 14, five participants, or 36%, rated their goal 
attainment as a +2 or “always exceeded” goal. 
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Figure 14. Goal Attainment Scale for participants (n = 17) who responded to the 2nd follow-up 
survey. Fourteen out of 17 (82%) met (GAS 0) or exceeded (GAS 1 or 2) their SMART goal. 
The majority of participants (8/17 or 47%) rated their goal achievement as a +2 or “always 
exceeded” goal.  
 
 The GAS score means of the two follow-up surveys were calculated in Table 15. The 
results were then analyzed with an independent samples t-test to determine if there was a 
statistically significant difference from the first follow-up to the second follow-up, shown in 
Table 16. This test was required because the two samples are of different sizes and unmatched; 
the same group of STD ERRNs did not take both follow-up surveys. A Levene’s test for equality 
of variances was performed that resulted in F = 0.244 and p = 0.625; equal variances can be 
assumed. These results were calculated with SPSS software.  
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Table 15 
Goal Attainment Scale Group Statistics 
 Group N Mean SD Standard error 
mean 
GAS 1 14 0.43 1.51 .40 
2 18 0.78 1.40 .33 
Note. GAS = Goal Attainment Scale. 
Table 16 
Goal Attainment Scale Independent Samples Test 
 t dF p value Mean 
difference 
Standard 
error 
difference 
95% CI 
GAS -0.68 30 0.25 -0.35 0.52 -1.40 - 0.70 
Note. GAS = Goal Attainment Scale. CI = Confidence Interval. 
There was no statistically significant difference in GAS scores from the 1st follow-up 
survey (M = 0.43, SD = 1.51) to the 2nd follow-up survey (M = 0.78, SD = 1.40; t [30] = -0.68, p 
= 0.25). 
Follow-Up Survey Barriers 
The STD ERRNs were asked, “What are some barriers you encountered when screening 
for depression in your STD clinic?” on question 2 of the 1st follow-up survey and question 7 of 
the 2nd follow-up survey in a “select all that apply” format. The two pie charts in Figure 15 
represent the changes in responses from the 1st to the 2nd follow-up.  
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Figure 15. Comparison of barriers reported on the first and second follow-up surveys.  
The “other” responses from the 1st follow-up survey included: 
• “Integrated well into the STD clinic flow.” 
• An STD ERRN said she was not working in the STD clinic during the first 3 weeks. 
5, 38%
1, 8%
4, 31%
3, 23%
1st Follow Up Survey: Barriers
Not enough or limited time
No adequate referral options to
mental health services
I did not encounter any barriers
or was able to resolve them
without much difficulty
Other
7, 33%
1, 5%
2, 9%
9, 43%
2, 10%
2nd Follow Up Survey: Barriers
Not enough or limited time
Comfort level with administering
and interpreting depression
screens
No adequate referral options to
mental health services
I did not encounter any barrriers
or was able to resolve them
without much difficulty
Other
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• Another STD ERRN that stated she was initially forgetting to do the surveys, then had 2 
patients who did not want to fill out the survey, and there was another time in which 
he/she forgot to document results. 
The “other” responses from the 2nd follow-up survey included:  
• “Did not work in the STD clinic during time frame of study.” 
• “Rarely, patients did not want to fill out the survey.” 
Follow-Up Survey Supportive Factors 
The STD ERRNs were asked, “What are some supportive factors you found when screening 
for depression in your STD clinic?” on question 3 of the 1st follow-up survey and question 8 of 
the 2nd follow-up survey in a “select all that apply” format. The two pie charts in Figure 16 
represent the changes in responses from the 1st to the 2nd follow-up.  
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Figure 16. Comparison of supportive factors reported between the first and the second follow-up 
surveys.  
 
8, 24%
9, 28%8, 24%
5, 15%
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1st Follow Up Survey: Supportive Factors
Support from leadership
I had the education and/or tools
I needed to implement
depression screens
My STD clinic's medical record
system allowed for easy
documentation of depression
screen results
I had adequate time to screen
patients for depression during
the STD visit
Other
12, 29%
14, 33%
10, 24%
6, 14%
2nd Follow Up Survey: Supportive Factors
Support from leadership
I had the education and/or tools
I needed to implement
depression screens
My STD clinic's medical record
system allowed for easy
documentation of depression
screen results
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patients for depression during
their STD visit
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The “other” responses from the 1st follow-up survey included: 
• “[Primary care providers] available and resources available.” 
• “Have not worked in the STD clinic during the past three weeks.” 
• “None applicable.” 
First Follow-Up Survey Comments 
Six participants responded to question 4, which asked the participants to “Please provide 
any additional comments you have about your experience implementing depression screens in 
your STD clinic.” There were 3 positive responses and 3 responses that suggested ways to 
improve. Two responses stated the patients were receptive to the screening. Another stated an 
opinion that alluded to a common misconception about depression: depressed people will look 
depressed. This STD ERRN stated “[I] was surprised to see how many patients scored high on 
the PHQ-2 questions…not sure if we would have caught that if they hadn’t filled out the 
questionnaire.” 
 Three participants offered means for improvement. One stated a theme echoed in the 
posttest comments: 
The issue with time is not in the screening process, it is with the referral process. We are 
to call to make an appointment while the client is with us, and the facility may keep them 
on the phone (in our office) for over 30 minutes. 
 
Another suggested the “process would be smoother if it were a part of the current [electronic 
medical record].” One participant stated the patients “didn’t seem to be too interested in the 
screenings” and “only one so far has taken a referral.” 
Second Follow-Up Survey Comments 
Five participants responded to question 9 in the second follow-up survey which asked for 
additional comments. There were positive comments about the helpfulness of the screening and 
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the on-site provider, comments about the time barrier, and two comments that spoke to some of 
the stereotypes of depression. One participant stated the “tools were easy to use and helpful to 
our patients.” On-site providers were also helpful to implement screenings: “having an upper 
level provider on site at least part of the time and 100% by phone was helpful.” The participant 
that stated time was a barrier commented: 
Time to do an adequate assessment for someone who seriously needs help is difficult as 
appointments are scheduled every 45 minutes with no break between clients. When 
someone is identified who needs more attention, it really leads to backing up the clinic. In 
our area this has the potential on some days to cause a real problem. 
 
Two comments spoke to some of the common misconceptions of depression. Similar to 
the comment in the first follow-up, a STD ERRN said, “I was surprised at some of the patients 
that voiced signs of depression.” Additionally, one STD ERRN had concerns about the reliability 
of patients’ self-report on the depression screen: “[clients] were willing to answer the questions, 
but [I’m] unsure if ALL were TRUTHFUL.” These misconceptions will be discussed further in 
the analysis. 
Repeat Knowledge-Based Questions 
Questions 2-6 of the 2nd follow-up survey were the same knowledge questions as pretest 
questions 11-15 and posttest questions 6-10. These were used to determine if there was any loss 
of knowledge during the time from the end of the course to the end of the follow-up surveys. 
Questions were scored 1 for correct and 0 for incorrect to calculate the total score for each 
participant. The 2nd follow-up mean score was 4.53. In comparison, the posttest mean score was 
4.23. 
Analysis and Discussion of Follow-Up Surveys/SMART Goals 
The follow-up surveys are indicative of how well the STD ERRNs met their SMART 
goals among the barriers and supports they found in their STD clinics. They had set SMART 
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goals to increase screening for 50% to 100% of clients. In both the first and second follow-up 
surveys the majority of STD ERRNs stated they “always exceeded their goals” (score of +2), 
followed by “met their goals” (score 0). In the 1st follow-up, 5/14, or 36%, always exceeded their 
goal, 2/14 (15%) sometimes exceeded their goal, and 3/14 (21%) met their goal. In the 2nd 
follow-up survey, the GAS scores increased to: 8/17 (47%) always exceeded their goal, 3/17 
(18%) sometimes exceeded their goal, and 3/17 (18%) met their goal.  
The final learning outcome for this course was met; to increase the STD ERRNs progress 
on their individual SMART goals as measured by an improvement on the GAS. The GAS scores 
were high for both the first and the second follow-up surveys. Although there was no statistically 
significant difference in scores between the two follow-up surveys, the third learning outcome 
was met because the GAS scores did increase and were high for both time points. In the first 
follow-up survey, 10/14 (71%) always exceeded, sometimes exceeded, or met their goal. In the 
second follow-up survey, 14/17 (82%) always exceeded, sometimes exceeded, or met their goal. 
This shows the course and policy implementation were effective and the STD ERRNs were able 
to meet their goals at time point 1 similarly to time point 2. 
 The STD ERRNs reported the largest barrier to screening in the STD clinic on the first 
follow-up survey was time (38%). This stayed fairly consistent on the second follow-up: 33% of 
STD ERRNs reported time was a barrier. Only 15% reported on the 1st follow-up that they had 
adequate time to screen for depression; this number was 14% on the 2nd follow-up survey. 
No STD ERRNs reported that their comfort level was a barrier on the first follow-up 
survey, although one (5%) reported that comfort was a barrier on the second survey. This STD 
ERRN could have had a difficult experience after the 1st follow-up that might have affected 
her/his comfort level at the 2nd follow-up time point.  
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Not all STD ERRNs experienced barriers. From the first to the second follow-up surveys, 
the number of STD ERRNs who stated they had no barriers or were able to resolve them easily 
increased from 31% to 43%. This could be due to the increase in comfort level in dealing with 
depression that they reported. 
Supportive factors included a cohesive medical record system, leadership support, and 
education and tools provided. Twenty four percent of STD ERRNs in both follow-ups stated that 
their medical record system allowed for easy documentation of depression screens. This was a 
barrier for those that did not have a cohesive medical record system. In one follow-up comment, 
an STD ERRN suggested the screening process would be smoother if the screens were 
incorporated into the medical record. Depression screen implementation was easier for those 
STD clinics that were able to incorporate the depression screen into their electronic medical 
record during the six weeks, as opposed to clinics that required scanning the PHQ-2 paper copy 
into the chart. STD ERRNs reported an increase in support from leadership (from 24% to 29%) 
and an increase in the belief that they had the education and tools needed to screen (from 28% to 
33%). In the comments, STD ERRNs noted that on-site provider access was advantageous and 
the depression screen was easy to use and beneficial.  
The follow-up comments show an area where STD ERRNs and other health care 
clinicians can improve: the perception that a patient will look depressed if they are depressed, 
and the stereotype that self-reported mental health symptoms may not be real. Two STD ERRNs 
stated they were surprised to see how many scored high on the depression screen. This speaks to 
the necessity for screenings, as observation alone is not as sensitive. Depression screens remove 
the subjectivity of a personal assessment that is often clouded by bias. More information will 
need to be shared about these biases in future courses. 
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The mean of the follow-up knowledge questions was 4.53, and the mean of the posttest 
was 4.23. This shows that the STD ERRNs retained their knowledge over the course of six 
weeks. This knowledge could have contributed to the high GAS scores. It should be noted that 
the sample sizes for the follow up (n = 17) and the posttest (n = 35) were very different, so this 
comparison is not precise. 
Phase Two and Three Conclusions 
 The course was effective at meeting all three learning outcomes: to increase knowledge 
from pretest to posttest, to increase comfort and confidence level when performing depression 
screens, and to improve the GAS scores. Multiple STD ERRNs stated the course was beneficial 
and that it helped to expose needs in the STD clinic. The posttest showed the STD ERRN 
participants were able to increase their comfort level, as evidenced by responses on posttest 
question 12 and the high GAS scores on both follow-ups. The STD ERRN participants brought 
up common themes that were beneficial to screening: a cohesive medical record system that 
incorporates depression screens into the visit, access to on-site providers and resources, and 
support from leadership. If not met, these supportive factors were derailments toward screening 
and increased the time it would take to screen. The time barrier was echoed in the Needs 
Assessment Survey, pilot, and final course. This concern about time was usually associated with 
the positive screens. The referral process at some STD clinics is arduous; as one STD ERRN 
pointed out it takes her/him about 30 minutes to connect a patient to a mental health resource. 
With barriers aside and the appropriate education and tools in place, STD ERRNs are willing and 
able to screen effectively. Most STD ERRNs reported they were almost always likely to exceed 
their screening goals, with goals set anywhere from 50% to 100% of clients. Results from this 
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project show that addressing these system issues to decrease the time it takes to refer patients 
would improve implementation of depression screens in the STD clinics.  
 This project was successful in completing the two project purposes:  
1. Expand the STD ERRNs’ education to include an understanding of the association of 
depression with STD risk factors, be able to identify those at high risk for depression, and 
give them an evidence-based tool to screen for depression, thus enhancing the STD 
ERRNs’ comfort and self-efficacy to screen for depression to facilitate evidence-based 
practice change in the clinical setting  
2. Provide the STD ERRNs with a temporary policy addendum and depression screening 
guidelines to support them as they perform depression screens in the STD clinic 
This project provided a course that included evidence-based recommendations for screening 
for depression and a validated depression screening tool, along with a temporary policy 
addendum, to support STD ERRNs as they screened for depression in the STD clinics. These 
interventions were proven successful, as evidenced by the statistically significant increase in 
correct answers from pretest to posttest, increased comfort level, improved reported knowledge 
level, as well as high GAS scores in both follow-ups.  
Phase Two and Three Limitations 
 Limitations for this project include the small sample size, pretest/posttest questions, and 
self-report questions. Thirty-five STD ERRN participants were included in the analyses for the 
pretest/posttest, 14 for the 1st follow-up, and 17 for the 2nd follow-up. The pretest/posttest logistic 
regression was difficult to analyze due to the limited number of STD ERRNs broken into each 
demographic category. The follow-up sample size was a limitation because this was the group 
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that reported on the practicality of meeting their screening goals in the STD clinic setting. A 
larger sample size would have added to the strength of the results.  
 Pretest questions 11-14 and posttest questions 6-9 could have been more effective at 
determining a change in knowledge. The starting mean for the pretest questions was high at 3.89 
on a scale of 0-5. The course could have been better evaluated had these questions been more 
difficult. 
 Additionally, many of the pretest, posttest, and follow-up questions were based on a self-
report. For example, the follow-up surveys asked the STD ERRNs how many patients they 
believed they screened for depression. Self-report is subject to bias, and an objective 
measurement to support the STD ERRNs’ claims would have been a better indicator of the 
success of screening in the STD clinics.   
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CHAPTER NINE: SUSTAINABILITY 
 There are two options to increase the sustainability of this project. First, the results will 
be presented to the NC DPH Communicable Disease Branch to recommend incorporation of this 
education into future STD ERRN courses so that all future ERRNs will have the knowledge and 
skill to utilize depression screens in the STD clinic. Second, recommendations will also be made 
to the LHD STD clinics to incorporate depression screening as a standard component of an STD 
visit at their local health department. Because a Temporary Policy Addendum was supported by 
the NC DPH to adopt or adapt an implementation of depression screening in STD clinics, there is 
a promising future for the hope that local health departments will continue with this evidence-
based quality improvement project. 
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CHAPTER TEN: NEED FOR FURTHER RESEARCH 
 Future research is needed to assess why time is a top barrier in the STD clinics. From this 
project, it appears that mental health referrals would most likely be contributors to the time 
challenges STD ERRNs already face. Future research is needed to determine why mental health 
referrals are difficult to provide to public health STD clinics and ways this process can become 
more efficient. 
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APPENDIX 1: NC DPH STD CLINIC ASSESSMENT FORM  
 
 
 
Sexually Transmitted Diseases 
Form 2808
N.C. Department of Health and Human Services 
Division of Public Health
1. Last Name First Name Mi
2. Patient Number 3. Date of Birth
4. Race o 1. White o 4. Asian  o 6. Other ________________________
 o 2. Black/African American o 5. Native Hawaiian/Other Pacific Islander 
 o 3. American Indian/Alaskan Native
5. Gender
o 1. Male 
o 2. Female
o 3. Transgender
6. County of Residence 7. Allergies:
DATE OF VISIT ______________________________
Present Absent Symptom
Symptom Parameters 
Specify location, quality, severity, duration, frequency 
and associated symptoms, if applicable. Document 
what the client did to relieve the symptoms and the 
effectiveness of the action.
o o Itch
o o Irritation
o o Pain
o o Discharge
o o Dysuria
o o Ulcer/Lesion
o o Rash
10. Sexual Risk Assessment
Sexual partners past 60 days:
# male ________   # female ________
Sites of client’s exposure (last 60 days):
o Mouth o Penis o Vagina o Anus
Have you ever:
Yes/No
o o Had sex with partner of the 
              same sex
o o Had sex with a bisexual male
o o Had sex for drugs or money
o o Had sex with intravenous  
              drug user
o o Had sex with HIV(+) partner
o o Paid for sex
o o Shared needles
Date of last sexual encounter:
_____________________________
In last 2 weeks:
# sexual encounters _____________
# with condom use ______________
Do you currently use:
Alcohol   o No o Yes
Frequency  ____________________
Injectable drugs o No o Yes
Last injection ________________
Non-injectable drugs o No o Yes
_____________________________
_____________________________
o STD Screen/Check
o Asymptomatic
o Symptomatic
o *Positive test for_________________
o  Referred by DIS or Health Care  
Provider or ED
o  Contact to person treated for_______
o Exposed to partner with symptoms
o Other_________________________
o  Partner notification card for 
___________________________
o Referral Source_______________
o NC EDSS event ID
o Verbalization of Partner/Contact
o  Medical Record of Partner/Contact 
____________________________ 
____________________________ 
____________________________
11. For Women
LMP: ______ /______ /______
o Regular o Irregular
Frequency_________________
Last Pap: _____ /_____ /_____
o Normal o Abnormal
Douche:  o Yes   o No
Frequency_________________
Last______________________
Are you pregnant? 
o  Yes   o  No   o  Don’t know
Are you breastfeeding: 
o  Yes   o  No
Contraception:
o None
o Emergency Contraceptive Pill
o OCP
o Injectable
Last given _______________
o Implant
o Diaphragm
o IUD
o Tubal ligation
o Condoms
o Hysterectomy
o Other
13. Comments:
Month           Day                  Year
H__
Ethnicity: Hispanic Origin? o  Yes  o  No
12. Other Pertinent History (document additional information in comments)
8a. Reason(s) for Visit (check all that apply):
Signature/Title of Interviewer:       Signature/Interpreter:
Signature/Title of Provider if not the Interviewer:
Date:
Date:
DHHS 2808 (Revised Feb 2014)
Antibiotics: 
(last 2 weeks)
o None  o Yes
Other present  
medication(s):
o None  o Yes
Reviewed client’s self-history 
form when used by agency:
o  Yes  o  No  o  N/A
8b.  Contact(s) verified by  
(Check at least one): 9b. Vaccines & Testing
Hep B Vaccine
o No o Yes o Unk
# injections _________________
Last injection date :___________
Twinrix Vaccine
o No o Yes o Unk
# injections _________________
Last injection date :___________
Tdap Vaccine
o No o Yes o Unk
Last injection date :___________
HPV Vaccine   
o No o Yes o Unk
# injections _________________
Last injection date :___________
Prior HIV Test
o No o Yes o Unk
Last test date :_______________
HBV Status
o Unk   o Acute   o Chronic
(Date Dx) ___________________
HCV Status
o Unk   o Acute   o Chronic
(Date Dx) ___________________
9a. Prior STD/STI & Date Dx
o Bacterial Vaginosis___________
o Chlamydia__________________
o Genital Warts_______________
o Gonorrhea_________________
o HIV_______________________
 Date Dx:___________________
 State/Country Dx:____________
o Herpes o oral _____________
 o genital___________
o MPC______________________
o NGU______________________
o PID_______________________
o Syphilis____________________
 Date Dx:___________________
 State/Country Dx:____________
 Titer:______________________
o Trichomoniasis______________
o Yeast______________________
o Other______________________
o None______________________
o   *If client is returning for treatment/counseling, re-interview the client for changes and if history remains the same, check this box.
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o Oropharynx: no lesions; no erythema;
no tonsillar exudate   o abnl:
o Penis: no lesions; no discharge
o abnl:  Circumcised: o yes o no
o Scalp, brows, lashes: no nits; no hair loss
o abnl:
o Scrotum: no tenderness; no nodules
o abnl:
o Cervical/supraclavicular/axillary/epitr-
ochlear nodes: no adenopathy   o abnl:
o Vulva: no lesions/rashes; no lice/nits
o abnl:
o Skin: clear; no lesions/rashes
o abnl:
o Vagina: no lesions; no erythema;
no discharge   o abnl:
o Abdomen: no tenderness to palpation; no
rebound tenderness   o abnl:
o Cervix: no lesions; no erythema;
no discharge; no CMT   o abnl:
o Inguinal nodes: no adenopathy
o abnl:
o Uterus: no enlargement; no tenderness
o abnl:
o Pubic area: no lesions/rashes; no lice/nits
o abnl:
o Anus: no lesions
o abnl:
ATTACH PATIENT LABEL HERE
14. Physical Examination*
Description of discharge (if present):
Color (check all that apply):
o clear o yellow
o gray/off white o  green
o bloody o purulent
o  color of discharge
matches the white swab
Color  (check all 
that apply):
o clear
o yellow
o green
o purulent
o other, specify
______________
Vital Signs, if clinically indicated: T:___ B/P: ___P____R____
*Additional Findings:
Notes:  
Primary Provider Signature _______________________________________  Co-signature (if applicable) __________________________________________
o  Enhanced Role RN  o  CNM o  NP  o  PA  o  MD Time Enhanced Role RN spent with patient: _______ min.=_______ units
DHHS 2808 (Revised Feb 2014)
Amount:
o small
o moderate
o large
Odor (with or 
without KOH):
oyes   ono
pH: o≥4.5  o<4.5
Amount:
o small
o  moderate
o large
Adheres to vaginal wall: oyes  ono
Female Clients Male Clients
15. Laboratory
o Gonorrhea test: o NAAT o culture
o Cervical  o Urethral o Urine
o Rectal o Pharyngeal  o Vaginal
o Urethral gram stain:
o No GNID found o ≥ 5 white cells, no GND
o GNID found o Extracellular GND only
o Herpes test: o culture o serology
o HIV
o Chlamydia test: o NAAT o other
o Cervical  o Urethral o Urine
o Rectal  o Pharyngeal  o Vaginal
o Syphilis serology
o Stat RPR: o reactive o non-reactive
o Darkfield: o found o not found
oWet prep: o clue cells o yeast
o KOH+   o trich oWBCs _____________
o Pap smear: o HPV
o Pregnancy test: o positive o negative
o LE (leukoesterase): o positive o negative
o Other __________________________________
18. Instructions/Counseling
o  Abstain from sex for ____ week(s) and until
partner is treated
o Use condoms for risk reduction
o RTC if symptoms increase/persist
o  RTC in _______(specify days, weeks or months)
o  Partner notification discussed:     o  Cards given
o Expedited partner therapy (EPT)  # cards______
o  Control measures and counseling
provided for  HIV+
o Printed risk reduction/disease information given
o  Client given a list of services provided/tests
performed
o Referrals
16. Clinical Impressions/Diagnosis
o Bacterial vaginosis
o Candidal infection
o Cervicitis/MPC
o Chlamydia
o Epididymitis
o Gonorrhea
o Herpes - 1st episode or recurrent
o HIV
o HPV/Genital warts
o NGU
o Pediculosis pubis
o PID
o Scabies
o Syphilis:  o Unknown duration
o Primary o Early latent
o Secondary  o Late latent
o Tinea cruris
o Trichomoniasis
o Contact to: ______________________________
o Normal STD Screening, lab tests pending:
_________________________________________
o Other: _________________________________
19. Follow-up for Test Results:
o  Clinic will call with results only if a test result is
abnormal or requires re-testing
o Clinic will call with all test results
o Client will call for results
o  Unique password to obtain test results by phone
_______________________________________
o  Preferred phone # to contact client:
_______________________________________
o Clinic may leave message at preferred #
o Other
17. Treatment/Therapy
o None
o Reviewed client’s allergy history
o Reviewed client’s pregnancy status
o Reviewed client’s breastfeeding status
o Amoxicillin 500 mg PO TID x 7 days
o Azithromycin 1 gm PO stat x 1
o Azithromycin 2 gm PO stat x 1
o  Benzathine penicillin G 2.4 MU IM
o bilateral gluteal muscles
o other site
o Ceftriaxone 250 mg IM stat x 1
o Doxycycline 100 mg PO BID x ______days
o Metronidazole 250 mg PO TID x 7 days
o Metronidazole 500 mg PO BID x 7 days
o Metronidazole 2 gm PO stat x 1
o Acyclovir/Valacyclovir/Famciclovir
______________________________________
o Cryotherapy
o TCA/Podophyllin/Client applied _________
o OTC pediculosis pubis treatment
o OTC fungal/yeast treatment
o Other _____________________________
Date/Signature/Title of person 
administering/dispensing treatment if not 
the primary provider
o  Medication instructions provided according
to policy
o Restrictions for Alcohol Consumption given
Specify: ______________________________
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North Carolina Department of Health and Human Services. Form 2808. Retrieved from 
 http://epi.publichealth.nc.gov/cd/lhds/manuals/std/clinical/DHHS-2808-
 SexuallyTransmittedDiseases.pdf 
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APPENDIX 2: PATIENT HEALTH QUESTIONNAIRE-2 AND INSTRUCTIONS FOR USE 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Thibault, J. (2004). Efficient identification of adults with depression and dementia. American 
 Family Physician, 70(6). Retrieved from http://www.aafp.org/afp/2004/0915/p1101.html 
 
 
PHQ-2 
Over the past two weeks, how often have you been bothered by any of the 
following problems?  
Little interest or pleasure in doing things.  
0 = Not at all  
1 = Several days  
2 = More than half the days  
3 = Nearly every day 
Feeling down, depressed, or hopeless.  
0 = Not at all  
1 = Several days  
2 = More than half the days  
3 = Nearly every day  
Total point score: ______________ 
Score interpretation: 
PHQ-2 
score 
Probability of major depressive disorder 
(%) 
Probability of any depressive disorder 
(%) 
1 15.4 36.9 
2 21.1 48.3 
3 38.4 75.0 
4 45.5 81.2 
5 56.4 84.6 
6 78.6 92.9  
 
 
Figure 1. Patient Health Questionnaire-2 (PHQ-2). This questionnaire is used as the initial 
screening test for major depressive episode.  
Information from Kroenke K, Spitzer RL, Williams JB. The Patient Health Questionnaire-2: validity of a 
two-item depression screener. Med Care 2003; 41:1284-92. 
 
 
 
 
Thibault JM, Prasaad Steiner, RW. Efficient identification of adults with depression and dementia.                          
American Family Physician, Vol. 70/No. 6 (September 15, 2004)
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APPENDIX 3: PATIENT HEALTH QUESTIONNAIRE-9 AND INSTRUCTIONS FOR USE 
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Scottish Government. Delivering for health: Using self-help in primary care and community 
 based everyday service delivery for mild to moderate psychological problems. Retrieved 
 from http://www.gov.scot/Publications/2007/01/09114002/12 
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APPENDIX 4: INSTITUTIONAL REVIEW BOARD 
 
------ Original message------ 
From: IRB  
Date: Tue, May 30, 2017 7:52 AM 
To: Grimes, Jessica; 
Cc: Davison, Jean Ann; Miller, Lisa H; 
Subject:IRB Notice – 17-1048 
 
To: Jessica Grimes 
School of Nursing 
 
From: Office of Human Research Ethics 
 
Date: 5/30/2017  
RE: Determination that Research or Research-Like Activity does not require IRB Approval 
Study #: 17-1048 
 
Study Title: Improving STD Enhanced Role RN Education of the Importance of Depression 
Screening during STDs/HIV Risk Assessments to Evoke Practice Change 
  
This submission was reviewed by the Office of Human Research Ethics, which has determined 
that this submission does not constitute human subjects research as defined under federal 
regulations [45 CFR 46.102 (d or f) and 21 CFR 56.102©(e)(l)] and does not require IRB 
approval.  
 
Study Description:  
 
Purpose: This DNP project is an educational project targeting Enhanced Role Registered Nurses 
(ERRN) who work in the NC Local Health Department STD Clinics. The PI (Jessica Grimes) 
will provide evidence-based education to the ERRNs on the importance of utilizing depression 
screens for patients at risk for HIV or STDs and evaluate the effectiveness of the education and 
the ERRN's self-reported efficacy and frequency of depression screens in the STD Clinics. 
 
Participants: Enhanced Role Registered Nurses who work in the NC Local Public Health 
Department STD Clinics 
 
Procedures (methods): 
 
This project will be completed in three phases. During Phase One, the ERRNs will complete a 
voluntary participation needs assessment survey to determine the ERRN’s baseline knowledge 
and skills along with barriers to practice. 
 
In Phase Two, the PI will design and offer an evidence based Continuing Nurse Education 
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(CNE) course on depression screening to the ERRNs to meet the knowledge and skills gap 
identified in the needs assessment. The CNE will include pretest and posttest questions to 
measure learner outcomes.  CNE will be offered for participants who request CNE, via the NC 
Division of Public Health Public Health Nursing and Professional Development Unit, which is 
the regulatory body that awards CNE credit to ERRNs.  This DNP project will look at pre/post 
test results with names and identifying data removed. 
 
Finally, in Phase Three, the ERRNs who voluntarily participate in the course will receive two 
surveys spaced three weeks apart weeks to evaluate the ERRNs' knowledge on the association 
between risk for STDs/HIV and depression, the ERRNs self-reported self-efficacy and practice 
change as measured by self-reported frequency of depression screens performed in the STD 
Clinics, and achievement of Specific, Measurable, Attainable, Realistic and Timely (SMART) 
goals they set after the CNE course. 
 
 
 
 
 
Please be aware that approval may still be required from other relevant authorities or 
"gatekeepers" (e.g., school principals, facility directors, custodians of records), even though IRB 
approval is not required. 
 
If your study protocol changes in such a way that this determination will no longer apply, you 
should contact the above IRB before making the changes. 
 
 
 
CC: 
Jean Davison, School of Nursing 
Lisa Miller , School of Nursing Deans OfficeIRB Informational Message - please do not use 
email REPLY to this address 
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APPENDIX 5: JUNE 11, 2017 EMAIL WITH MEMO TO DIRECTORS OF NURSING 
Sent on behalf of Jessica Grimes, RN, DNP candidate at UNC SON.  Please send all replies to Jessica. 
  
To NC LHD Directors of Nursing and Nurse Supervisors, 
  
My name is Jessica Grimes and I am a second year Doctor of Nursing Practice (DNP) student at 
the University of North Carolina at Chapel Hill School of Nursing. I am emailing you to request 
your support for my DNP project designed to provide education to the Enhanced Role Registered 
Nurses about the importance of depression screening in the STD clinics. I have attached a memo 
for further detail of my objectives and wishes for my DNP Project. I welcome any questions, 
comments, or suggestions you have. I appreciate your feedback and support. I look forward to 
working with you! 
  
Jessica Grimes, BSN, RN 
DNP Candidate 
University of North Carolina at Chapel Hill 
  
301-717-2290 mobile 
jkaylyn@email.unc.edu 
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Memo Attachment 
TO:  NC LHD Directors of Nursing and Nurse Supervisor 
FROM: Jessica Grimes, RN, and DNP Candidate 
SUBJECT: Requesting Support for Providing Education to ERRNs on Depression Screening during STD 
Clinic Visits 
 
 
My name is Jessica Grimes and I am a Doctor of Nursing Practice (DNP) Family Nurse Practitioner 
student at the University of North Carolina at Chapel Hill.  I am beginning a DNP Project designed to 
enhance healthcare systems through evidence-based interventions and guidelines on depression screening 
and request your support for my DNP Project.  I am passionate about incorporating mental health into 
primary care. Depression screening is an effective way to identify individuals needing mental health care. 
The United States Preventative Services Task Force (USPSTF) recommends depression screening for all 
adolescents and adults. Research shows that individuals who are at risk for STDs are also at risk for 
depression because both share some of the same risk factors like drug/substance use and unprotected sex. 
 
In learning about the Enhanced Role Registered Nurses’ pivotal role in the STD Clinics, I believe the 
ERRNs are in a great position in their daily interactions with individuals at risk for STDs to also screen 
for depression in accordance with the USPSTF guidelines. 
 
For my DNP Project, I will provide Continuing Nurse Education (CNE)* to ERRNs about the importance 
of depression screening in the STD Clinics in hopes that the ERRNs will be able to take this education 
and screen patients in the STD Clinics for depression. I understand that there will be a multitude of 
barriers to address. Therefore, I will send out a needs assessment survey to the ERRNs to assess the 
learning gaps and barriers to better tailor my CNE to fit the ERRNs’ needs. Following the dissemination 
of the CNE course, I will follow up with the ERRNs to see if the education has changed or affected their 
practice. 
 
I am fortunate to have Dr. Jean Davison as my DNP Project chair and Dr. Susan Little on my committee 
who have both been instrumental in helping me to understand the structure and role of the ERRNs in the 
STD Clinics as I prepare to offer this CNE. In addition, the NC Communicable Disease Branch and 
TATP Nurse Consultants are in support of this project. Your leadership is key in supporting the ERRNs 
as they care for underserved populations. I hope that I can add to the strong contribution the ERRNs make 
to their communities through my DNP Project. Please let me know any questions you have and I look 
forward to working with you.  
 
Sincerely, 
 
Jessica Grimes, BSN, RN 
DNP Candidate 
University of North Carolina at Chapel Hill School of Nursing 
301-717-2290 mobile 
jkaylyn@email.unc.edu  
 
 
*The Public Health Nursing and Professional Development Unit, North Carolina Division of Public Health, is approved as a provider of 
continuing nursing education by the North Carolina Nurses Association, an accredited approver by the American Nurses Credentialing Center’s 
Commission on Accreditation. 
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APPENDIX 6: JUNE 11, 2017 EMAIL WITH MEMO: LHD DON FEEDBACK 
Email with Question 
 
From: LHD DON  
Sent: Monday, June 12, 2017 8:15 AM 
To: Little, Susan H 
Subject: RE: Depression Screening in the STD Clinic 
  
Susan, has this been vetted with the STD Nurse Consultants across the regions? Is depression 
screening a mandated part of the STD assessment and exam and is there a tool recommended 
currently for the assessment?  I think this is the only way it will be incorporated as a required 
element of the patient care for the STD ERRNs? Will it be taught as a part of the ERRN 
coursework in Chapel Hill? I am drafting a policy for working with new CH ERRNs and the 
CRAAFT screening tool is a required element for them for adolescent assessments. Thanks 
  
LHD DON 
  
CONFIDENTIALITY NOTICE: This message and any attachments included are from the 
Mecklenburg County Health Department and are for sole use by the intended recipient(s).  The 
information contained herein may include confidential or privileged information. Unauthorized 
review, forwarding, printing, copying, distributing, or using such information is strictly 
prohibited and may be unlawful. If you received this message in error, or have reason to believe 
you are not authorized to receive it, please contact the sender by reply email and destroy all 
copies of the original message. Thank you! 
 
Email Response from Susan Little  
 
From: Little, Susan H 
Sent: Monday, June 12, 2017 8:41 AM 
To: LHD DONs and Nurse Supervisors  
Cc: STD Nurse Consultant>; jkaylyn@email.unc.edu 
Subject: RE: Depression Screening in the STD Clinic 
  
Good morning, LHD DON; 
  
Thank you so much for your insightful questions.  Jessica is using this DNP project and the 
related CNE training and practice evaluation to evaluate the integration of EB depression 
screening, as recommended by the United States Preventative Services Task Force, into the STD 
ERRN visit.  The STD Nurse Consultant, of the CD Branch, and Dr. Jean Davison, UNC SPH 
Instructor of the STD ERRN training have been involved in the planning of the project (Dr. 
Davison is Jessica’s DNP Committee Chair).  The STD Nurse Consultant has been 
communicating with the other TATP Nurse Consultants about the project. 
  
We have spoken at length about some of the barriers that will need to be addressed, policy being 
one of them.  They will use a tool that is already addressed in the STD ERRN training (PHQ-
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2).  Agency policy and where/how to document in the existing STD visit encounter form will be 
addressed as part of the training. Dr. Davison will assess the DNP project outcomes with the 
intention of integrating the content into the STD ERRN training once the project is complete and 
data has been collected.  
  
Please let me know if you have any other questions! 
  
Take 
Susan 
 
Email Response from LHD DON 
 
Great to know all sides are working on this to incorporate into the ERRN STD assessment. 
Behavioral Health is so much a missed opportunity in all areas of our practice. THX 
  
LHD DON 
  
CONFIDENTIALITY NOTICE: This message and any attachments included are from the 
Mecklenburg County Health Department and are for sole use by the intended recipient(s).  The 
information contained herein may include confidential or privileged information. Unauthorized 
review, forwarding, printing, copying, distributing, or using such information is strictly 
prohibited and may be unlawful. If you received this message in error, or have reason to believe 
you are not authorized to receive it, please contact the sender by reply email and destroy all 
copies of the original message. Thank you! 
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Selected LHD DON Email Response with Support 
 
Email One 
 
You are absolutely correct in that many of my clients have issues with depression and low self-
esteem.  These are not stupid people that seem to be on a revolving door into my clinic.  There 
poor choices are rather a product of needing attention in some cases rather than not knowing of 
the risks and dangers of having unprotected sex with “strangers”.  I use the word strangers a lot 
in discussing risk reduction in that when you know someone’s name and facial recognition, that 
does not mean that you know them.  I look forward to you presenting the course to NC STD 
ERRN’s.  I have been an STED ERRN since 1996 and am anxious to learn anything new to help 
my clients.  
  
LHD DON 
 
Email Response from Jessica Grimes  
 
LHD DON, 
 
It is wonderful to hear a first-hand experience from caring for this vulnerable population. I really 
hope I can make a difference and strengthen a wonderful program and cause! 
 
Thank you for your support! 
 
Jessica Grimes  
Email Two  
 
Thank you for sharing your project, yes I think this is a great idea and I wholeheartedly support 
it. I am actually doing a project where we are incorporating Post-Partum Depression Screening in 
our WIC clinics. I am copying our Health Manager for our Adult Clinics to let her know I am in 
support of this initiative. Please advise how I can help. I actually have over 30 years of 
community behavioral experience. I just joined the PHD two years ago. I look forward to 
speaking to you in the future. 
  
LHD DON 
 
Email Response from Jessica Grimes 
 
LHD DON, 
  
Thank you so much for your thoughtful and supportive response. I am excited to work with such 
an influential group of nurses and hope I can make a difference for these clients. Thank you for 
copying your Health Manager to this email. I will definitely email you for any advice going 
forward.  
  
I look forward to working with you! 
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Jessica Grimes, BSN, RN 
DNP Candidate  
University of North Carolina at Chapel Hill 
  
301-717-2290 mobile 
jkaylyn@email.unc.edu 
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APPENDIX 7: NEEDS ASSESSMENT SURVEY 
At the start of the survey, the ERRN were asked to enter a best contact email and state the 
county the ERRN works in. Additionally, the ERRNs were asked the following question to see if 
they would be interested in a CNE opportunity:  
A Continuing Nurse Education will be offered to ERRNs addressing the importance of 
depression screening during STDs/HIV risk assessments and the application of depression 
screening into practice. Would you find this Continuing Nurse Education content beneficial? 
a. Yes  
b. No  
c. Maybe  
If interested, may we contact you by email? 
a. Yes 
b. No 
After the introduction question, the survey will begin with a statement of confidentiality 
and voluntary consent: “Thank you for voluntarily taking this survey. This is a Doctor of Nursing 
Practice project with the University of North Carolina at Chapel Hill School of Nursing. Your 
responses will be anonymous and data will be compiled so that your comments and responses 
will not be associated with your email or personal identifying information.” 
 The survey questions are as follows: 
1. How many years have you worked as an STD Enhanced Role RN? 
a. 0-1 years 
b. 1-2 years 
c. 3-4 years 
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d. 5 years or greater 
2. How many days per week are STD services available at your agency? 
a. 1-2 days 
b. 3-4 days 
c. 5 days or more 
3. What is the average number of patients/clients you assess as an STD Enhanced Role RN 
in the STD clinic per week? 
a. 1-5 clients 
b. 6-10 clients 
c. 11-15 clients 
d. 16-20 clients 
e. 21 clients or more 
4. Do you function in other ERRN or clinic roles? If so what are those roles? 
a. No 
b. Yes. Please describe.  
5. How often does your agency screen for depression? 
a. My agency screens all adults for depression regardless of clinic 
b. Depression screening is done in some agency clinics but not in the STD clinics* 
c. My agency screens females for depression in clinics such as the prenatal care, 
women’s health, family planning, and/or Breast and Cervical Cancer Control 
Program (BCCCP) but males are not a part of these clinics so males do not get 
screened for depression 
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If a survey participant selects answer choice 5b they will be directed to the following question: 
What agency clinics do screen for depression? Please write in your answer. 
6. How often do you screen for depression? Please choose the best answer that reflects your 
personal screening practices. 
a. I personally screen for depression if a patient presents with signs of depression. 
Signs of depression include but are not limited to apathy in regards to treatment of 
STDs, lack of social support, depressed mood, expressing feelings of 
hopelessness, self-care deficit, or changes in behavior, mood, or affect if you see 
this patient on multiple occasions**. 
b. I personally screen all patients for depression regardless of subjective or objective 
signs of depression**. 
c. I personally do not screen for depression in the STD clinic, but screen in women’s 
health and/or prenatal clinics. 
d. I personally do not screen for depression due to my comfort level, lack of mental 
health referral services, and because depression screening is not required on our 
assessment forms***. 
**If a survey participant selects answer choice 6a or 6b they will be directed to the following 
question: How do you screen for depression? 
a. A verified screening tool. If yes, what is the screening tool? Please write in your 
answer. 
b. I use my own questions I feel are most appropriate for the patient or situation. 
*** If a survey participant selects answer choice 6d they will be directed to the following 
question: Individually check all that apply. I personally do not screen for depression due to: 
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a. My comfort level 
b. I believe mental health referral options are limited should a patient screen positive 
on the depression screen 
c. Depression screens are not required on our assessment forms 
d. Other. Please write in your answer.  
7. What are some barriers to depression screening in your STD Clinic? Check all that 
apply. 
a. No enough or limited time 
b. Not recommended or supported in our STD clinic 
c. Comfort level with administering and interpreting depression screens 
d. No adequate referrals to mental health services 
e. I am concerned with what to do if I get a positive result 
f. I am not familiar with the mental health services available 
g. I cannot bill for depression screens in the STD Clinic 
h. Other. Please describe 
8. I am comfortable and confident in my ability to screen for depression and refer to mental 
health resources as necessary. 
a. Strongly agree 
b. Agree 
c. Neither agree nor disagree 
d. Strongly disagree 
9. Are you familiar with the mental health resources available to your patients in your 
community? 
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a. Yes 
b. No 
c. Somewhat  
10. Does your agency have a referral process in place for clients needing mental health 
services? 
a. Yes 
b. No 
c. I don’t know 
11. What are some risk factors STDs/HIV and depression share? Select all that apply. 
a. Unprotected sex 
b. Sex with multiple partners  
c. Sexual relations with sex workers 
d. Drug and or alcohol use 
e. Sexual compulsivity  
f. Sex for drugs or money 
12. I understand the association between populations at risk for STDs/HIV and depression 
and can apply this concept into my role as an Enhanced Role RN. 
a. Strongly agree 
b. Agree 
c. Neither agree nor disagree 
d. Strongly disagree 
13. Please share your preferred learning method. Check all that apply. 
a. Live webinars where I can ask questions 
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b. Online modules I can take at anytime 
c. Other. Please describe. 
14. Please share your preferred learning style. Select all that apply. 
a. Visual 
b. Verbal (such as writing out the new concept in your own words via an outline or 
notes) 
c. Auditory 
d. Learning through experience or practice 
e. Taking time to reflect on what you know and the new information you will be 
learning 
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APPENDIX 8: NEEDS ASSESSMENT SURVEY CROSS TABULATION TABLES 
Table 3 
ERRN Years of Experience with Depression Screening Practices  
 ERRN years of experience 
  0-1 years 1-2 years 3-4 years 
5 years or 
more Total 
I personally do not screen 
for depression. 1 (11%) 2 (20%) 1 (8%) 3 (10%) 7 (11%) 
I personally do not screen 
for depression in the STD 
clinic, but screen in 
women’s health and/or 
prenatal clinics. 3 (33%) 2 (20%) 9 (75%) 9 (30%) 23 (38%) 
I personally screen for 
depression if a patient 
presents with signs of 
depression. 2 (22%) 5 (50%) 2 (17%) 16 (53%) 25 (41%) 
I personally screen all 
patients for depression 
regardless of subjective or 
objective signs of 
depression. 3 (33%) 1 (10%) 0 (0%) 2 (7%) 6 (10%) 
Total number (n) 9 10 12 30 61 
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Table 4 
ERRN Years of Experience with Comfort Level with Administering Depression Screens and 
Referring to Mental Health 
 
 ERRN years of experience  
“I am comfortable and 
confident in my ability to 
screen for depression and 
refer to mental health 
services if needed.” 0-1 years 1-2 years 3-4 years 
5 years 
or more Total 
Strongly disagree 0 (0%) 0 (0%) 1 (9%) 0 (0%) 1 (2%) 
Disagree 1 (11%) 1 (10%) 1 (9%) 3 (10%) 6 (10%) 
Neither agree nor disagree 2 (22%) 4 (40%) 4 (36%) 4 (14%) 14 (24%) 
Agree 5 (56%) 5 (50%) 4 (36%) 19 (66%) 33 (56%) 
Strongly agree 1 (11%) 0 (0%) 1 (9%) 3 (10%) 5 (8%) 
Total number (n) 9 10 11 29 59 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
115 
Table 5 
ERRN’s Comfort Level with Administering Depression Screens and Referring to Mental Health 
with Depression Screening Practices 
 
 
“I am comfortable and confident in my ability to screen for 
depression and refer to mental health services if needed.” 
Strongly 
disagree Disagree 
Neither 
agree 
nor 
disagree Agree 
Strongly 
agree 
 
 
Total 
I personally do not 
screen for depression.     0 (0%) 
3  
(50%) 
3  
(21%) 
1  
(3%) 
0  
(0%) 
7  
(12%) 
I personally do not 
screen for depression in 
the STD clinic, but 
screen in women’s 
health and/or prenatal 
clinics. 1 (100%) 
1  
(17%) 
4  
(29%) 
12 
 (36%) 
 3  
(60%) 
21 
 (36%) 
I personally screen for 
depression if a patient 
presents with signs of 
depression. 
0  
(0%) 
2  
(33%) 
6  
(43%) 
15 
 (45%) 
2  
(40%) 
25 
 (42%) 
I personally screen all 
patients for depression 
regardless of subjective 
or objective signs of 
depression. 
0  
(0%) 
0  
(0%) 
1  
(7%) 
5  
(15%) 
0  
(0%) 
6  
(10%) 
Total number (n) 1 6 14 33 5 59 
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Table 6 
ERRN’s Understanding of the Association between STDs/HIV and Depression with Depression 
Screening Practices 
 
 I understand the association between populations at risk for 
STDs/HIV and depression and can apply this concept into my 
role as an Enhanced Role RN. 
Disagree Neither 
agree nor 
disagree 
Agree Strongly 
agree 
Total 
I personally do not screen 
for depression. 
 
0 (0%) 
 
3 (19%) 
 
4 (12%) 
 
0 (0%) 
 
7 (12%) 
I personally do not screen 
for depression in the STD 
clinic, but screen in 
women’s health and/or 
prenatal clinics.  1 (50%) 5 (31%) 12 (36%) 3 (43%) 21 (36%) 
I personally screen for 
depression if a patient 
presents with signs of 
depression. 1 (50%) 5 (31%) 15 (45%) 3 (43%) 24 (42%) 
I personally screen all 
patients for depression 
regardless of subjective or 
objective signs of 
depression. 0 (0%) 3 (19%) 2 (6%) 1 (14%) 6 (10%) 
Total number (n)             2 16 33 7 58 
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Table 7 
Average Number of Patients Seen per Week with Depression Screening Practices 
 Average number of patients seen in STD clinic per week 
 1-5 
patients 
6-10 
patients 
11-15 
patients 
16-20 
patients 
21 patients 
or more 
Total 
I personally do 
not screen for 
depression. 0 (0%) 1 (8%) 0 (0%) 1 (14%) 5 (33%) 7 (11%) 
I personally do 
not screen for 
depression in 
the STD clinic, 
but screen in 
women’s 
health and/or 
prenatal 
clinics. 9 (47%) 5 (42%) 3 (38%) 2 (29%) 4 (27%) 23 (38%) 
I personally 
screen for 
depression if a 
patient 
presents with 
signs of 
depression. 8 (42%)  (50%)  (38%)  (57%)  (27%) 5 (41%) 
I personally 
screen all 
patients for 
depression 
regardless of 
subjective or 
objective signs 
of depression. 2 (11%) 0 (0%) 2 (25%) 0 (0%) 2 (13%) 6 (10%) 
Total number 19 (31%)  12 (20%) 8 (13%) 7 (11%) 15 (25%) 61 
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APPENDIX 9: EMAIL TO BRANCH HEADS REQUESTING TEMPORARY POLICY 
ADDENDUM APPROVAL WITH ATTACHED TEMPORARY POLICY ADDENDUM 
 
Dear Branch Heads, 
  
Hello, my name is Jessica Grimes and I am a Doctor of Nursing Practice (DNP) student at the 
University of North Carolina at Chapel Hill. For my DNP Project, I am excited to work with the 
STD Enhanced Role RNs (ERRNs) to incorporate a depression screening questionnaire into the 
STD risk history assessment.  I will provide the ERRNs with training on the Patient Health 
Questionnaire-2 or PHQ-2 to screen all clients in the STD clinics for depression. The PHQ-2 is a 
great option for STD clinics because it is quick, easy to use, includes the same symptoms as the 
American Psychiatric Association’s diagnostic criteria for depression, and has a high sensitivity 
and specificity. I have worked with Dr. Jean Davison from the UNC School of Nursing and Dr. 
Susan Little and a TATP Nurse Consultant from the NC DPH during the planning of this project 
and creation of the training and related documents. 
  
I understand that in order for the Enhanced Role RNs to screen for depression in the STD Clinic, 
there must be a temporary LHD STD program policy addendum in place. I have attached a 
proposed policy addendum to this email that I created in consultation with Dr. Little and the 
TATP Nurse Consultant. I would greatly appreciate any feedback, comments, or concerns. 
  
I am grateful for the opportunity to collaborate with NC DPH and work with the Enhanced Role 
RNs over the course of my DNP Project.  I hope I can enhance the great work the Enhanced Role 
RNs do every day to improve the health of our communities. Thank you for your time and 
consideration. I look forward to hearing from you soon with any feedback or suggestions to 
improve the draft policy addendum I have attached. 
  
  
Sincerely, 
  
Jessica Grimes, BSN, RN 
DNP Candidate  
University of North Carolina at Chapel Hill 
  
301-717-2290 mobile 
jkaylyn@email.unc.edu 
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                                     COUNTY HEALTH DEPARTMENT 
Policy and Procedure Addendum 
 
 
Purpose:  The United States Preventative Services Task Force recommends depression 
screening for all adolescents and adults.  Because depression is associated with the risk of 
STDs/HIV, all STD Enhanced Role RNs (ERRNs) will integrate depression screening into the 
STD visits during a pilot project conducted by the UNC School of Nursing.  The pilot project 
will start once the STD ERRNs have received training and will continue through December 
2017.   
 
Policy: The STD Enhanced Role RNs will screen all patients they assess in the STD Clinic using 
the PHQ-2 depression screen. 
 
Definitions:  The Patient Health Questionnaire-2 or PHQ-2 is a two question depression screen 
filled out by the patient and scored by the clinician. The PHQ-2 asks the patient the frequency of 
anhedonia or depressed mood over the past two weeks.  
 
Responsibilities:  STD Enhanced Role RNs 
 
Procedure: 
1. The ERRNs will give a paper copy of the PHQ-2 to the patients they assess in the STD 
Clinic for the patient to complete.  
2. The ERRNs will score, date, and sign the paper PHQ-2, affix a patient label, and scan the 
screen into the patient’s chart. 
3. If the PHQ-2 score is positive as indicated by a score of 3 or above, the ERRN will ask 
the patient “Have you had thoughts that you would be better off dead or of hurting 
yourself in some way?” and record the answer in the comments section. 
 
Title:   ERRN Depression Screening in the 
STD Clinic 
 
Category/Number: 
 
Approved By: __________________________ 
 
                         __________________________ 
 
Section: ______________________________ 
 
Program: _____________________________ 
 
 
Effective Date: _______  
 
Current Revision Effective Date: 
 
Revision History Date/s: _________________ 
 
 
Review Date/s: _________________________ 
 
______________________________________ 
 
______________________________________ 
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4. In the comments section of the visit encounter, the STD ERRN will also add a note with 
the results of the PHQ-2 screening, any information provided to the patient, and any 
referrals made to mental health resources. 
 
References: The United States Preventative Services Task Force recommends depression 
screening for all adolescents and adults.  
 
U.S. Preventative Services Task Force. (2016). Final recommendation statement:  depression in 
adults: screening. Retrieved from  https://www.uspreventiveservicestaskforce.org/ 
 Page/Document/RecommendationStatementFinal/depression-in-adults-screening1 
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APPENDIX 10: SEPTEMBER 25, 2017 EMAIL REQUESTING SUPPORT TO THE 
DIRECTORS OF NURSING AND NURSE SUPERVISORS 
 
To the Directors of Nursing and Nurse Supervisors, 
  
Hello, my name is Jessica Grimes and I am a Doctor of Nursing Practice (DNP) student at UNC 
Chapel Hill. In partial fulfillment of my degree, I am conducting a DNP Project in which I will 
be disseminating a course which is eligible to count toward STD ERRN continuing education 
requirements.  The course is about the importance of performing depression screens in the STD 
clinics due to the close association between depression and the risk of STDs/HIV and the 
USPSTF’s recommendation to screen all adolescents and adults for depression.  I originally 
reached out to you about this project on 6/11/2017 and am seeking your support in helping the 
ERRNs conduct depression screens in your STD clinic after they complete the required online 
course.  I have included a copy of the course presentation (attached to this email). 
  
I am grateful to have Dr. Susan Little and Dr. Jean Davison on my project committee who have 
been instrumental in helping me formulate and offer this course to the STD ERRNs. I have 
created a temporary policy addendum (attached to this email) with the help of Dr. Little, Dr. 
Davison, and three TATP STD Nurse Consultants that has been approved by NC DPH Branch 
Heads to support the STD ERRNs as they begin to conduct depression screens in the STD clinic. 
Depending on the policies and logistics of your health department, you may adopt this temporary 
policy addendum as is or adapt it as you see fit to support the ERRNs performing depression 
screens in the STD clinic. 
  
The below timeline was created to support implementation during this pilot project: 
1. October 2 to October 16: The course will be sent out the ERRNs and they will have two 
weeks to view the course and complete the course requirements 
2. October 16 to October 30: The ERRNs will be asked to communicate and work with you 
to decide the best way to implement depression screens in your clinic including change in 
clinic process to include new practice, adopting or adapting the temporary policy 
addendum, and training ERRNs and other affected agency employees on the new policy 
3. October 30: The ERRNs will begin implementing depression screens in the STD clinic 
4. November 20: I will send out an initial survey asking the ERRNs to self-report their 
progress on their SMART goal around screening for depression in the STD clinic. This is 
a self-report, I am not asking for any specific client data  
5. December 11: I will send out a final survey asking the ERRNs to self-report their 
progress on screening for depression in the STD clinic (again, I am not asking for any 
client data or chart audits) 
  
Please let me know if you have any questions or concerns and I would be happy to address them 
with you. Thank you for your consideration, time, and support. I look forward to working with 
you and the ERRNs. 
  
  
Sincerely, 
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Jessica Grimes, BSN, RN 
DNP Candidate  
University of North Carolina at Chapel Hill 
  
301-717-2290 mobile 
jkaylyn@email.unc.edu 
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APPENDIX 11: EMAIL TO STD ERRNS OFFERING COURSE 
 
Sent on behalf of Jessica Grimes, RN, DNP candidate at UNC SON.  Please send all replies to Jessica 
(jkaylyn@email.unc.edu).  Please excuse this email if you are not involved in the STD clinic.  Susan 
  
STD ERRNs, 
  
Hello, my name is Jessica Grimes and I am a Doctor of Nursing Practice (DNP) student at UNC 
Chapel Hill.  You may remember this summer I sent a survey to all STD ERRNs asking about 
current depression screening practices in the STD clinic.  Based on your feedback, I am offering 
a course with CNE contact hours, which can be used toward your required ERRN continuing 
education, on the benefit and need to perform depression screening in the STD clinic. This 
course will provide you with the knowledge and tools to understand why depression screening is 
vital to patients presenting to the STD clinic, information about depression, how to perform 
depression screens specific to the STD clinic and this project and set goals to assist transitioning 
knowledge into practice. 
  
After completing the online course, STD ERRNs are asked to conduct depression screening in 
the STD clinic for this pilot project. The timeline below was created to support implementation 
and has been shared with nursing supervisors and DONs: 
  
October 2 to October 16: View the course and complete the course requirements 
  
October 16 to October 30:  Work with your program or nursing supervisor/DON to decide the 
best way to implement depression screens in your clinic including any change in clinic process to 
include new practice, adopting or adapting the temporary policy addendum, and training STD 
ERRNs and other affected agency employees on the new policy 
  
October 30:  Begin implementing depression screens in the STD clinic 
  
November 20:  I will send out an initial survey asking the STD ERRNs to self-report their 
progress on their goal around screening for depression in the STD clinic. This is a self-report, I 
am not asking for any specific client data 
  
December 11:   I will send out a final survey asking the STD ERRNs to self-report their progress 
on screening for depression in the STD clinic 
  
To receive 2.0 CNE contact hours for this course, you must complete the pretest prior to the 
course, the course, and the posttest. For your reference, this email includes the following 
attachments: the PowerPoint presentation with speaker notes and PowerPoint presentation 
handout, mental health resources available to you and your patients, the PHQ-2 depression 
screen, and a temporary policy addendum in support of STD ERRNs performing depression 
screens in the STD clinic. The links to the pretest, course, and posttest are below. 
  
Pretest: https://unc.az1.qualtrics.com/jfe/form/SV_dgsnevMcxMFOJM1 
  
Course: https://echo360.org/media/ff2d88db-446d-4b10-858e-5c7f0f9e7815/public 
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Posttest and link to certificate: https://unc.az1.qualtrics.com/jfe/form/SV_e3RLiw2I0eWOFHT 
  
Please let me know if you have any questions. I look forward to working with you! 
  
  
Jessica Grimes, BSN, RN 
DNP Candidate 
University of North Carolina at Chapel Hill 
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APPENDIX 12: FOLLOW-UP SURVEYS 
 
First Follow-Up Survey 
 
1. Reflect on the SMART goal you set a few weeks ago. Measure your SMART goal 
progress using the Goal Attainment Scale below. 
a. I always exceeded my goal 
b. I almost always exceeded my goal 
c. I met my goal 
d. I sometimes met my goal 
e. I never met my goal 
2. What are some barriers you encountered when screening for depression in your STD 
clinic? Select all that apply. 
a. Not enough or limited time 
b. We weren’t able to get support from our leadership 
c. Comfort level with administering and interpreting depression screens 
d. No adequate referrals options to mental health services 
e. I am not familiar with the mental health services available  
f. It was difficult to document depression screen results in the medical record 
g. I did not encounter any barriers or was able to resolve them without much 
difficulty 
h. Other. Please describe. 
3. What are some supportive factors you found when screening for depression in your STD 
clinic? Select all that apply. 
a. Support from leadership 
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b. I had the education and /or tools I needed to implement depression screens 
c. My STD clinic’s medical record system allowed for easy documentation of 
depression screen results 
d. I had adequate time to screen patients for depression during the STD visit 
e. Other. Please describe.  
4. Please provide any additional comments you have about your experience implementing 
depression screens in your STD clinic. 
Second Follow Up Survey 
1. Reflect on the SMART goal you set a few weeks ago. Measure your SMART goal 
progress using the Goal Attainment Scale below. 
a. I always exceeded my goal 
b. I almost always exceeded my goal 
c. I met my goal 
d. I sometimes met my goal 
e. I never met my goal 
2. What are some risk factors STDs/HIV and depression share? Check one or more that 
apply. 
a. Unprotected sex 
b. Sex with multiple partners 
c. Sexual relations with sex workers 
d. Drug and or alcohol use 
e. Sexual compulsivity 
f. Sex for drugs or money 
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g. All of the above 
3. What are signs and symptoms of depression? 
a. Anhedonia (inability to feel pleasure in things that were once pleasurable) 
b. Psychomotor agitation (movements that serve no purpose such as pacing around 
the room, tapping your toes, or abruptly starting and stopping tasks) 
c. Feeling tired or having little energy 
d. All of the above 
4. How does the United States Preventative Services Task Force recommend clinicians 
screen for depression? 
a. Screen only adults 
b. Screen adults and adolescents with appropriate systems in place to ensure 
adequate follow up 
c. Screen in mental health clinics only that are more equipped to deal with 
depression 
d. Screen adults only if they show signs and symptoms of depression 
5. The PHQ-2 is 
a. A brief depression screen 
b. Establishes a diagnosis of depression 
c. Uses symptoms from DSM-5 
d. Both A and C 
6. The PHQ-2 asks the following two questions: 
a. Feeling bad about yourself or that you are a failure or have let yourself or your 
family down  
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b. Thoughts that you would be better off dead or of hurting yourself in some way 
c. Little interest or pleasure in doing things 
d. Feeling down, depressed, or hopeless 
7. What are some barriers you encountered when screening for depression in your STD 
clinic? Select all that apply. 
a. Not enough or limited time 
b. We weren’t able to get support from our leadership 
c. Comfort level with administering and interpreting depression screens 
d. No adequate referrals options to mental health services 
e. I am not familiar with the mental health services available  
f. It was difficult to document depression screen results in the medical record 
g. I did not encounter any barriers or was able to resolve them without much 
difficulty 
h. Other. Please describe. 
8. What are some supportive factors you found when screening for depression in your STD 
clinic? Select all that apply. 
a. Support from leadership 
b. I had the education and /or tools I needed to implement depression screens 
c. My STD clinic’s medical record system allowed for easy documentation of 
depression screen results 
d. I had adequate time to screen patients for depression during the STD visit 
e. Other. Please describe.  
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9. Please provide any additional comments you have about your experience implementing 
depression screens in your STD clinic. 
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APPENDIX 13: DEPRESSION SCREENING IN THE STD CLINIC COURSE  
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APPENDIX 14: ANCC NC DPH PUBLIC HEALTH NURSING & PROFESSIONAL 
DEVELOPMENT UNIT: ACTIVITY PLANNING TABLE – LIVE/ENDURING MATERIAL  
 
Title of Activity: Depression Screening in the STD Clinic 
Identified Gap(s): The learners do not know the relationship between depression and risk for STDs 
and could potentially not be applying this knowledge and skill into practice. A needs assessment 
survey, deployed outside of the context of this learning activity, will help to determine the 
current knowledge and skills base to best formulate the CNE to meet the ERRN's needs.  See 
needs assessment results attached. 
Description of current state: NC STD ERRNs do not consistently use depression screening tools 
in STD visits in LHDs. This may be due to lack of supporting policy or lack of understanding 
the association between depression and high-risk sexual activities. 
Description of desired/achievable state: The learner should be able to understand the association 
between risk for STDs and depression; USPSTF depression guidelines; use the PHQ2 regularly 
in the STD clinics; be able to recognize and work to overcome barriers to screening for 
depression in the STD clinics. 
Gap to be addressed by this activity: X   Knowledge      X   Skills              Practice                
Other: Describe       
Learning Outcome (s)   
1. The learner will understand the association between risks for STDs and depression 
2. The learner will be able to interpret the PHQ2  
3. The learner will be able to apply the PHQ2 in the STD clinic 
4. The learner will create a SMART Goal related to using the PHQ2 in their practice in the 
STD clinic 
Select all that apply: Nursing Professional Development     X  Patient Outcome            
Other: Describe       
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CONTENT 
(Topics) 
TIME 
FRAME 
(If live) 
PRESENTER/AUT
HOR 
TEACHING 
METHODS/ 
LEARNER 
ENGAGEMENT 
STRATEGIES 
§ Information about STDs/HIV 
(quick review and update for 
the ERRN) 
o Prevalence of 
STDs/HIV with an 
emphasis on those 
who do not know their 
STDs/HIV status and 
those that are 
STDs/HIV positive 
but not in treatment  
o Comparison of 
national STDs/HIV 
goals and the progress 
North Carolina has 
made to meet these 
national objectives 
o Pathophysiology of 
STDs/HIV 
transmission 
o STDs/HIV risk factors 
o Ways to reduce 
STDs/HIV risks via 
primary prevention 
measures including 
pre-exposure 
prophylaxis  
o STDs/HIV screening 
recommendations/seco
ndary prevention 
o Importance of getting 
an HIV+ person into 
treatment to prevent 
the comorbidities of 
HIV and progression 
to AIDS/tertiary 
prevention 
o Legal and ethical 
2 hours Jessica Grimes • Webinar will 
have visual 
PowerPoint 
slides with 
voice over 
• Demonstration 
videos of how 
to perform and 
interpret 
depression 
screens 
• Follow along 
question and 
answer 
• Opportunities 
to reflect on 
current practice 
and potential to 
integrate new 
knowledge into 
practice 
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considerations for 
people living with 
STDs/HIV and 
providers caring for 
people living with 
STDs/HIV 
§ Information about depression 
o Prevalence of 
depression and 
prevalence of 
depression in people 
living with STDs/HIV 
o USPSTF guidelines on 
depression screening 
for adolescents and 
adults 
o Signs and symptoms 
of depression 
o Differences in 
mood/affect/behavior 
o Overview of 
suicide/homicide 
o Brief overview of 
depression 
management and 
treatment 
o Comorbidities of 
depression and 
association with 
STDs/HIV risk factors 
o Depression’s effect on 
treatment follow up 
and medication 
compliance for people 
living with STDs/HIV 
o USPSTF guidelines on 
depression screening 
§ Depression and risk of 
STDs/HIV 
o Risk factors shared 
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between depression 
and STDs/HIV 
o How screening for 
depression is 
beneficial to reduce a 
person’s risk of 
acquiring STDs/HIV 
o How to recognize risk 
factors for STDs/HIV 
as an increased need 
for depression 
screening 
o Types of depression 
screening and why the 
PHQ-2 is most 
appropriate for 
populations seeking 
care from a STD clinic 
o How to use and 
interpret results from 
the PHQ-2 and PHQ-9 
o Role play 
demonstration videos 
on how to screen for 
depression   
o Barriers to depression 
screening and how to 
address these barriers 
o Brief motivational 
interviewing 
techniques for patients 
who identify as 
depressed 
o Available mental 
health resources 
o How and when to 
refer to mental health 
o Psychiatric 
emergencies and how 
to handle these 
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emergencies 
o Provider bias of 
people living with 
depression 
§ Specific, Measurable, 
Achievable, Realistic, and 
Timely goals (SMART) 
o What are SMART 
goals 
o How do SMART 
goals provoke or 
influence practice 
change 
o How to set up 
SMART goals and 
measure progress via 
the GAS 
o Create one or two 
SMART goals in 
“class” 
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If Live: 
Note: Time spent evaluating the learning activity may be included in the total time when 
calculating contact hours. 
 Total Minutes TBD divided by 60=       contact hour(s) 
 
If Enduring: 
Method of calculating contact hours: 
        Pilot Study             Historical Data             Complexity of Content              
Other: Describe         
 Number of Contact Hours to be awarded:       
 
Completed By:  
      Name and Credentials            Date 
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NC DPH Public Health Nursing & Professional Development Unit Conflict of Interest 
Form 
Instructions for completing the Depression Screening in the STD Clinic Conflict of Interest 
Form: 
1. Please complete sections 1, 2, & 3 only.  Please provide only the information requested.  
We do not need a resume or CV. 
2. The form must remain in word format, so your dated electronic signature is accepted in 
lieu of an original signature. 
3. Once you have completed the form, please email it to Susan Little at 
susan.little@dhhs.nc.gov.  If you have any questions, do not hesitate to give me a call 
919-215-4471. 
 
Warm regards, 
 
Susan Little, DNP, RN, PHNA-BC, CPHQ 
Continuing Nursing Education Specialist/Primary Nurse Planner 
Public Health Nurse Consultant 
Division of Public Health, Local Technical Assistance and Training Branch 
Public Health Nursing & Professional Development Unit 
North Carolina Department of Health and Human Services 
 
919-215-4471 mobile 
susan.little@dhhs.nc.gov 
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Title of Educational Activity: Depression Screening in the STD Clinic 
Educational Activity Date: TBD  
Role in Educational Activity: (Check all that apply)       Nurse Planner   
        X  Content Expert 
        X  Faculty/Presenter/Author 
             Content Reviewer   
             Other – Describe:  
 
Section 1:  Demographic Data 
Name with Credentials/Degrees:  Jessica Grimes, BSN, RN 
 
If RN, Nursing Degree(s):        AD         Diploma   X BSN          Masters         Doctorate 
 
Address:  710 Perkins Drive Chapel Hill, NC 27514 
 
Phone Number:  301-717-2290    Email Address:  jkaylyn@email.unc.edu 
 
Current Employer and Position/Title: UNC Health Care, RN on Child and Adolescent Psychiatry 
unit 
 
Please describe expertise and years of training specific to the educational activity listed 
above. (If the description of expertise does not provide adequate information, the activity 
Nurse Planner may request additional documentation.) 
My expertise for this educational activity includes my role as a RN and my Doctor of Nursing 
Practice candidacy. As a psychiatric nurse, I perform depression screens, counsel patients 
suffering from depression, and counsel patients who perform high risk behaviors such as drug 
use, prostitution, and or compulsive sexual behavior. In these patient interactions, I must 
consistently interpret depression screens and make recommendations to the healthcare team. In 
addition, I am currently in the second year of the University of North Carolina at Chapel Hill 
School of Nursing DNP program. As a DNP student, I am researching the effect of depression on 
STD risk behavior and formulating a CNE for Enhanced Role Registered Nurses on the 
importance of performing depression screens in the STD clinics. 
 
Section 2: Conflict of Interest 
 
The potential for conflicts of interest exists when an individual has the ability to control or 
influence the content of an educational activity and has a financial relationship with a 
commercial interest,* the products or services of which are pertinent to the content of the 
educational activity. The Nurse Planner is responsible for evaluating the presence or absence of 
conflicts of interest and resolving any identified actual or potential conflicts of interest during the 
planning and implementation phases of an educational activity. If the Nurse Planner has an 
actual or potential conflict of interest, he or she should recuse himself or herself from the role as 
Nurse Planner for the educational activity.    
*Commercial interest, as defined by ANCC, is any entity producing, marketing, reselling, or 
distributing healthcare goods or services consumed by or used on patients, or an entity that is 
owned or controlled by an entity that produces, markets, resells, or distributes healthcare goods 
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or services consumed by or used on patients. (Please reference content integrity document for 
further clarity http://www.nursecredentialing.org/Accreditation-CEContentIntegrity.pdf ) 
All individuals who have the ability to control or influence the content of an educational activity 
must disclose all relevant relationships** with any commercial interest, including but not 
limited to members of the Planning Committee, speakers, presenters, authors, and/or content 
reviewers. Relevant relationships must be disclosed to the learners during the time when the 
relationship is in effect and for 12 months afterward. All information disclosed must be shared 
with the participants/learners prior to the start of the educational activity. 
**Relevant relationships, as defined by ANCC, are relationships with a commercial interest if 
the products or services of the commercial interest are related to the content of the educational 
activity.     
• Relationships with any commercial interest of the individual’s spouse/partner may be 
relevant relationships and must be reported, evaluated, and resolved. 
 
• Evidence of a relevant relationship with a commercial interest may include but is not 
limited to receiving a salary, royalty, intellectual property rights, consulting fee, 
honoraria, ownership interest (stock and stock options, excluding diversified mutual 
funds), grants, contracts, or other financial benefit directly or indirectly from the 
commercial interest.   
 
• Financial benefits may be associated with employment, management positions, 
independent contractor relationships, other contractual relationships, consulting, 
speaking, teaching, membership on an advisory committee or review panel, board 
membership, and other activities from which remuneration is received or expected from 
the commercial interest. 
 
Is there an actual, potential or perceived conflict of interest for yourself or spouse/partner? 
       Yes  X No 
 
If yes, please complete the table below for all actual, potential or perceived conflicts of 
interest**: 
 
Mark all  
that apply 
Category Description 
 Salary  
 Royalty  
 Stock  
 Speakers Bureau  
 Consultant  
 Other  
 
* *All conflicts of interest, including potential ones, must be resolved prior to the planning,    
implementation, or evaluation of the continuing nursing education activity. 
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Section 3:  Statement of Understanding 
Completion of the line below serves as the electronic signature of the individual completing this 
Conflict of Interest Form and attests to the accuracy of the information given above. 
Jessica Grimes, BSN, RN Name and Credentials (Required)  6/9/17 Date 
 
Section 4:  Conflict Resolution (to be completed by Nurse Planner) 
       Supporting documentation attached 
 
A. Procedures used to resolve conflict of interest or potential bias if applicable for this activity:  
       Not applicable since no conflict of interest. 
       Removed individual with conflict of interest from participating in all parts of the 
educational activity. 
       Revised the role of the individual with conflict of interest so that the relationship is no 
longer relevant to the educational activity. 
       Not awarding contact hours for a portion or all of the educational activity.   
       Undertaking review of the educational activity by the Nurse Planner and/or member of 
the planning committee to evaluate for potential bias, balance in presentation, evidence-based 
content or other indicator of integrity, and absence of bias, AND monitoring the educational 
activity to evaluate for commercial bias in the presentation.  
      Undertaking review of the educational activity by the Nurse Planner and/or member of the 
planning committee to evaluate for potential bias, balance in presentation, evidence-based 
content or other indicator of integrity, and absence of bias, AND reviewing participant feedback 
to evaluate for commercial bias in the activity.  
      Undertaking review of the educational activity by a content reviewer to evaluate for 
potential bias, balance in presentation, evidence-based content or other indicators of integrity, 
and absence of bias, AND monitoring the educational activity to evaluate for commercial bias in 
the presentation. 
      Undertaking review of the educational activity by a content reviewer to evaluate for 
potential bias, balance in presentation, evidence-based content or other indicators of integrity, 
and absence of bias, AND reviewing participant feedback to evaluate for commercial bias in the 
activity. 
      Other - Describe:        
 
 Nurse Planner Signature (*If form is for the activity Nurse Planner, a different Nurse 
Planner must review and sign). 
Completion of the line below serves as the electronic signature of the Nurse Planner reviewing 
the content of this Conflict of Interest Form.  
       Name and Credentials (Required)       Date 
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APPENDIX 15: MENTAL HEALTH RESOURCES HANDOUT 
 
 
Mental Health Managed Care Organizations 
 
  
MCO Counties Served Contact Information 
Vaya Health Alexander, Alleghany, Ashe, Avery, 
Buncombe, Caldwell, Cherokee, 
Clay, Graham, Haywood, Henderson, 
Jackson, Macon, Madison, 
McDowell, Mitchell, Polk, 
Rutherford, Swain, Transylvania, 
Watauga, Wilkes, Yancey 
# 828-225-2785 
Crisis # 800-849-6127 
http://vayahealth.com/ 
Cardinal 
Innovations 
Healthcare 
Solutions Office 
Alamance, Cabarrus, Caswell, 
Chatham, Davidson, Davie, Forsyth, 
Franklin, Granville, Halifax, 
Mecklenburg, Orange, Rockingham, 
Person, Rowan, Stanly, Stokes, 
Union, Vance and Warren 
# 704-939-7700 
Crisis # 800-939-5911 
https://www.cardinalinnovations.org/ 
Partners 
Behavioral 
Health 
Management 
Burke, Catawba, Cleveland, Gaston, 
Iredell, Lincoln, Surry, Yadkin 
# 704-884-2501 
Crisis # 888-235-4673 
https://www.partnersbhm.org/ 
Alliance 
Behavioral 
Healthcare  
Cumberland, Durham, Johnston, 
Wake 
# 919-651-8401 
Crisis # 800-510-9132 
https://www.alliancebhc.org/ 
Sandhills Center Anson, Guilford, Harnett, Hoke, Lee, 
Montgomery, Moore, Randolph, 
Richmond 
# 910-673-9111 
Crisis # 800-256-2452 
http://www.sandhillscenter.org/ 
Trillium Health 
Resources 
Brunswick, Carteret, New Hanover, 
Onslow, Pender, Beaufort, Bertie, 
Camden, Chowan, Craven, Currituck, 
Dare, Gates, Hertford, Hyde, Jones, 
Martin, Northampton, Pamlico, 
Pasquotank, Perquimans, Pitt, Tyrrell, 
Washington 
# 866-998-2597 
Crisis # 877-685-2415 
https://www.trilliumhealthresources.org/ 
Eastpointe Bladen, Columbus, Duplin, 
Edgecombe, Greene, Lenoir, Nash, 
Robeson, Sampson, Scotland, Wayne, 
Wilson 
# / Crisis # 800-913-6109 
http://www.eastpointe.net/ 
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APPENDIX 16: PILOT LHD EMAIL 
Dear LHD STD ERRNs, 
  
Hello, my name is Jessica Grimes and I am a Doctor of Nursing Practice (DNP) student at UNC 
Chapel Hill. In fulfillment of my degree, I am conducting a DNP Project; I will be teaching STD 
ERRNs a course on the benefit and need to conduct depression screens in the STD clinic which 
will be eligible for CNE contact hours. I will also be following up with the ERRNs after the 
course to see their progress on conducting depression screens in the STD clinic and to offer 
support/answer any questions. You may remember this summer I sent a survey to the ERRNs 
asking about current depression screen practices that I incorporated into the course so I can make 
my course as successful as it can be. 
  
I am grateful for the opportunity to present you information about depression screening in the 
STD clinic to receive your feedback before I disseminate the course to all ERRNs. Attached to 
this email is the PowerPoint presentation, a PDF of mental health resources, and a PDF of the 
PHQ-2 depression screen. In order to receive CNE contact hours for this course, please take the 
pretest before the course and the posttest after the course. The links to the pretest, course, and 
posttest are below. 
  
  
Pretest: https://unc.az1.qualtrics.com/jfe/form/SV_b4yA2UDzDu0O7at 
Course: https://echo360.org/media/7ec649e1-cf97-4065-b2bd-18f1152f3ede/public 
Posttest: https://unc.az1.qualtrics.com/jfe/form/SV_b2CHfvsjwpoJ0cR 
  
  
Please bring any notes and feedback about the course, pretest, and posttest to our meeting on 
Tuesday, September 19thfrom 11-12 so I can present the best possible information to the rest of 
the ERRNs. Your input is pivotal to the success of this project. As this is a pilot, Dr. Susan Little 
will be creating the CNE certificates after our meeting on the 19th. 
  
Please let me know if you have any questions and I look forward to meeting you soon! 
  
  
Sincerely, 
  
Jessica Grimes, BSN, RN 
DNP Candidate  
University of North Carolina at Chapel Hill 
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APPENDIX 17: PRETEST 
1. Name 
2. Email 
3. How many years have you worked as an STD Enhanced Role RN? 
a. 0-1 years 
b. 1-2 years 
c. 3-4 years 
d. 5 years or greater 
4. How many days per week are STD services available at your agency? 
a. 1-2 days 
b. 3-4 days 
c. 5 days or more 
5. What is the average number of patients/client you assess as an STD Enhanced Role RN 
in the STD clinic per week? 
a. 1-5 clients 
b. 6-10 clients 
c. 11-15 clients 
d. 16-20 clients 
e. 21 clients or more 
6. Do you function in other ERRN or clinic roles? If so, what are those roles? 
a. No 
b. Yes. Please describe. 
7. How often does your agency screen for depression? 
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a. My agency screens all adults for depression regardless of clinic 
b. Depression screening is done in some agency clinics but not in the STD clinics* 
c. My agency screens females for depression in clinics such as prenatal care, 
women’s health, family planning, and/or Breast and Cervical Cancer Control 
Program (BCCCP) but males are not a part of these clinics so males do not get 
screened for depression 
* If choice 7b is selected, the participant will be directed to the following question:  
What agency clinics do screen for depression? Write in your answer. 
8. How often do you screen for depression? Please choose the best answer that reflects your 
personal screening practices. 
a. I personally screen for depression if a patient presents with signs of depression. 
Signs of depression include but are not limited to apathy in regards to treatment of 
STDs, lack of social support, depressed mood, expressing feelings of 
hopelessness, self-care deficit, or changes in behavior, mood, or affect if you see 
this patient on multiple occasions**. 
b. I personally screen all patients for depression regardless of subjective or objective 
signs of depression**. 
c. I personally do not screen for depression in the STD clinic, but screen in women’s 
health and/or prenatal clinics. 
d. I personally do not screen for depression due to my comfort level, lack of mental 
health referral services, and because depression screening is not required on our 
assessment forms***. 
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**If a survey participant selects answer choice 6a or 6b they will be directed to the following 
question: How do you screen for depression? 
a. A verified screening tool. If yes, what is the screening tool? Please write in your 
answer. 
b. I use my own questions I feel are most appropriate for the patient or situation. 
*** If a survey participant selects answer choice 6d they will be directed to the following 
question: Individually check all that apply. I personally do not screen for depression due to: 
a. My comfort level 
b. I believe mental health referral options are limited should a patient screen positive 
on the depression screen 
c. Depression screens are not required on our assessment forms 
d. Other. Please write in your answer.  
9. What are some barriers to depression screening in your STD clinic? 
a. Not enough or limited time 
b. Not recommended or supported in our STD clinic 
c. Comfort level with administering and interpreting depression screens 
d. No adequate referrals to mental health services 
e. I am concerned with what to do if I get a positive result 
f. I am not familiar with the mental health services available  
g. I cannot bill for depression screens in the STD clinic 
h. Other. Please describe.  
10. Are you familiar with the mental health resources available to your patients in your 
community? 
 
 
 
159 
a. Yes 
b. No  
c. Maybe 
11. What are some risk factors STDs/HIV and depression share? Select one or more that 
apply. 
a. Unprotected sex 
b. Sex with multiple partners 
c. Sexual relations with sex workers 
d. Drug and or alcohol use 
e. Sexual compulsivity 
f. Sex for drugs or money 
g. All of the above 
12. What are signs and symptoms of depression? 
a. Anhedonia (inability to feel pleasure in things that were once pleasurable) 
b. Psychomotor agitation (movements that serve no purpose such as pacing around 
the room, tapping your toes, or abruptly starting and stopping tasks) 
c. Feeling tired or having little energy 
d. All of the above 
13. How does the United States Preventative Services Task Force recommend clinicians 
screen for depression? 
a. Screen only adults 
b. Screen adults and adolescents with appropriate systems in place to ensure 
adequate follow up
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c. Screen in mental health clinics only that are more equipped to deal with 
depression 
d. Screen adults only if they show signs and symptoms of depression 
14. The PHQ-2 is 
a. A brief depression screen 
b. Establishes a diagnosis of depression 
c. Uses symptoms from DSM-5 
d. Both A and C 
15. The PHQ-2 asks the following two questions: 
a. Feeling bad about yourself or that you are a failure or have let yourself or your 
family down  
b. Thoughts that you would be better off dead or of hurting yourself in some way 
c. Little interest or pleasure in doing things 
d. Feeling down, depressed, or hopeless 
16. I understand the association between populations at risk for STDs/HIV and depression 
and can apply this concept into my role as an Enhanced Role RN 
a. Strongly agree 
b. Agree 
c. Neither agree nor disagree 
d. Disagree 
e. Strongly disagree 
17. I am comfortable and confident in my ability to screen for depression and refer to mental 
health resources as necessary  
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a. Strongly agree 
b. Agree 
c. Neither agree nor disagree 
d. Disagree 
e. Strongly disagree 
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APPENDIX 18: PILOT POSTTEST 
1. Name 
2. Email 
3. How many years have you worked as an STD Enhanced Role RN? 
a. 0-1 years 
b. 1-2 years 
c. 3-4 years 
d. 5 years or greater 
4. How many days per week are STD services available at your agency? 
a. 1-2 days 
b. 3-4 days 
c. 5 days or more 
5. Are you familiar with the mental health resources available to your patients in your 
community? 
a. Yes 
b. No  
c. Maybe 
6. What are some risk factors STDs/HIV and depression share? Select one or more that 
apply. 
a. Unprotected sex 
b. Sex with multiple partners 
c. Sexual relations with sex workers 
d. Drug and or alcohol use 
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e. Sexual compulsivity 
f. Sex for drugs or money 
g. All of the above 
7. What are signs and symptoms of depression? 
a. Anhedonia (inability to feel pleasure in things that were once pleasurable) 
b. Psychomotor agitation (movements that serve no purpose such as pacing around 
the room, tapping your toes, or abruptly starting and stopping tasks) 
c. Feeling tired or having little energy 
d. All of the above 
8. How does the United States Preventive Services Task Force recommend clinicians screen 
for depression? 
a. Screen only adults 
b. Screen adults and adolescents with appropriate systems in place to ensure 
adequate follow up 
c. Screen in mental health clinics only that are more equipped to deal with 
depression 
d. Screen adults only if they show signs and symptoms of depression 
9. The PHQ-2 is 
a. A brief depression screen 
b. Establishes a diagnosis of depression 
c. Uses symptoms from DSM-5 
d. Both A and C 
10. The PHQ-2 asks the following two questions: 
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a. Feeling bad about yourself or that you are a failure or have let yourself or your 
family down  
b. Thoughts that you would be better off dead or of hurting yourself in some way 
c. Little interest or pleasure in doing things 
d. Feeling down, depressed, or hopeless 
11. I understand the association between populations at risk for STDs/HIV and depression 
and can apply this concept into my role as an Enhanced Role RN 
a. Strongly agree 
b. Agree 
c. Neither agree nor disagree 
d. Disagree 
e. Strongly disagree 
12. I am comfortable and confident in my ability to screen for depression and refer to mental 
health resources as necessary  
a. Strongly agree 
b. Agree 
c. Neither agree nor disagree 
d. Disagree 
e. Strongly disagree 
13. Create a S.M.A.R.T. goal to help you implement depression screens in the STD clinic. 
For example: “I will use the PHQ-2 to screen 60% of patients in the STD Clinic by one 
month."  To make sure your goal is a S.M.A.R.T. goal, please write in how your goal is 
specific, measurable, attainable, relevant, and timely.  
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a. Specific: 
b. Measureable: 
c. Attainable: 
d. Relevant: 
e. Timely: 
f. Your S.M.A.R.T. goal:  
14. Please rate your intention to change your practice as a result of this educational activity 
a. I have no intention to use this information in my practice 
b. I possibly will use this information at some point in the future 
c. I probably will use this information in the near future 
d. I plan to use this information immediately in my practice 
15. I anticipate the following supportive factors in implementing what I learned in my 
workplace. Check all that apply.  
a. Supervisor support 
b. Access to appropriate technology, supplies, and/or equipment 
c. Time to implement 
d. Organizational policy 
e. Timely, constructive, and supportive feedback 
f. Directly related to my job duties 
g. Incentives for good performance 
h. Other. Please specify.  
16. I anticipate the following barriers in implementing what I learned in my workplace. 
Check all that apply. 
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a. Lack of supervisor support 
b. Lack access to appropriate technology, supplies, and/or equipment 
c. Lack of time to implement 
d. Lack of supporting organizational policy 
e. Lack of timely, constructive, and supportive feedback 
f. Not directly related to my job duties 
g. Lack of incentives for good performance 
h. Other. Please specify. 
17. Please provide any comments you have about the training, screening for depression 
during STD visits, using the PHQ-2 in your STD ERRN practice, or any other related 
information you would like for us to know.  Your comments will remain confidential. 
18. Please provide your email address if you are willing to be contacted via email twice over 
the next 4-8 weeks to follow up on your SMART goal progress and to answer any 
questions you may have or provide support. All participants will be entered to win a retail 
gift card.  
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APPENDIX 19: PILOT PHQ-2 HANDOUT 
 
 
Date:  
 
Name:  
 
Patient Health Questionnaire-2  
 
Total Score:                     
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Over the past two 
weeks, how often have 
you been bothered by 
any of the following 
problems? 
 
 
 
 
 
 
Not at All 
 
 
 
 
 
 
Several Days 
 
 
 
 
 
More than Half 
the Days 
 
 
 
 
 
 
Nearly Every Day  
Little interest or 
pleasure in doing 
things 
0 1 2 3 
Feeling down, 
depressed, or hopeless 
0 1 2 3 
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APPENDIX 20: FINAL PHQ-2 HANDOUT 
Name: 
 
Date: 
 
Patient Health Questionnaire-2 
 
Over the last two weeks how often have you been bothered by any of the following problems? 
Please circle your response according to the scale below.  
 
0 = Not at all           1 = Several days           2 = More than half the days           3 = Nearly every 
day 
 
1. Little interest of pleasure in doing things 
 
0 1 2 3 
2. Feeling down, depressed, or hopeless 
 
0 1 2 3 
3. Thoughts that you would be better off dead or of hurting 
yourself in some way 
 
Yes No   
 
For clinicians.  Total score of questions 1 and 2 only:                         
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APPENDIX 21: FINAL REVISED POSTTEST 
1. Name 
2. Email 
3. How many years have you worked as an STD Enhanced Role RN? 
a. 0-1 years 
b. 1-2 years 
c. 3-4 years 
d. 5 years or greater 
4. How many days per week are STD services available at your agency? 
a. 1-2 days 
b. 3-4 days 
c. 5 days or more 
5. Are you familiar with the mental health resources available to your patients in your 
community? 
a. Yes 
b. No  
c. Maybe 
6. What are some risk factors STDs/HIV and depression share? Select one or more that 
apply. 
a. Unprotected sex 
b. Sex with multiple partners 
c. Sexual relations with sex workers 
d. Drug and or alcohol use 
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e. Sexual compulsivity 
f. Sex for drugs or money 
g. All of the above 
7. What are signs and symptoms of depression? 
a. Anhedonia (inability to feel pleasure in things that were once pleasurable) 
b. Psychomotor agitation (movements that serve no purpose such as pacing around 
the room, tapping your toes, or abruptly starting and stopping tasks) 
c. Feeling tired or having little energy 
d. All of the above 
8. How does the United States Preventive Services Task Force recommend clinicians screen 
for depression? 
a. Screen only adults 
b. Screen adults and adolescents with appropriate systems in place to ensure 
adequate follow up 
c. Screen in mental health clinics only that are more equipped to deal with 
depression 
d. Screen adults only if they show signs and symptoms of depression 
9. The PHQ-2 is 
a. A brief depression screen 
b. Establishes a diagnosis of depression 
c. Uses symptoms from DSM-5 
d. Both A and C 
10. The PHQ-2 asks the following two questions: 
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a. Feeling bad about yourself or that you are a failure or have let yourself or your 
family down  
b. Thoughts that you would be better off dead or of hurting yourself in some way 
c. Little interest or pleasure in doing things 
d. Feeling down, depressed, or hopeless 
11. I understand the association between populations at risk for STDs/HIV and depression 
and can apply this concept into my role as an Enhanced Role RN 
a. Strongly agree 
b. Agree 
c. Neither agree nor disagree 
d. Disagree 
e. Strongly disagree 
12. I am comfortable and confident in my ability to screen for depression and refer to mental 
health resources as necessary  
a. Strongly agree 
b. Agree 
c. Neither agree nor disagree 
d. Disagree 
e. Strongly disagree 
13. Create a S.M.A.R.T. goal to help you implement depression screens in the STD clinic. 
For example: “I will use the PHQ-2 to screen 60% of patients in the STD Clinic by one 
month."  To make sure your goal is a S.M.A.R.T. goal, please write in how your goal is 
specific, measurable, attainable, relevant, and timely. This goal does not have to be 
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evaluated using actual client data. You can evaluate your goal based on your personal 
self-report or how well you think you are meeting your goal.  
a. Specific: 
b. Measureable: 
c. Attainable: 
d. Relevant: 
e. Timely: 
f. Your S.M.A.R.T. goal:  
14. Please rate your intention to change your practice as a result of this educational activity 
a. I have no intention to use this information in my practice 
b. I possibly will use this information at some point in the future 
c. I probably will use this information in the near future 
d. I plan to use this information immediately in my practice 
15. I anticipate the following supportive factors in implementing what I learned in my 
workplace. Check all that apply.  
a. Supervisor support 
b. Access to appropriate technology, supplies, and/or equipment 
c. Time to implement 
d. Organizational policy 
e. Timely, constructive and supportive feedback 
f. Directly related to my job duties 
g. Incentives for good performance 
h. Other. Please specify.  
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16. I anticipate the following barriers in implementing what I learned in my workplace. 
Check all that apply. 
a. Lack of supervisor support 
b. Lack access to appropriate technology, supplies, and/or equipment 
c. Lack of time to implement 
d. Lack of supporting organizational policy 
e. Lack of timely, constructive and supportive feedback 
f. Not directly related to my job duties 
g. Lack of incentives for good performance 
h. Other. Please specify. 
17. Please provide any comments you have about the training, screening for depression 
during STD visits, using the PHQ-2 in your STD ERRN practice, or any other related 
information you would like for us to know.  Your comments will remain confidential. 
18. Please provide your email address if you are willing to be contacted via email twice over 
the next 4-8 weeks to follow up on your SMART goal progress and to answer any 
questions you may have or provide support. All participants will be entered to win a $50 
retail gift card. In the follow up, you will be self-evaluating your progress on your goal 
and do not have to obtain real client data about how many patients you screen for 
depression. Your goal will be measured based on your subjective report of how many 
patients you believe you screened for depression. 
 
 
 
 
 
 
174 
REFERENCES 
 
Adams, J. L., Gaynes, B. N., McGuinness, T., Modi, R., Willig, J., & Pence, B. W. (2012). 
 Treating depression within the HIV ‘medical home’: A guided algorithm for 
 antidepressant management by HIV clinicians. AIDS Patient Care & STDs, 26(11), 
 647-654. 
 
American Psychiatric Association. (2013). Diagnostic and statistical manual of mental disorders 
 (5th ed.). Arlington, VA: American Psychiatric Association.  
 
Bandura, A. (1994). Self-efficacy. Encyclopedia of Human Behavior, 4. New York: Academic 
 Press. Retrieved from https://www.uky.edu/~eushe2/Bandura/BanEncy.html 
 
Bess, K. D., Adams, J., Watt, M. H., O’Donnell, J. K., Gaynes, B. N., Thielman, N. M., et al. 
 (2013). Providers’ attitudes towards treating depression and self-reported depression 
 treatment practices in HIV outpatient care. AIDS Patient Care and STDs, 27(3),  171-
 180. 
 
Centers for Disease Control and Prevention. (2017a). Basic statistics. Retrieved from 
 https://www.cdc.gov/hiv/basics/statistics.html 
 
Centers for Disease Control and Prevention. (2014). Depression in the U.S. household 
 population, 2009-2012. Retrieved from 
 https://www.cdc.gov/nchs/data/databriefs/db172.htm 
 
Centers for Disease Control and Prevention. (2016a). HIV/AIDS basic statistics. Retrieved 
 from https://www.cdc.gov/hiv/basics/statistics.html  
 
Centers for Disease Control and Prevention. (2016b). HIV in the United States by  geographic 
 distribution. Retrieved from 
 https://www.cdc.gov/hiv/statistics/overview/geographicdistribution.html 
 
Centers for Disease Control and Prevention. (2016c). National Center for Health Statistics: 
 Depression. Retrieved from http://www.cdc.gov/nchs/fastats/depression.htm 
 
Centers for Disease Control and Prevention. (2017b). National profile. Retrieved from 
 https://www.cdc.gov/std/stats16/natoverview.htm 
 
Centers for Disease Control and Prevention. (2017c). Sexually transmitted diseases: Adolescents 
 and young adults. Retrieved from https://www.cdc.gov/std/life-stages-
 populations/adolescents-youngadults.htm 
 
Centers for Disease Control and Prevention. (2017d). Sexually transmitted disease surveillance 
 2016. Retrieved from https://www.cdc.gov/std/stats16/CDC_2016_STDS_Report-
 for508WebSep21_2017_1644.pdf 
 
 
 
 
175 
Centers for Disease Control and Prevention. (2015). State HIV Prevention Progress Report 
 2010-2013. Retrieved from https://www.cdc.gov/hiv/pdf/policies/progressreports/cdc-
 hiv-stateprogressreport.pdf 
 
Centers for Disease Control and Prevention. (2017d). State ranking tables. Retrieved from 
 https://www.cdc.gov/std/stats16/tables/StateRankingTables.pdf 
 
Centers for Disease Control and Prevention. (2017e). STDs at record high, indicating urgent 
 need for prevention. Retrieved from https://www.cdc.gov/media/releases/2017/p0926-
 std-prevention.html 
 
Centers for Disease Control and Prevention. (2010). The role of STD prevention and treatment in 
 HIV prevention. Retrieved from https://www.cdc.gov/std/hiv/stds-and-hiv-fact-sheet-
 press.pdf 
 
DualDiagnosis.org. (2017). Depression and addiction. Retrieved from 
 http://www.dualdiagnosis.org/depression-and-addiction/ 
 
Faust, C. (2002). Orlando’s deliberative nursing process theory: A practice application in an 
 extended care facility. Journal of Gerontological Nursing, 28(7). 
 
Fendrich, M. Avci, O., Johnson, T., Mackesy-Amiti, M. (2012). Depression, substance abuse and 
 HIV risk in a probability sample of men who have sex with men. Addictive 
 Behaviors, 38. Doi: 10.1016/j.addbeh.2012.09.005 
 
Greenberg, P. Fournier, A. Sisitsky, T., Pike, C., & Kesseler, R. (2015). The economic burden of 
 adults with major depressive disorder in the United States. The Journal of Clinical 
 Psychiatry, 72(2). doi: 10.4088/JCP.14m09298 
 
Hindmarch, T., Hotopf, M., Owen, G. (2013). Depression and decision-making capacity for 
 treatment or research: a systematic review. BMC Medical Ethics, 14(54). doi: 
 10.1186/1472-6939-14-54 
 
Jackson, J. Seth, P., DiClemente, R. & Lin, A. (2015). Association of depressive symptoms and 
 substance use with risky sexual behavior and sexually transmitted infections among 
 African American female adolescents seeking sexual health care. American Journal of 
 Public Health, 105(10). Doi: 10.2105/AJPH.2014.302493 
 
Leykin, Y., Roberts, C., DeRubeis, R. (2011). Decision-making and depressive symptomatology. 
 Cognitive Therapy and Research, 35(4). doi: 10.1007/s10608-010-9308-0 
 
Kolb, D. (1984). Experiential learning; experience as the source of learning and development. 
  Englewood Cliffs, New Jersey: Prentice Hall. Retrieved from 
 https://pdfs.semanticscholar.org/f6ec/20a7a3150822140be7466353d0de572cc4bb.pdf 
 
 
 
 
176 
Kroenke, K., Spitzer, R., Williams, J. (2003). The Patient Health Questtionnare-2: Validity of a 
 two item depression screener. Medical Care, 41(11). Doi: 
 10.1097/01.MLR.0000093487.78664.3C 
 
Kroenke, K., Spitzer, R., Williams, J. (2001). The PHQ-9: Validity of a brief depression severity 
 measure. Journal of General Internal Medicine, 16(9). Doi: 10.1046/j.1525-
 1497.201.016009606.x 
 
Kurt, K., Spritzer, R., Williams, J. (2003) The Patient Health Questionnaire-2: Validity of a two-
 item depression screener, 41(11). Retrieved from http://journals.lww.com/lww-
 medicalcare/Abstract/2003/11000/The_Patient_Health_Questionnaire_2__Validity_of_a.
 8.aspx 
 
Mezirow, J. (1997). Transformative learning: Theory to practice. New Directions for Adult and 
 Continuing Education, 74. Doi: 10.1002/ace.7401 
 
National Alliance on Mental Illness. (2017). African American Mental Health. Retrieved from 
 https://www.nami.org/Find-Support/Diverse-Communities/African-Americans 
 
National Alliance on Mental Illness. (2017). Depression. Retrieved from 
 http://www.nami.org/Learn-More/Mental-Health-Conditions/Depression 
 
North Carolina Communicable Disease Branch. (2017). Communicable Disease Branch 
 Technical Assistance and Training Program nurse consultants serving local health 
 departments. Retrieved from 
 http://epi.publichealth.nc.gov/cd/lhds/manuals/cd/tat/TATPMap.pdf 
 
North Carolina Department of Health and Human Services. (2017). 2016 North Carolina 
 HIV/STD/Hepatitis Surveillance Report. Retrieved from 
 http://epi.publichealth.nc.gov/cd/stds/figures/std16rpt_rev3.pdf 
 
North Carolina Department of Health and Human Services. (2016). 2015 North Carolina 
 HIV/STD Surveillance Report. Retrieved from 
 http://epi.publichealth.nc.gov/cd/stds/annualrpts.html 
 
North Carolina Department of Health and Human Services. Form 2808. Retrieved from 
 http://epi.publichealth.nc.gov/cd/lhds/manuals/std/clinical/DHHS-2808-
 SexuallyTransmittedDiseases.pdf 
 
Office of Disease Prevention and Health Promotion. (2017). Sexually transmitted diseases. 
 Retrieved from https://www.healthypeople.gov/2020/topics-objectives/topic/sexually-
 transmitted-diseases 
 
Parsons, J., Grov, C., & Golub, S. (2012). Sexual compulsivity, co-occurring psychosocial health 
 problems, and HIV risk among gay and bisexual men: further evidence of a 
 syndemic. American Journal of Public Health, 102(1). Doi: 10.2105/AJPH.2011.300284 
 
 
 
177 
 
Pharmaceutical Physician. (2014). Journal of the British Association of Pharmaceutical 
 Physicians, 24(6). Retrieved from  
 http://www.gaea.myzen.co.uk/downloads/PP2406sml.pdf#page=18 
 
Remmers, C., Topolinski, S., Dietrich, D., Michalak, J. (2015). Impaired intuition in patients 
 with major depressive disorder. British Psychological Society, 54(2). doi: 
 10.1111/bjc.12069 
 
Rogers, M., Lemstra, M., Moraros, J. (2015). Risk indicators of depressed mood among sex-
 trade workers and implications for HIV risk behavior. Canadian Journal of 
 Psychiatry, 60(12). Doi: 10.1177/070674371506001205 
 
Sanders, R. (2013). Adolescent psychosocial, social, and cognitive development. American 
 Academy of Pediatrics, 34(8), doi: 10.1542/pir.34-8-354 
 
Scottish Government. Delivering for health: Using self-help in primary care and community 
 based everyday service delivery for mild to moderate psychological problems. Retrieved 
 from http://www.gov.scot/Publications/2007/01/09114002/12 
 
Sin, N. & DiMatteo, R. (2014). Depression treatment enhances adherence to antiretroviral 
 therapy: a meta-analysis. The Society of Behavioral Medicine, 4. Doi: 10.1007/s12160-
 013-9559-6. 
 
Storholm, E., Satre, D., Kapadia, F., & Halkitis, P. (2015). Depression, compulsive sexual 
  behavior, and sexual risk-taking among urban young gay and bisexual men: The P18 
  Cohort Study. Archives of Sexual Behavior, 45. Doi: 10.1007/s10508-015-0566-5 
 
Thibault, J., Steiner, P. (2004). Efficient identification of adults with depression and dementia. 
 American Family Physician, 70(6). Retrieved from 
 http://www.aafp.org/afp/2004/0915/p1101.html 
 
Tross, S., Feaster, D., Thorens, G., Duan, R., Gomez, Z., Pavlicova, M., Hu, M., Kyle, T., 
 Erickson, S., Spector, A., Haynes, L., Metsch, L. (2015). Substance abuse, depression, 
  and sociodemographic determinants of HIV sexual risk behavior in outpatient  
  substance abuse treatment programs. Journal of Addiction Medicine, 8(6). Doi: 
 10.1097/ADM.0000000000000162 
 
U.S. Department of Health and Human Services. (2017). Who is at risk for HIV? Retrieved 
 from https://www.hiv.gov/hiv-basics/overview/about-hiv-and-aids/who-is-at-risk-for-hiv 
 
U.S. Preventive Services Task Force. (2016). Final recommendation statement: depression in 
 adults: screening. Retrieved from https://www.uspreventiveservicestaskforce.org/ 
 Page/Document/RecommendationStatementFinal/depression-in-adults-screening1 
 
 
 
 
178 
U.S. Preventive Services Task Force. (1999). Patient Health Questionnaire (PHQ-9). Retrieved 
 from https://www.uspreventiveservicestaskforce.org/Home/GetFileByID/218 
 
Wilson, P., Stadler, G., Boone, M., Bolger, N. (2014). Fluctuations in depression and well-being 
 are associated with sexual risk episodes among HIV-positive men. American 
 Psychological Association, 33(7). Doi: 10.1037/a0035405 
 
World Health Organization. (2012). Depression: A global crisis. Retrieved from 
 http://www.who.int/mental_health/management/depression/wfmh_paper_depression_wm
 hd_2012.pdf 
 
 
